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Abstract 
 
 Chapter 1: Development of Efficient and Kinetically E-Selective Cross-Metathesis 
to Generate Alkenyl Halides 
We have devised a broadly applicable strategy to achieve kinetically E-selective cross-
metathesis to generate a valuable set of E-alkenyl chlorides and fluorides in high 
efficiency. Synthetic utility was demonstrated through several concise syntheses of E-
alkenyl chloride and fluoride precursors to biologically active molecules. The design 
principles delineated in this study are expected to initiate a wider range of efficient and 
kinetically controlled E-selective olefin metathesis processes where there is a diminished 
preference for the E isomer such as macrocyclic ring-closing metathesis. 
 Chapter 2: Development of Efficient and Kinetically E-Selective Macrocyclic Ring-
Closing Metathesis 
We devised a strategy to achieve high E selectivity in ring-closing metathesis to afford 
E-macrocyclic alkenes of various ring sizes regardless of the associated thermodynamic 
preferences.  The key findings revealed that E-alkenylB(pin), widely recognized for its 
broad use in catalytic cross-coupling chemistry, possesses the appropriate steric and 
 
 
electronic attributes to serve as a suitable cross-partner in ring-closing metathesis with 
Mo alkylidenes. Synthetic utility was demonstrated through ring-closing metathesis at a 
late stage of a multi-step route. The investigation described herein offers a practical 
solution to a compelling problem in olefin metathesis, further elevating the utility of this 
widely used transformation. 
 Chapter 3: Stereoselective Synthesis of E- and Z-Trisubstituted Alkenes by 
Combining Stereoretentive Catalytic Cross-Metathesis and Catalytic Cross-
Coupling 
We introduced a general solution to a longstanding and compelling problem in olefin 
metathesis: a broadly applicable strategy for reliable and efficient synthesis of acyclic E- 
and Z-trisubstituted alkenyl halides. Complications resulted from formation of an 
unstable methylidene species or less reactive disubstituted alkylidene complexes can be 
addressed by utilizing a stereo-defined E- or Z-trisubstituted alkene and a 1,2-
disubstituted olefin as substrates. By merging two central catalytic transformations in 
organic synthesis, cross-coupling and CM, various E- or Z-trisubstituted alkenyl chloride 
and bromides were readily accessed by the same catalytic system without the need for 
directing groups. The synthetic utility of the present protocol was demonstrated through 
several concise and efficient synthesis of biologically active natural products/synthetic 
precursors. Notably, the E- or Z-trisubstituted alkenyl halides prepared by CM may be 
readily converted to other trisubstituted olefins with complete retention of stereochemical 
purity by means of a second cross-coupling reaction. Based on the new findings, we 
revisited previously unaddressed problems and establish that readily available isoprenoid 
alkenes can serve as suitable surrogate for unhindered terminal alkenes in CM. 
 
 
 Chapter 4: In situ Protection/Deprotection for Catalytic Olefin Metathesis in the 
Presence of Polar Protic Functional Groups 
We demonstrated that protic groups such as alcohols and carboxylic acids that are 
problematic with high-oxidation-state alkylidenes could be effectively masked in situ 
prior to CM reactions by an appropriate borane reagent. Commercial sample of alkenes 
that are usually contaminated with protic impurities could be ‘purified’ in situ by sub-
stoichiometric amount of pinacolborane. Deprotection of the in situ boron-based 
protecting group proceeded under mild conditions and could be performed in the same 
vessel. The one-pot protection/cross-metathesis/deprotection of alcohol and carboxylic 
acid-containing alkenes described herein is likely to have an impact on the diversity of 
organic molecules that can be prepared in a laboratory setting. 
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Chapter One 
Development of Efficient and Kinetically E-Selective 
Cross-Metathesis to Generate Alkenyl Halides 
1.1. Introduction 
Olefin metathesis (OM) is a powerful chemical transformation that allows rapid 
construction of C=C bonds from readily available and stable alkene starting materials.1,2 
Since the first report of kinetically Z-selective cross-metathesis (CM) from our group in 
2009,3 several classes of complexes4,5,6 were developed to promote efficient and Z-selective 
OM.  As illustrated in Scheme 1.1.1, a common design principle utilized by these catalyst 
scaffolds to achieve high Z selectivity relies on the size differentiation of the two ligands 
occupying the axial positions of trigonal-bipyramidal metallacyclobutane (mcb) 
intermediates (1.1cis and 1.1trans, Scheme 1.1.1), thus the substituents on the metallacycle 
are positioned away from the larger ligand (i.e., aryloxide in 1.2, mesityl ring in the NHC 
ligand of 1.3 and 1.4, and the sizable thiophenolate in 1.5) in order to avoid penalizing 
steric repulsion. Despite these notable advances in Z-selective CM, the corresponding E-
selective transformation through which E-alkenes could be synthesized stereoselectively 
remained underdeveloped. Although trans-selective CM involving Ru-catechothiolate 
                                                 
(1) Hoveyda, A. H.; Zhugralin, A. R. Nature 2007, 450, 243–251. 
(2) Grubbs, R. H.; Wenzel, A. G.; O’Leary, D. J.; Khosravi, E. Eds., Handbook of Metathesis (Wiley, 2014). 
(3) Meek, S. J.; O'Brien, R. V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 471, 461–466. 
(4) Endo, K.; Grubbs, R. H. J. Am. Chem. Soc. 2011, 133, 8525–8527. 
(5) Occhipinti, G.; Hansen, F. R.;  Törnroos, K. W.;  Jensen, V. R. J. Am. Chem. Soc. 2013, 135, 3331–3334.  
(6) Khan, R. K. M.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2013, 135, 10258–10261. 
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complex7 was reported in early 2016, the thermodynamically preferred E isomers of 
unfunctionalized 1,2-disubstituted aliphatic alkenes were obtained in low yield8 (≤25% 
isolated yield). Although E alkenes are generally lower in energy compared to the Z 
isomers and thus generated preferentially in most cases, methods to prepare them in an 
efficient and highly stereoselective manner are much needed for several reasons: The 
 
                                                 
(7) Koh, M.-J.; Khan, R. K. M.; Torker, S.; Yu, M.; Mikus, M. S.; Hoveyda, A. H. Nature 2015, 517, 181–
186. 
(8) Johns, A. M.; Ahmed, T. S.; Jackson, B. W.; Grubbs, R. H.; Pederson, R. L. Org. Lett. 2016, 18, 772–
775. 
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energy difference between alkene isomers is usually insufficient (ca. 1 kcal/mol favoring 
E isomers in 1,2-disubstituted aliphatic alkenes due to less steric repulsion between the 
vicinal substituents, Scheme 1.1.2) to promote high E selectivity without catalyst control; 
E isomers are not always thermodynamically preferred; Separation of a mixture of E and 
Z alkene more often than not requires specialized procedure (e.g. AgNO3-impregnated 
silica gel)9 or an additional step to  consume the Z isomer selectively.10  The most relevant 
example involves acyclic alkenyl halides where the Z isomers are preferred11 because of  
 
hyperconjugation of the σC-H orbital to the low-lying σ*C-halogen orbital and Coulombic 
attraction between the partially positive alkyl group and electron-rich fluorine (1.6) or a 
significant dispersion interaction between methyl and the polarizable chlorine atom (1.7, 
Scheme 1.1.2). E-1,2-disubstituted alkenyl chlorides are important building blocks for 
                                                 
(9) Zhang, H.; Yu, E. C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 16493–
16496. 
(10) Marinescu, S. C.;  Levine, D. S.; Zhao, Y.; Schrock, R. R.;  Hoveyda, A. H. J. Am. Chem. Soc. 2011, 
133, 11512–11514. 
(11) Wiberg, K. B.; Wang, Y. G.; Peterson, G. A.; Bailey, W. F. J. Chem. Theory Comput. 2009, 5, 1033–
1037. 
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catalytic cross-coupling reactions, one of the most influential transformations in modern 
synthetic chemistry.12 These isomer are commonly found in biologically active natural 
products;13 two examples are the anti-tumor kimbeamide A14 and anti-inflammatory 
pitinoic acid B15 (Scheme 1.1.3). E-Alkenyl fluorides represent a valuable set of 
organofluorine compounds that receive increasing attention in medicine16 and 
agrochemicals17. An example of a biologically active fluoro-alkene related to the 
deoxyribose derivative E-1.8 and Z-1.8 in Scheme 1.1.3 was presented where the activity 
was most likely derived from the alkenyl fluoride moiety18. However, a mixture of E and 
Z isomers was evaluated for activity due to difficulties in accessing either 
stereoisomerically pure alkenyl fluoride as well as isolation of each isomer by conventional 
 
                                                 
(12) Johansson-Seechurn, C. C. C.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Angew. Chem. Int. Ed. 2010, 
51, 5062–5085. 
(13) Chung, W. J.; Vanderwal, C. D. Angew. Chem. Int. Ed. 2016, 55, 4396–4434. 
(14) Nunnery J. K. et al. J. Org. Chem. 2012, 77, 4198–4208. 
(15) Montaser, R.; Paul, V.J.; Luesch, H. Org. Lett. 2013, 15, 4050–4053. 
(16) Müller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881–1886. 
(17) Fujiwara, T.; O’Hagan, D. J. Fluor. Chem. 2014, 167, 16–29. 
(18) Wnuk, S. F. et al. Bioorg. Med. Chem. 2008, 16, 5090–5102. 
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purification methods. E-1,2-Disubstituted alkenyl chlorides can be prepared by a number 
of methods (Scheme 1.1.4). Aldehydes may be transformed into E-alkenyl chlorides with 
chloroform and excess chromium(II) chloride.19 E-Alkenylboronic acids prepared from 
terminal alkynes by a two-step procedure (such as hydroboration followed by hydrolysis) 
can be converted in the third step to E-alkenyl chlorides through stereoretentive 
chlorodeboronation with N-chlorosuccinimide.20 Alternatively, a similar sequence 
involves reacting E-alkenyl trifluoroborate salts (obtained from treating the hydroboration 
product of terminal alkynes with excess KHF2) with trichloroisocyanuric acid.21 A handful 
of procedures furnish E-alkenyl fluorides from aldehydes22, 23  and terminal alkynes24, 25  
 
                                                 
(19) Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986, 108, 7408–7410. 
(20) Petasis, N. A.; Zavialov, I. A. Tetrahedron Lett. 1996, 37, 567–570. 
(21) Molander, G. A.; Cavalcanti, L. N. J. Org. Chem. 2011, 76, 7195–7203. 
(22) Zhu, L.; Ni, C.-F.; Zhao, Y.-C.; Hu, J.-H. Tetrahedron 2010, 66, 5089–5100. 
(23) Surya Prakash, G. K.; Shakhmin, A.; Zibinsky, M.; Ledneczki, I.; Chacko, S.; Olah,  G. A. J. Fluor. 
Chem. 2010, 131, 1192–1197. 
(24) Furuya, T.; Ritter, T. Org. Lett. 2009, 11, 2860–2863. 
(25) Lee, S. H.; Schwartz, J. J. Am. Chem. Soc. 1986, 108, 2445–2447. 
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(Scheme 1.1.5). Most of the reported methods is non-catalytic and several protocols require 
strongly basic conditions (e.g. tert-butyl lithium25 or LiHMDS),22 and/or toxic reagent 
(HMPA,22 CrCl2).21 In another report, stereoisomerically pure E-2-fluorovinyl tosylate 
1.26 had to be prepared in three steps before it was subjected to Suzuki cross coupling.26 
A catalytic CM protocol that converts robust, abundant, and less costly alkenes (compared 
to alkynes and aldehydes) to E-alkenyl chlorides and fluorides efficiently and in high 
stereoselectivity would not only provide a complementary retrosynthetic disconnection 
F
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(26) Zhang, H.; Zhou, C.-B.; Chen, Q.-Y.; Xiao, J.-C.; Hong, R. Org. Lett. 2011, 13, 560–563. 
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to existing methods but also represent a significant advance in the field of OM where 
kinetic control of E selectivity is relevant and especially desirable. 
1.2. Design Principles for Kinetically E-Selective Cross-Metathesis 
CM reactions that involve halogenated alkenes are scarce and existing reports show 
that Ru-based complexes tend to form halo-substituted carbene intermediates that exhibit 
low activity.27, 28 We recently demonstrated that monoaryloxide pyrrolide (MAP) complex 
Mo-129 (Scheme 1.2.1) possesses distinct electronic attributes to promote efficient CM  
 
                                                 
(27) Macnaughtan, M. L.; Gary, J. B.; Gerlach, D. L.; Johnson, M. J. A.; Kampf, J. W. Organometallics 
2009, 28, 2880–2887. 
(28) For decomposition pathways of chloro-carbene generated from Grubbs-second generation catalyst, see: 
Macnaughtan, M. L.; Johnson, M. J. A.; Kampf, J. W. J. Am. Chem. Soc. 2007, 129, 7708–7709. 
(29) Koh, M.-J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; Hoveyda, A. H. Nature 2016, 531, 459–465. 
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with Z-1,2-dihaloalkenes (CM with terminal halo-alkene cross-partner such as vinyl 
chloride was inefficient and less Z-selective). Design of the E-selective variant, however, 
poses several challenges. Not only was there no strategy for kinetically controlled E-
selective CM but the E- alkenyl halide products obtained in such processes would be the 
higher energy isomers as illustrated in Scheme 1.1.2. E- alkenyl halides are likely to 
undergo post-metathesis isomerization that could lead to erosion of kinetic selectivity. In 
contemplating a strategy to achieve E selectivity, we revisited the stereochemical model 
for Z-selective CM of alkenyl halides29 and realized an overlooked principle. Reactions 
that occur through reactive intermediate 1.30 (Scheme 1.2.1), although more favored than 
1.31 due to two severe steric repulsions between the large aryloxide ligand and two chlorine 
atoms in the latter, are not without penalty. Eclipsing interaction in 1.30 is inevitable and 
can at times render such intermediate energetically inaccessible. In fact, CM of sterically 
demanding aryl olefins such as 1.32 with Z-1,2-dichloroethene 1.28 was unsucceful (<5% 
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conv. to desired product, only trans-4-methoxystilbene was observed) likely due to the 
elevated repulsion between C-Aryl and two C-Cl bonds in 1.35 (Scheme 1.2.2). Contrary 
to transformation with 1.28, CM with Z-1-bromo-2-fluoroethene 1.33  (coomercially 
available and used without further purification) proceeded readily and regioselectively to 
furnish Z--fluorostyrene 1.34 in 93:7 F:Br and 71% isolated yield. The drastic differences 
in reaction efficiency as well as the observed selectivity for formation of alkenyl fluoride 
1.34 suggested that the lower steric repulsion in 1.35 was most likely derived from the 
smaller size of fluorine. If it is true that minimization of eclipsing strain lowers the energy 
barrier leading to the formation of such an intermediate, the question then became whether 
CM with commercially available pure E-1,2-dichloroethene 1.37 would proceed through  
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intermediate 1.39 more preferentially than intermediate 1.40 (Scheme 1.2.3).30 In 1.39, 
eclipsing interaction between C-G and C-H (not explicitly drawn) in a planar 
molybdacyclobutane31 would be less severe compared to that between C-G and C-Cl in 
1.40. The latter would be further destabilized because of the steric repulsion caused by 
placing C-Cl (circled and shaded in 1.40) close to the peripheral ring of the aryloxide 
ligand although C-Cl in 1.39 would  be similarly situated in close proximity to the ethyl 
groups (circled and shaded in 1.39). 32 Nevertheless, breakage of 1.40 would lead to a 
higher energy alkylidene species 1.41anti.33 Overall, we were convinced that formation of 
E-alkenyl chloride product should be preferred but it  was unclear to what extent 1.39 
would be more favored than 1.40 and how high E selectivity would be. Mindful of the 
existence of an X-Ray crystal structure of an unsubstituted metallacyclobutane (mcb),31 we 
noticed that the Mo-C distance is 2.33 Å, boxed structure in Scheme 1.2.3), which might 
translate to less steric repulsion between C-Cl and the aryloxide ligand in 1.39 compared 
to C-Cl in 1.40. 
1.3. Identification of an Optimal Aryloxide Ligand for E-Selective CM 
The above reasoning implied that an entirely new catalyst scaffold might not be 
needed to achieve high E selectivity and that stereoselectivity might be improved simply 
by reducing the size of the aryloxide ligand in Mo-1. We set out to validate our hypothesis 
                                                 
(30) This hypothesis is based on the assumption that mcb formation is the rate-limiting step. In CM of 1.28, 
formation of VII is likely the rate-limiting step as suggested by DFT calculation: Koh, M.-J.; Nguyen, T. T.; 
Lam, J. K.; Hyvl, J.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. Nature 2017, 542, 80–85. 
(31) Unsubstituted mcb exhibits a planar conformation instead of puckered, for X-ray structure of such 
species, see: Marinescu, S. C.; Schrock, R. R.; Müller, P.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 
10840–10841. 
(32) As suggested by the lowest energy conformation of a DFT-generated stereochemical model 
(33) Schrock, R. R.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4592−4633. 
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by performing CM using commercially available and easy-to-dispense E-1,2-
dichloroethene 1.37 with allylic-branched olefin 1.42. Near complete consumption of 1.42 
was observed in 2 hours with 5.0 mol % of Mo-1. The desired alkenyl chloride product 
1.43 was isolated in 70% yield as a 80:20 mixture in favor of the thermodynamically less 
favored E isomer (Scheme 1.1.2). It is worth mentioning that isomerization of 1.37 was not 
detected by 1H NMR analysis of the unpurified product mixture. Therefore, the undesired 
Z isomer was most likely generated from the competitive formation of mcb 1.40. As 
mentioned earlier, E selectivity can be improved by modifying the aryloxide ligand to 
adjust the steric pressure exerted onto mcb 1.39. Indeed, the same catalyst loading of Mo-
2, whose peripheral rings of the aryloxide ligand contain no substituent led to significantly 
higher E selectivity (91:9 E:Z compared to 80:20 E:Z with Mo-1) although efficiency was  
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lower (41% versus 72% yield with Mo-1). We attributed the observed results with Mo-2 
to the smaller size of the aryloxide ligand. Steric repulsion between C-Cl and the aryloxide 
should be alleviated but the smaller ligand around the metal center could lead to 
decomposition through bimolecular reduction of Mo-alkylidenes.33 To promote high E 
selectivity without compromising efficiency, we evaluated a number of complexes whose 
aryloxide ligands are larger than that in Mo-2. For instance, the sterically more encumbered 
complexes Mo-3-6 all delivered appreciable efficiency (70−95% conv. to 1.43) in about 
90% E selectivity. Optimal yield of 1.43 (93%) and further improvement in E selectivity 
(93:7 vs. 89:11 E:Z with 5.0 equiv. 1.37) was achieved with 20 equivalents of 1.37; a larger 
amount of cross-partner presumably suppressed the non-stereoselective side reaction 
between 1.42 and vinyl chloride29 generated from the reaction (excess 1.37 was easily 
removed under reduced pressure). It merits mentioning that complete consumption of 1.42 
was achieved with Mo-6 in just 5 min (vs. 92% conv. with Mo-1 in 2 hours). The 
considerably improved efficiency delivered by Mo-6 further substantiated our proposed 
stereochemical model where productive CM proceeds preferentially through the lower 
energy mcb 1.39, which rendered reaction with 1.37 much more facile. 
1.4. Kinetically Controlled E-Selective CM to Access E-Alkenyl Chlorides 
At the outset of this study, we chose to first explore the CM of aryl olefins as this 
class of substrates presents several challenges: Aryl olefins, unlike their allylicbranched 
aliphatic counterparts, tend to undergo facile self-metathesis with Mo-alkylidene and the 
trans-stilbenes formed are generally unreactive,34 thus reducing the overall CM efficiency; 
The only report related to Ru-carbene-catalyzed CM of 4-methoxystyrene with 1.37 
                                                 
(34) Crowe, W. E.; Zhang, Z. J. J. Am. Chem. Soc. 1993, 115, 1099810999. 
Page 13 
required forcing conditions35 (100 equiv. 1.37, 50 oC for 20 hours) to afford mostly Z--
chlorostyrene product (~83:17 Z:E). 
An array of E-alkenyl chlorides was accessed from readily available aryl olefins.  
CM of various aryl and heteroaryl olefins was typically promoted by 3.0−5.0 mol% of Mo-
6 in four hours or less to afford products in 54% to 85% yield at room temperature (see the 
Experimental Section for details). Notably, the E alkene isomer was exclusively observed 
in all cases.  The discrepancies between conversion of starting alkenes and isolated yield  
 
                                                 
(35) Sashuk, V.; Samojłowicz, C.; Szadkowska, A.; Grela, K. Chem. Commun. 2008, 0, 2468−2470. 
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of products is largely due to the formation of trans-stilbene homocoupling byproducts. It 
is worth mentioning that product 1.12 can be accessed from trans-stilbene which had been 
shown to be unreactive towards CM promoted by Mo-alkylidene.34 Heteroaromatic 
moieties such as benzofuran 1.52, benzothiophene 1.53, as well as unprotected indole 1.54 
are tolerated. Aryl halides 1.45, 1.47, and arylboronate 1.50 are noteworthy because their 
preparation through cross-coupling could be complicated by chemoselectivity issues.36, 37 
Challenges:
1. Competitive unselective homocoupling of terminal olefins
2. Isomerization of E-alkene asubstrates faster than cross-metathesis
3. Post-metathesis isomerization to lower energy Z isomers more likely
Scheme 1.4.2. Difficulties with CM of Unhindered Terminal Olefins
1.56
79% yield, 74:26 E:Z
1.37
10 equiv
benzene, 22 ºC, 15 min
5.0 mol% Mo-6
Cl
Cl
Br
Cl
Br
Br
Br Br Br
n-oct
10 equiv 1.37
benzene, 22 ºC, 4 h
5.0 mol% Mo-6
1.59
>98% yield, 70:30 E:Z
CO2Me
1.58
pure E
n-oct
1.60
84% yield, 72:28 E:Z
Cl
1.55
Cl
CO2Me
ClG
Cl
ClG
Readily available in pure E form
Sufficiently large to minimize homocoupling
Small enough to allow CM to proceed
Possible Solution: E- -alkylstyrenes as substrates
E-1.57 Z-1.57
 
                                                 
(36) Billingsley, K. L.; Buchwald, S. L. J. Org. Chem. 2008, 73, 5589–5591. 
(37) Barluenga, J.; Moriel, P.; Aznar, P.; Valdés, C. Adv. Synth. Catal. 2006, 348, 347–353. 
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Despite the encouraging E selectivity obtained with aryl or allylic-branched olefins, 
preparation of sterically unhindered E-alkenyl chloride such as 1.43 presented another 
complication (Scheme 1.4.2). CM of sterically unhindered 8-bromo-1-octene 1.55 was 
efficient, although E selectivity was lower than what was observed with more sterically 
demanding substrates (70:30 versus ~90:10 to >98:2 E:Z, Scheme 1.3.1 and Scheme1.4.1). 
Competitive self-metathesis of the starting alkene followed by isomerization of the 
homocoupling product could lead to a mixture of E- and Z-1.57, which then reacts with 
1.37 to afford an isomeric mixture of products. In addition, less hindered E-alkenyl chloride 
products could be more susceptible to post-metathesis isomerization. The former 
possibility could be probed experimentally, CM of pure trans-methyl oleate 1.58 under 
otherwise identical conditions afforded products 1.59 and 1.60 with similar level of 
selectivity (~70:30 E:Z), which suggested that facile homocoupling/isomerization pathway 
is likely responsible for the diminished E selectivity.  
This finding also confirmed that Mo-alkylidene derived from Mo-6 is able to 
catalyze efficient CM between E-1,2-disubstituted alkenes such as E-1.58 or trans-stilbene 
as previously mentioned (cf. 1.12, Scheme 1.4.1). Such high activity of complex Mo-6 
implied that we might be able to use trans-alkenes as ‘masked’ terminal olefin substrates 
in what would be equivalent to a catalytic and stereoretentive substituent exchange (grey 
box, Scheme 1.4.2). The ideal substituent should be easily accessible in pure E form; it 
should be large enough to minimize self-metathesis but sufficiently small so as not to 
inhibit CM with 1.28. We selected E--alkylstyrene for several reasons: Isomerization of 
the double bond during CM can be obviated due to thermodynamic preference for the E-
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isomer; this is evidenced by numerous reports on CM of styrenes and aliphatic olefins.38 
This class of substrates, like other trans-1,2-disubstituted alkenes, tends to undergo self-
metathesis at comparatively slower rates (vs. terminal olefins) so that CM can compete 
more efficiently; The trans-styrenyl moiety is robust and can be prepared by various 
methods as showcased in Scheme 1.4.3. The first example relates to the formal synthesis 
of pitinoic acid B, an anti- inflammatory agent. The substrate for CM was synthesized in 
one step as reported39 starting from enantiomerically pure and commercially available alkyl 
 
                                                 
(38) Chatterjee, A. K. Olefin Cross-Metathesis. In Handbook of Metathesis; Grubbs, R. H., Ed; Wiley-VCH, 
Weinheim, Germany, 2003; pp 246−292. 
(39) Molander, G. A.; Argintaru, O. A. Org. Lett. 2014, 16, 19041907. 
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chloride 1.61 and trifluoroborate 1.13. Catalytic cross-coupling followed by catalytic 
cross-metathesis rapidly constructed E-alkenyl chloride 1.50, which has been previously 
transformed to pitinoic acid B.15 Another case involves the preparation of the amine 
fragment in kimbeamide A from commercially available propargylic alcohol 1.64 and 
carboxylic acid 1.65. Partial hydrogenation of 1.68, followed by Mitsunobu reaction 
installed the required E--alkyl styrene in 1.69 that also contains a Z-alkene moiety. 
Subsequent treatment with 3.0 mol% of Mo-6 and 1.37 afforded alkenyl chloride 1.70 in 
95% yield and >98% Z selectivity. Here, the Z-alkene allylic to the phthalimide group was 
left untouched, highlighting the exceptional chemoselectivity of the CM reaction. Other 
than facilitating the synthesis of biologically active compounds, the CM approach allows 
for efficient conversion of E--substituted styrene moiety found in pharmaceutical 
products to E-alkenyl chloride, which can then be coupled with catalytic cross-coupling to 
access various heteroaromatic derivatives. In this context, we were able to convert 0.74 
gram of cinnarizine, an anti-convulsant agent, to E-alkenyl chloride 1.71 in 94% yield and 
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with >98% E selectivity (Scheme 1.4.4). Importantly, 5.0 mol% of Mo-6 was delivered in 
the form of air- and moisture-resistant paraffin pellet (~5 wt% in paraffin). To ensure 
complete release of Mo-MAP complex, the reaction mixture was conducted at 50 oC in 
toluene under a nitrogen atmosphere. After 4 hours, the product mixture can be purified by 
standard silica gel chromatography. The newly developed Mo-paraffin pellets allow CM 
to be conveniently performed outside of a glovebox without any loss of reaction efficiency. 
Compound 1.71 represents an interesting entry to various analogs of anti-convulsant 
cinnarizine, which cannot be synthesized by direct CM with aryl olefins; the three 
examples shown above (1.72-1.74, Scheme 1.4.4) obtained by catalytic cross-coupling 
with commercially available aryl boronic acid or pinacol esters, are illustrative. 
1.5. Kinetically Controlled E-Selective CM to Access E-Alkenyl Fluorides  
The strategy developed for E-selective CM with 1.37 is not readily applicable to 
the E-alkenyl fluoride variant because of cost and practicality issues: E-1,2-difluoroethene 
1.75 (Scheme 1.5.1) is prohibitively expensive and difficult to handle (boiling point, −42 
oC). We selected the commercially available E-1-chloro-2- fluoroethene 1.76, a less costly 
and easier-to-handle fluoroalkene, as an alternative vinyl fluoride transfer agent. Although 
volatile (boiling point, −4 oC), 1.76 can be conveniently dispensed at ambient temperature 
and pressure as a solution in toluene. The question was whether transformation with 1.76 
would be E- and selective for the alkenyl fluoride as CM can proceed via four different 
intermediates (1.77-1.80) of which only 1.77 would produce the desired E-fluoroalkene 
isomer. In light of the principles discussed in Scheme 1.2.3, we reasoned that metallacycles 
1.77 and 1.79 (leading to E-alkenyl fluoride and chloride products, respectively) would be 
more favored than 1.78 and 1.80 as the latter two intermediates would be destabilized by 
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eclipsing interaction as well as unfavorable repulsion between C-halogen and the 
aryloxide ligand. Indeed, CM of vinyl indole 1.81 with 10 equiv. of 1.76 afforded pure E-
fluoride 1.82 and E-chloride 1.83 in 77:23 ratio favoring the fluoroalkene (Scheme 1.5.2). 
The preference for fluoroalkene 1.82 is likely derived from an electronic match40 between  
 
the Mo-alkylidene (electron-rich at carbon) and the polarized C=C bond of 1.76 [as 
suggested by the 1H NMR chemical shifts of the alkenyl protons (boxed structure, Scheme 
1.5.1)]. Both alkene products were generated in >98% E selectivity, thus indicating that 
CM was channeled through 1.77 and 1.79 and that reaction via 1.79 is most likely the major 
pathway contributing to formation of E-chloroalkene 1.83. If that is the case, the fluoro- to 
chloroalkene ratio would improve with the original MAP complex Mo-1. We reasoned that 
                                                 
(40) For discussion on how the electronic match between an incoming alkene and Mo-alkylidene can 
influence CM efficiency as well as regioselectivity of alkene products, see reference 24 and reference 29. 
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the steric repulsion between C-F and the aryloxide ligand in 1.77 would be less affected 
than the corresponding interaction in 1.79 because of the smaller size of fluorine as well as 
shorter C-F bond length (~1.35 Å vs. ~1.77 Å for C-Cl bond). Indeed, under otherwise 
identical conditions with Mo-1, CM of 1.81 reached completion after 2 hours at ambient 
temperature, generating 1.82 in improved selectivity (89% fluoroalkene compared to 77% 
with Mo-6). Pure 1.82 was isolated by routine silica gel chromatography in 82% yield as a 
single E isomer.  
 
With Mo-1 as the optimal catalyst for fluoro- and E-selective CM of 1.76, we 
proceeded to explore the scope of this method. An assortment of pure E-alkenyl fluorides 
could be prepared in 59−79% yield (Scheme 1.5.3). Similar to cases shown in Scheme 
1.4.2, CM with unhindered terminal alkenes (e.g. 1.89) was less E-selective (89:11 E:Z, 
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Scheme 1.5.3). Attempts to utilize E--alkylstyrenes to improve E selectivity was 
unsuccessful and led to mostly -fluorostyrene and aliphatic chloroalkene product. Notable  
 
examples include sterically hindered 1.90 the C=C bond of which is situated next to an all-
carbon quaternary center and allylic ether 1.91 that can be converted to deoxyribose 
derivative E-1.8. The present approach afforded the alkenyl fluoride 1.8 in pure E form 
which could facilitate structure-activity relationship study (an inseparable mixture of E- 
and Z- fluoroalkenes had to be used for bio-assays).18 
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1.6. Conclusions  
In summary, we have devised a broadly applicable strategy to achieve kinetically 
E-selective CM to generate a valuable set of E-alkenyl chlorides and fluorides in high 
efficiency. Synthetic utility was demonstrated through several concise syntheses of E-
alkenyl chloride and fluoride precursors to biologically active molecules. The design 
principles delineated in this study are expected to initiate a wider range of efficient and 
kinetically controlled E-selective OM processes where there is a diminished preference for 
the E isomer such as macrocyclic ring-closing metathesis. 
1.7. Experimental Section 
1.7.1 General 
Unless otherwise noted, transformations were performed with distilled and 
degassed solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried 
glassware with standard dry box or vacuum line techniques. Infrared (IR) spectra were 
recorded on a Bruker FTIR Alpha (ATR Mode) spectrometer, vmax in cm-1.  Bands are 
characterized as broad (br), strong (s), medium (m), or weak (w). 1H NMR spectra were 
recorded on a Varian Unity INOVA 400 (400 MHz), 500 (500 MHz) or 600 (600 MHz) 
spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance resulting from incomplete deuterium incorporation as the internal standard 
(CDCl3: δ 7.26 ppm, C6D6: δ 7.16 ppm, CD2Cl2: δ 5.32 ppm, CD3OD: δ 3.31 ppm). Data 
are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR 
spectra were recorded on a Varian Unity INOVA 400 (101 MHz),  500 (126 MHz), or 600 
(151 MHz) spectrometers with complete proton decoupling. Chemical shifts are reported 
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in ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: 
δ 77.16 ppm, C6D6: δ 128.00 ppm, CD2Cl2: δ 54.00 ppm, CD3OD: δ 49.00 ppm). 19F NMR 
spectra were recorded on a Varian Unity INOVA 400 (376 MHz) spectrometer. High-
resolution mass spectrometry was performed on a Micromass LCT ESI-MS and JEOL 
Accu TOF Dart (positive mode) at the Boston College Mass Spectrometry Facility. Melting 
points were determined using a Thomas Hoover Uni-melt capillary melting point 
apparatus. Values for E:Z ratios of products were determined by analysis of 1H NMR 
spectra. 
Solvents: 
Solvents (CH2Cl2, pentane, benzene and toluene) were purified under a positive pressure 
of dry argon gas by an Innovative Technologies purification system. Tetrahydrofuran was 
distilled from Na/benzophenone. Methanol was distilled over MgSO4. Acetone was used 
as received. All purification procedures of CM products were carried out with reagent 
grade solvents (purchased from Fisher) under bench-top conditions. 
Reagents: 
Vinylcylohexane (Aldrich), trans--methylstyrene (TCI), 2-fluorostyrene (Aldrich), trans-
stilbene (Aldrich), 3-bromostyrene (Aldrich), 4-chlorostyrene (Aldrich), 4-bromostyrene 
(Aldrich), 4-acetoxystyrene (Aldrich), 4-trifluoromethylstyrene (Aldrich), 4-
vinylphenylboronic acid pinacol ester (Aldrich), 8-bromo-1-octene (Aldrich), trans-methyl 
oleate (TCI), cinnarizine (AK Scientific) were either distilled (from CaH2 or CaCl2) under 
vacuum or dried by azeotropic distillation (with benzene) prior to use.  
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3-Vinylbenzo[b]thiophene,41 2-vinylbenzofuran,42 tert-butyl 5-vinyl-1H-indole-1-
carboxylate,43 3-vinyl-1H-indole,44 tert-butyl 3-vinyl-1H-indole-1-carboxylate,45 tert-
butyl((2,6-dimethyl-7-octen-2-yl)oxy)dimethylsilane,46 and rosavin persilylated ether46  
(from rosavin (AK Scientific)) were prepared in analogy to reported procedures. Isopimaric 
acid methyl ester47  (from isopimaric acid (Aldrich)) and (4S,5R,6S)-2-(4-methoxyphenyl)-
5-methyl-4-((S,E)-5-phenyl-3-penten-2-yl)-6-vinyl-1,3-dioxane48 were prepared 
according to reported procedures.  
E-1,2-Dichloroethene (Aldrich), 3,5-dimethylphenylboronic acid (Aldrich), 3,5-di-tert-
butylphenylboronic acid (Combi-blocks), E-1-chloro-2-fluoroethene (Synquest), (R)-(+)-
4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane (Aldrich), potassium trans--
styryltrifluoroborate (Alfa Aesar), 1-methylindole-5-boronic acid (Combi-Blocks), 2,6-
difluoropyridine-3-boronic acid (Combi-Blocks), 3,5-Dimethylisoxazole-4-boronic acid 
pinacol ester (Combi-Blocks), cesium fluoride (Alfa Aesar) , palladium(II) acetate (Strem), 
SPhos (Strem) were used as received. 
Organometallic Complexes: 
                                                 
(41) Maity, S.; Manna, S.; Rana, S.; Naveen, T.; Mallick, A.; Maiti, D. J. Am. Chem. Soc. 2013, 135, 3355–
3358.  
(42) Falk, A.; Fiebig, L.; Neudoerfl, J.-M.; Adler, A.; Schmalz, H.-G. Adv. Synth. Catal. 2013, 357, 3317–
3320. 
(43) Daun, J.; Field, S.; Kobayashi, S. U.S. Pat. Appl. Publ., 20040186127, 23 September 2004. 
(44) Gioia, C.; Hauville, A.; Bernardi, L.; Fini, F.; Ricci, A. Angew. Chem. Int. Ed. 2008, 47, 9236–9239. 
(45) Silva Jr., L. F.; Craveiro, M. V.; Gambardella, M. T. P. Synthesis 2007, 3851–3857. 
(46) Aponick, A.; Li, C.-Y.; Palmes, J. A. Org. Lett. 2009, 11, 121–124. 
(47) González, M. A.; Zaragozá, R. J. J. Nat. Prod. 2014, 77, 2114–2117. 
(48) Gillingham, D. G.; Kataoka, O.; Garber, S. B.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 12288–
12290. 
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Mo monoaryloxide pyrrolide (MAP) complexes Mo-1-6 were prepared in situ from Mo 
bis-pyrrolide precursor and the corresponding 2,6-diarylphenol (see Section 1.7.2) 
according to previously reported procedure.49 Mo complexes were manipulated under an 
atmosphere of N2 in a glove box. Paraffin pellets containing Mo-6 were received from 
XiMo, AG. 
1.7.2. Synthesis of 2,6-Diarylphenol (S1-6) 
 
Phenol S1,29 S3, 50  and S451 were prepared according to reported procedures.  
Phenol S2 (Aldrich) was used as received. 
Phenol S552 was prepared according to previously reported procedures. An oven-dried 
round-bottom flask equipped with a magnetic stir bar was charged with 1,3-dibromo-2-
(methoxymethyl)benzene53 (296 mg, 1.00 mmol), 3,5-dimethylphenylboronic acid (375 
mg, 2.50 mmol), K3PO4 (1.28 g, 6.00 mmol), Pd2(dba)3 (46 mg, 0.0500 mmol), SPhos (82 
mg, 0.200 mmol) and toluene (10 mL). The mixture was allowed to stir for 12 h at 110 °C, 
then allowed to cool to 22 °C, diluted with EtOAc, and filtered through a pad of Celite. 
The filtrate was concentrated in vacuo and the brown oily residue was purified by silica 
                                                 
(49) I. Ibrahem, M. Yu, R. R. Schrock, A. H. Hoveyda, J. Am. Chem. Soc. 2009, 131, 3844–3845. 
(50) Townsend, E. M.; Kilyanek, S. M.; Schrock, R. R.; Müller, P.; Smith, S. J.; Hoveyda, A. H. 
Organometallics 2013, 32, 4612–4617. 
(51) H. Yang, A. S. Hay, Synthesis 1992, 467-472. 
(52) T. E. Barder, S. D. Walker, J. R. Martinelli, S. L. Buchwald, J. Am. Chem. Soc. 2005, 127, 4685–4696. 
(53) L. Hussein, N. Purkait, M. Biyikal, E. Tausch, P. W. Roesky, S. Blechert, Chem. Commun. 2014, 50, 
3862–3864. 
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gel chromatography (20:1 hexanes:EtOAc) to obtain the MOM-protected ether as waxy 
white solid, which was then dissolved in hot MeOH (25 mL) and concentrated HCl (1.0 
mL) was added. The solution was allowed to stir for 1 h at 60 °C, after which it was allowed 
to cool to 22 °C, causing off-white crystalline solid to precipitate. The mixture was allowed 
to stand at 0 °C for 12 h. The solid was collected by vacuum filtration, washed with cold 
methanol (3 x 5 mL), and dried under vacuum to obtain pure S5 (147 mg, 0.486 mmol, 
49% yield) as white solid. The spectral data for this compound were identical to those 
reported previously.54 
Phenol S6 was prepared in analogy to S5 from 1,3-dibromo-2-(methoxymethyl)benzene 
(296 mg, 1.00 mmol), 3,5-di-tert-butylphenylboronic acid (585 mg, 2.50 mmol), K3PO4 
(1.28 g, 6.00 mmol), Pd2(dba)3 (91.6 mg, 0.100 mmol), SPhos (164 mg, 0.400 mmol) to 
obtain pure S6 (436 mg, 0.926 mmol, 93% yield) as white solid. IR (in CH2Cl2): 3534 
(m), 2961 (s), 2905 (m), 2867 (m), 1593 (m), 1409 (m), 1393 (w), 1362 (m), 1258 (m), 
1222 (m), 1204 (m), 877 (m), 796 (s); 1H NMR (400 MHz, CDCl3): δ 7.45 (2H, t, J = 1.9 
Hz), 7.40 (4H, dd, J = 1.9, 0.6 Hz), 7.30 (2H, d, J = 7.6 Hz), 7.10 ̶ 7.04 (1H, m), 5.56 (1H, 
s), 1.37 (36H, s); 13C NMR (151 MHz, CDCl3): δ 151.3, 149.6, 136.9, 129.9, 129.8, 123.8, 
121.8, 120.5, 35.2, 31.7; HRMS [M+H]+ calcd for C34H47O: 471.3628, found: 471.3627.  
1.7.3. Synthesis of Mo MAP Complexes  
General procedure for in situ preparation of Mo-1d for NMR analysis: In a N2-filled 
glove box, an oven-dried 4 mL vial equipped with a magnetic stir bar was charged with 
pentafluorophenylimido Mo bispyrrolide complex54 (15.0 mg, 0.0251 mmol), S4 (11.8 mg, 
                                                 
(54) Yuan, J.; Schrock, R. R.; Müller, P.; Axtell, J. C.; Dobereiner, G. E. Organometallics 2012, 31, 4650–
4653. 
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0.0251 mmol) and C6D6 (1 mL), generating a dark-red solution. The vial was capped and 
the mixture was allowed to stir for 2 h at 22 C, after which time it was transferred to a 
screw cap NMR tube by a pipette. The NMR tube was capped and sealed with Teflon tape. 
Diagnostic NMR data for Mo-6: 1H NMR (400 MHz, C6D6): δ 11.88 (1H, s). 
General procedure for in situ preparation of Mo-1d: In a N2-filled glove box, an oven-
dried 4 mL vial equipped with a magnetic stir bar was charged with 
pentafluorophenylimido Mo bispyrrolide complex (59.8 mg, 0.100 mmol), S4 (47.1 mg, 
0.100 mmol) and C6H6 (1 mL), resulting in a dark red solution. The vial was capped and 
the mixture was allowed to stir for 2 h at 22 C, after which time the solution was 
transferred to the reaction mixture by syringe (dried at 65 °C). 
1.7.4. Kinetically E-Selective CM to Access E-Alkenyl Chlorides 
General CM Procedure: In a N2-filled glove box, an oven-dried 8 mL vial equipped with  
a magnetic stir bar was charged with alkene substrate and the corresponding E-1,2-
dihaloethene. A solution of Mo complex in benzene was then added. The resulting mixture 
was allowed to stir for 4 h at 22 C, after which time the reaction was quenched by the 
addition of wet CDCl3 (% conversion determined by 1H NMR analysis of the unpurified 
mixture). Purification was performed through silica gel chromatography. 
(E)-tert-Butyl((8-chloro-2,6-dimethyloct-7-en-2-yl)oxy)dimethylsilane (1.43): 
Following the general procedure, a solution of Mo-6 in benzene (0.1 M, 20 L, 2.0 mol) 
was transferred by syringe to an oven-dried vial containing E-1,2-dichloroethene (77.6 mg, 
0.800 mmol), tert-butyl((2,6-dimethyl-7-octen-2-yl)oxy)dimethylsilane (10.8 mg, 0.0400 
mmol). The resulting solution was allowed to stir for 15 min at 22 °C, after which time the 
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reaction was quenched by the addition of wet CDCl3 and analysis of the unpurified mixture 
revealed >98% consumption of starting alkene. The resulting orange oil was purified by 
silica gel chromatography (100% hexanes) to afford 1.43 (11.4 mg, 0.0374 mmol, 93% 
yield) in 93:7 E:Z ratio as colorless oil. IR (neat): 2956 (m), 2929 (m), 2956 (m), 1633 
(w), 1461 (m), 1381 (m), 1363 (m), 1251 (s), 1080 (m), 1039 (s), 1005 (m), 935 (m), 832 
(s), 806 (m), 770 (s), 688 (m); 1H NMR (400 MHz, CDCl3): E isomer (major): δ 5.89 (1H, 
dd, J = 13.3, 0.8 Hz), 5.76 (1H, dd, J = 13.3, 8.3 Hz), 2.24–2.11 (1H, m), 1.42–1.21 (6H, 
m), 1.16 (6H, s), 0.99 (3H, d, J = 6.7 Hz), 0.83 (9H, s), 0.04 (6H, s); Z isomer (minor, 
resolved signals only): δ 5.95 (1H, dd, J = 7.1, 0.8 Hz), 5.51 (1H, dd, J = 9.4, 7.0 Hz); 13C 
NMR (101 MHz, CDCl3) δ 139.8, 115.8, 73.5, 45.1, 37.3, 36.1, 30.0, 29.9, 26.0, 22.0, 
20.4, 18.3, -1.9; HRMS [M+H]+ calcd for C16H34ClOSi: 305.2067, found: 305.2061. 
(E)-(2-chlorovinyl)benzene (1.12): Following the general procedure, a solution of Mo-6 
in benzene (0.1 M, 25 L, 2.5 mol) was transferred by syringe to an oven-dried vial 
containing E-1,2-dichloroethene (96.9 mg, 1.00 mmol), trans-stilbene (9.0 mg, 0.0500 
mmol). The resulting solution was allowed to stir for 2 h at 22 °C, after which time the 
reaction was quenched by the addition of wet CDCl3 and analysis of the unpurified mixture 
revealed >98% consumption of trans-stilbene. The resulting orange oil was purified by 
silica gel chromatography (100% pentane) to afford 1.12 (11.8 mg, 0.0851 mmol, 85% 
yield) in >98:2 E:Z ratio as colorless oil. The spectral data for this compound were identical 
to those reported previously.55  
                                                 
(55) Bull, J. A.; Mousseau, J. J.; Charette, A. B. Org. Lett. 2008, 10, 5485–5488. 
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 (E)-1-(2-Chlorovinyl)-2-fluorobenzene (1.44): Following the general procedure, a 
solution of Mo-6 in benzene (0.1 M, 50 L, 5.0 mol) was transferred by syringe to an 
oven-dried vial containing E-1,2-dichloroethene (96.9 mg, 1.00 mmol) and 2-fluorostyrene 
(12.2 mg, 0.100 mmol). The resulting solution was allowed to stir for 4 h at 22 °C, after 
which time the reaction was quenched by the addition of wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of starting alkene. The resulting orange 
oil was purified by silica gel chromatography (100% pentane) to afford 1.44 (8.4 mg, 
0.0536 mmol, 54% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 3076 (w), 1606 (s), 
1575 (w), 1483 (s), 1455 (m), 1231 (s) 1199 (m), 941 (s), 932 (s), 842 (m), 826 (s), 749 
(s); 1H NMR (600 MHz, CDCl3): δ 7.30 (1H, td, J = 10.9, 8.2, 1.8 Hz), 7.25 (1H, dddd, J 
= 8.2, 7.2, 5.3, 1.8 Hz), 7.10 (1H, td, J = 7.2, 1.2 Hz), 7.06 (1H, ddd, J = 10.9, 8.2, 1.2 Hz), 
6.90 (1H, d, J = 13.8 Hz), 6.81 (1H, d, J = 13.8 Hz); 13C NMR (151 MHz, CDCl3): δ 160.0 
(d, J = 250.3 Hz), 129.6 (d, J = 8.7 Hz), 128.2 (d, J = 3.5 Hz), 126.9 (d, J = 1.7 Hz), 124.5 
(d, J = 3.6 Hz), 122.8 (d, J = 12.7 Hz), 121.8 (d, J = 8.7 Hz), 116.1 (d, J = 22.0 Hz); HRMS 
[M+H]+ calcd for C8H6ClF: 156.0142, found: 156.0147. 
(E)-1-Bromo-3-(2-chlorovinyl)benzene (1.45): Following the general procedure, a 
solution of Mo-6 in benzene (0.1 M, 16 L, 1.6 mol) was transferred by syringe to an 
oven-dried vial containing E-1,2-dichloroethene (53.0 mg, 0.546 mmol) and 3-
bromostyrene (10.0 mg, 0.0546 mmol). The resulting solution was allowed to stir for 4 h 
at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of 3-bromostyrene. The resulting orange 
oil was purified by silica gel chromatography (100% hexanes) to afford 1.45 (7.1 mg, 
0.0326 mmol, 60% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 3072 (w), 2926 
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(w), 1610 (m), 1586 (w), 1561 (m), 1470 (w), 1242 (w), 1072 (w), 933 (s), 831 (m), 768 
(s), 672 (m); 1H NMR (400 MHz, CDCl3): δ 7.45 (1H, s), 7.40 (1H, ddd, J = 6.7, 2.5, 1.5 
Hz), 7.24 ̶ 7.17 (2H, m), 6.77 (1H, d, J = 13.7 Hz), 6.66 (1H, d, J = 13.7 Hz); 13C NMR 
(101 MHz, CDCl3): δ 137.0, 132.1, 131.2, 130.4, 129.1, 124.9, 123.1, 120.5; HRMS 
[M+H]+ calcd for C8H6BrCl: 215.9341, found: 215.9338.   
(E)-1-(2-chlorovinyl)-4-methoxybenzene (1.46): Following the general procedure, a 
solution of Mo-6 in benzene (0.1 M, 30 L, 3.0 mol) was transferred by syringe to an 
oven-dried vial containing E-1,2-dichloroethene (96.9 mg, 1.00 mmol) and 4-vinylanisole 
(13.4 mg, 0.100 mmol). The resulting solution was allowed to stir for 3 h at 22 °C. The 
reaction was quenched by addition of wet CDCl3 and analysis of the unpurified mixture 
revealed >98% consumption of 4-vinylanisole. The resulting orange oil was purified by 
silica gel chromatography (5% EtOAc in hexanes) to afford 1.46 (13.5 mg, 0.0799 mmol, 
80% yield) in >98:2 E:Z ratio as colorless oil. The spectral data for this compound were 
identical to those previously reported.55 
(E)-1-Chloro-4-(2-chlorovinyl)benzene (1.47): Following the general procedure, a 
solution of Mo-6 in benzene (0.1 M, 40 L, 4.0 mol) was transferred by syringe to an 
oven-dried vial containing E-1,2-dichloroethene (77.6 mg, 0.800 mmol) and 4-
chlorostyrene (11.2 mg, 0.0808 mmol). The resulting solution was allowed to stir for 4 h 
at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of 4-chlorostyrene. The resulting orange 
oil was purified by silica gel chromatography (100% hexanes) to afford 1.47 (9.7 mg, 
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0.0560 mmol, 69% yield) in >98:2 E:Z ratio as colorless oil. The spectral data for this 
compound were identical to those previously reported.56 
(E)-4-(2-Chlorovinyl)phenyl acetate (1.48): Following the general procedure, a solution 
of Mo-6 in benzene (0.1 M, 24 L, 2.4 mol) was transferred by syringe to an oven-dried 
vial containing E-1,2-dichloroethene (77.6 mg, 0.800 mmol) and 4-acetoxystyrene (13.0 
mg, 0.802 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction 
was quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 
>98% consumption of 4-acetoxystyrene. The resulting orange oil was purified by silica gel 
chromatography (5% EtOAc/hexanes) to afford 1.48 (11.8 mg, 0.0600 mmol, 75% yield) 
in >98:2 E:Z ratio as white crystalline solid. Mp: 61 ̶ 63 °C; IR (neat): 3081 (w), 2927 (w), 
2852 (w), 1736 (s), 1740 (s), 1614 (w), 1601 (w), 1580 (m), 1506 (m), 1219 (s), 1204 (s), 
1185 (s), 1166 (s), 1011 (m), 937 (s), 909 (s), 846 (m), 819 (m), 800 (s), 778 (m), 650 (s), 
519 (s); 1H NMR (400 MHz, CDCl3): δ 7.30 (2H, d, J = 8.8 Hz), 7.06 (2H, d, J = 8.8 Hz), 
6.82 (1H, d, J = 13.7 Hz), 6.61 (1H, d, J = 13.7 Hz), 2.30 (3H, s); 13C NMR (151 MHz, 
CDCl3): δ 169.4, 150.6, 132.8, 132.5, 127.3, 122.1, 119.0, 21.3; HRMS [M+H]+ calcd for 
C10H10ClO2: 197.0369, found: 197.0373. 
(E)-1-(2-Chlorovinyl)-4-(trifluoromethyl)benzene (1.49) : Following the general 
procedure, a solution of Mo-6 in benzene (0.1 M, 30 L, 3.0 mol) was transferred by 
syringe to an oven-dried vial containing E-1,2-dichloroethene (58.2 mg, 0.600 mmol) and 
4-trifluoromethylstyrene (10.3 mg, 0.0598 mmol). The resulting solution was allowed to 
stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of 
the unpurified mixture revealed 84% consumption of 4-trifluoromethylstyrene. The 
                                                 
(56) Sodré, L. A.; Esteves, P. M.; de Mattos, M. C. S. J. Braz. Chem. Soc. 2013, 24, 212–218. 
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resulting orange oil was purified by silica gel chromatography (100% pentane) to afford 
1.49 (7.3 mg, 0.0353 mmol, 59% yield) in >98:2 E:Z ratio as clear colorless oil. IR (neat): 
3074 (w), 2869 (m), 1614 (m), 1574 (w), 1412 (m), 1321 (s), 1164 (m), 1120 (s), 1108 (s), 
1066 (s), 1017 (m), 930 (s), 823(m), 794 (m); 1H NMR (400 MHz, CDCl3): δ 7.58 (2H, 
d, J = 8.1 Hz), 7.40 (2H, d, J = 8.1 Hz), 6.87 (1H, d, J = 13.7 Hz), 6.76 (1H, d, J = 13.7 
Hz); 13C NMR (101 MHz, CDCl3): δ 132.2, 126.4, 125.9 (q, J =3.8 Hz), 121.6, 101.1; 
HRMS [M+H]+ calcd for C9H6ClF3: 206.0110, found: 206.0110. 
(E)-2-(4-(2-Chlorovinyl)phenyl)-4,4,5,5-tetramethyl-1,3-dioxolane (1.50): Following 
the general procedure, a solution of Mo-6 in benzene (0.1 M, 22 L, 2.2 mol) was 
transferred by syringe to an oven-dried vial containing E-1,2-dichloroethene (41.7 mg, 
0.430 mmol) and 4,4,5,5-tetramethyl-2-(4-vinylphenyl)-1,3-dioxolane (10.0 mg, 0.0430 
mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% 
consumption of 4,4,5,5-tetramethyl-2-(4-vinylphenyl)-1,3-dioxolane. The resulting orange 
oil was purified by silica gel chromatography (2% Et2O/hexanes) to afford 1.50 (7.0 mg, 
0.0262 mmol, 61% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 2978 (m), 2930 
(w), 1607 (m), 1398 (m), 1359 (s), 1323 (m), 1271 (m), 1143 (m), 1089 (m), 933 (w), 857 
(m), 793 (m), 636 (m); 1H NMR (400 MHz, CDCl3): δ 7.76 (1H, d, J = 8.1 Hz), 7.29 (2H, 
d, J = 7.9 Hz), 6.84 (1H, d, J = 13.7 Hz), 6.71 (1H, d, J = 13.7 Hz), 1.34 (12H, s); 13C 
NMR (101 MHz, CDCl3): δ 137.6, 135.4, 133.5, 125.5, 119.9, 84.0, 25.0; HRMS [M+H]+ 
calcd for C14H19BClO2: 265.1158, found: 265.1167.   
(E)-tert-Butyl 6-(2-chlorovinyl)-1H-indole-1-carboxylate (1.51): Following the general 
procedure, a solution of Mo-6 in benzene (0.1 M, 12 L, 1.2 mol) was transferred by 
Page 33 
syringe to an oven-dried vial containing E-1,2-dichloroethene (39.8 mg, 0.411 mmol) and 
tert-butyl 6-vinyl-1H-indole-1-carboxylate (10.0 mg, 0.0411 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed >98% consumption of tert-butyl 6-vinyl-
1H-indole-1-carboxylate. The resulting orange oil was purified by silica gel 
chromatography (5% Et2O/hexanes) to afford 1.51 (9.1 mg, 0.0328 mmol, 80% yield) in 
>98:2 E:Z ratio as colorless oil. IR (neat): 3073 (w), 2979 (w), 2934 (w), 1731 (s), 1437 
(m), 1336 (s), 1263 (m), 1148 (s), 1126 (s), 932 (m); 1H NMR (400 MHz, CDCl3): δ 8.12 
(1H, s), 7.58–7.53 (1H, m), 7.47 (1H, d, J = 8.1 Hz), 7.17 (1H, d, J = 8.1 Hz), 6.92 (1H, d, 
J = 13.7 Hz), 6.67 (1H, d, J = 13.7 Hz), 6.53–6.48 (1H, m), 1.66 (9H, s); 13C NMR (101 
MHz, CDCl3): δ 134.2, 131.3, 130.6, 126.9, 121.3, 121.1, 117.7, 113.3, 107.4, 84.1, 28.3; 
HRMS [M+H]+ calcd for C16H17ClNO2: 278.0948, found: 278.0937.   
(E)-2-(2-Chlorovinyl)benzofuran (1.52): Following the general procedure, a solution of 
Mo-6 in benzene (0.1 M, 35 L, 3.5 mol) was transferred by syringe to an oven-dried vial 
containing E-1,2-dichloroethene (67.2 mg, 0.694 mmol) and 2-vinylbenzofuran (10.0 mg, 
0.0694 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 84% 
consumption of 2-vinylbenzofuran. The resulting orange oil was purified by silica gel 
chromatography (2% Et2O/hexanes) to afford 1.52 (7.7 mg, 0.0431 mmol, 62% yield) in 
>98:2 E:Z ratio as colorless oil. IR (neat): 3084 (w), 2979 (w), 2925 (w), 2853 (w), 1625 
(w), 1450 (m), 1254 (m), 949 (m), 924 (m), 823 (s), 786 (m); 1H NMR (400 MHz, CDCl3): 
δ 7.52 (1H, ddd, J = 7.6, 1.3, 0.7 Hz), 7.42 (1H, ddd, J = 8.2, 1.7, 0.9 Hz), 7.31–7.26 (1H, 
m), 7.23–7.18 (1H, m), 6.91 (1H, dd, J = 13.5, 0.5 Hz), 6.75 (1H, d, J = 13.4, 1.3 Hz), 6.59 
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(1H, s); 13C NMR (101 MHz, CDCl3): δ 155.0, 151.9, 128.6, 125.2, 123.2, 122.1, 121.2, 
121.2, 111.1, 105.4; HRMS [M+H]+ calcd for C10H8ClO: 179.0264, found: 179.0264.   
 (E)-3-(2-Chlorovinyl)benzo[b]thiophene (1.53): Following the general procedure, a 
solution of Mo-6 in benzene (0.1 M, 31 L, 3.1 mol) was transferred by syringe to an 
oven-dried vial containing E-1,2-dichloroethene (60.5 mg, 0.624 mmol) and 3-
vinylbenzo[b]thiophene (10.0 mg, 0.0624 mmol). The resulting solution was allowed to 
stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of 
the unpurified mixture revealed 85% consumption of 3-vinylbenzo[b]thiophene. The 
resulting orange oil was purified by silica gel chromatography (2% Et2O/hexanes) to afford 
1.53 (8.4 mg, 0.0431 mmol, 69% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 3067 
(w), 2979 (w), 2920 (w), 2849 (w), 1607 (w), 1425 (m), 1263 (m), 1221 (w), 926 (m); 1H 
NMR (500 MHz, CDCl3): δ 7.87 (1H, d, J = 8.0 Hz), 7.84 (1H, d, J = 8.0 Hz), 7.43 (1H, 
td, J = 7.7, 1.2 Hz), 7.40–7.37 (2H, m), 7.10 (1H, d, J = 13.6 Hz), 6.73 (1H, d, J = 13.6 
Hz); 13C NMR (125 MHz, CDCl3): δ 126.2, 124.9, 124.7, 123.1, 123.0, 122.0, 120.0; 
HRMS [M+H]+ calcd for C10H8ClS: 195.0035, found: 195.0036.  
(E)-3-(2-Chlorovinyl)-1H-indole (1.54): Following the general procedure, a solution of 
Mo-6 in benzene (0.1 M, 40 L, 4.0 mol) was transferred by syringe to an oven-dried vial 
containing E-1,2-dichloroethene (77.6 mg, 0.800 mmol) and 3-vinyl-1H-indole (11.5 mg, 
0.0803 mmol). The resulting solution was allowed to stir for 2 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% 
consumption of 3-vinyl-1H-indole. The resulting orange oil was purified by silica gel 
chromatography (10% EtOAc/hexanes then 20% EtOAc/hexanes) to afford 1.54 (12.1 mg, 
0.0681 mmol, 85% yield) in >98:2 E:Z ratio as slight brown solid. Mp: >250 °C; IR (neat): 
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3382 (s), 2984 (w), 1730 (s), 1457 (m), 1373 (m), 1243 (s), 1099 (s), 1044 (s), 751 (s), 732 
(s).; 1H NMR (400 MHz, CDCl3) δ 8.14 (1H, s), 7.79–7.71 (1H, m), 7.43–7.35 (1H, m), 
7.30–7.16 (3H, m), 7.01 (1H, dd, J = 13.7, 0.6 Hz), 6.66 (1H, d, J = 13.7 Hz); 13C NMR 
(101 MHz, CDCl3): δ 136.7, 126.3, 125.1, 123.6, 123.0, 120.9, 120.0, 114.9, 112.9, 111.6.; 
HRMS [M+H]+ calcd for C10H9ClN: 178.0424, found: 178.0421. 
1.7.5. Formal Synthesis of Pitinoic Acid B 
(S,E)-4-(3-Chloroallyl)-2,2-dimethyl-1,3-dioxolane (1.63): Following the general 
procedure, a solution of Mo-6 in benzene (0.1 M, 14 L, 1.4 mol) was transferred by 
syringe to an oven-dried vial containing E-1,2-dichloroethene (48.5 mg, 0.500 mmol) and 
(S)-4-cinnamyl-2,2-dimethyl-1,3-dioxolaneError! Bookmark not defined. (10.3 mg, 
0.0472 mmol). The resulting solution was allowed to stir for 1 hour at 22 °C, after which 
time the reaction was quenched by the addition of wet CDCl3 and analysis of the unpurified 
mixture revealed >98% consumption of (S)-4-cinnamyl-2,2-dimethyl-1,3-dioxolane. The 
resulting orange oil was purified by silica gel chromatography (50:1 pentane/Et2O then 
10:1 pentane/Et2O) to afford 1.63 (6.2 mg, 0.0351 mmol, 70% yield) in >98:2 E:Z ratio as 
colorless oil. The spectral data for this compound were identical to those previously 
reported.15 
1.7.6. Synthesis of the Amine Fragment of Kimbeamide A 
 (But-3-yn-2-yloxy)triethylsilane (1.66): Triethylsilyl chloride (1.48 mL, 8.80 mmol) was 
added to a solution of 3-butyn-2-ol 1.64 (627 μL, 8.00 mmol) and imidazole (1.09 g, 16.0 
mmol) in CH2Cl2 (25 mL) at 0 °C. Once the addition was complete, the mixture was 
allowed to stir at 22 °C for 3 h before addition of a saturated solution of aqueous NaHCO3 
(25 mL). The phases were separated and the aqueous phase was back-washed with CH2Cl2 
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(3 × 10 mL). The combined organic layers were washed with 1 M solution of aqueous HCl 
(25 mL) and 5% w/v aqueous CuSO4 (25 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure. The product was purified by silica gel chromatography (200:1 
hexanes/EtOAc) to afford silyl ether 1.64 (1.42 g, 7.70 mmol, 96% yield) as colorless oil. 
The spectral data for this compound were identical to those previously reported.57 
(E)-8-phenyloct-7-en-3-yn-2-ol (1.68): LiAlH4 (617 mg, 16.2 mmol) was added to a 
solution of trans-3-styryl acetic acid 1.65 (1.00 g, 6.17 mmol) in THF (5 mL) at 0 °C. The 
mixture was allowed to stir at 0 °C for 20 min, then at 22 °C for 1 h. The reaction was 
cooled to 0 °C and quenched by addition of H2O (0.62 mL), followed by 1 M solution of 
aqueous NaOH (0.62 mL). The resulting mixture was allowed to stir at 0 °C for 5 min, then 
H2O (2 mL) was added. The mixture was allowed to stir at 22 °C for another 15 min before 
anhydrous MgSO4 was added. The mixture was filtered through celite and the filtrate was 
concentrated under reduced pressure. The product was purified by silica gel 
chromatography (4:1 hexanes/EtOAc) to afford (E)-4-phenylbut-3-en-1-ol (859 mg, 5.80 
mmol, 94% yield) as colorless oil. The spectral data for this compound were identical to 
those previously reported.57 
Trifluoromethanesulfonic anhydride (269 μL, 1.60 mmol) was added to a solution of 
pyridine (129 μL, 1.60 mmol) in CH2Cl2 (5 mL) at –20 °C and the resulting mixture was 
allowed to stir for 10 min before a solution of (E)-4-phenylbut-3-en-1-ol (222 mg, 1.50 
mmol) in CH2Cl2 (1 mL) was slowly added. The mixture was allowed to reach 22 °C over 
                                                 
(57) Spivey, A. C.; Laraia, L.; Bayly, A. R.; Rzepa, H. S.; White, A. J. P. Org. Lett. 2010, 12, 900–903. 
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10 min before it was concentrated on a rotary evaporator (water bath temperature 20 °C). 
Unpurified triflate 1.67 was immediately used in the next step. 
n-BuLi (1.6 M in hexanes, 4.88 mL, 7.80 mmol) was added to a solution of 1.66 (1.38 g, 
7.50 mmol) in THF (10 mL) at –20 °C. The mixture was allowed to stir at –20 °C for 15 
min, then a solution of triflate 1.67 in THF (5 mL) was added. Once the addition was 
complete, the mixture was allowed to stir at 0 °C for 30 min before (n-Bu)4NF (1.0 M in 
THF, 10 mL, 10.0 mmol) was added. The mixture was allowed to stir at 0 °C for another 
5 min, after which the reaction was quenched by the addition of H2O (20 mL) and diluted 
with Et2O (20 mL). The phases were separated and the aqueous phase was back-washed 
with Et2O (3 × 20 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure. The product was purified by silica gel 
chromatography (20:1 to 9:1 hexanes/EtOAc) to afford propargylic alcohol 1.68 (213 mg, 
1.06 mmol, 71% yield over 2 steps) as colorless solid. Rf = 0.14 (hexane/EtOAc, 9:1). Mp: 
36–38 °C; IR (neat): 3331 (w), 2980 (m), 2928 (m), 1152 (m), 1070 (s), 962 (m), 741 (m); 
1H NMR (400 MHz, CDCl3):  7.36 (2H, dt, J = 7.6, 1.6 Hz), 7.31 (2H, td, J = 7.6, 1.6 
Hz), 7.24–7.19 (1H, m), 6.45 (1H, d, J = 15.9 Hz), 6.25 (1H, dt, J = 15.9, 6.1 Hz), 4.53 
(1H, qd, J = 6.6, 2.7 Hz), 2.59 (1H, d, J = 2.7 Hz), 2.47–2.31 (4H, m), 1.45 (3H, d, J = 6.6 
Hz); 13C NMR (101 MHz, CDCl3):  137.4, 131.0, 128.6, 128.5, 127.1, 126.0, 83.6, 83.1, 
58.3, 32.1, 24.7, 18.9; HRMS [M+H–H2O]+ calcd for C14H15: 183.11738; found: 
183.11671. 
2-((3Z,7E)-8-Phenylocta-3,7-dien-2-yl)isoindoline-1,3-dione (1.69): A mixture of 
alkyne 1.68 (61 mg, 0.30 mmol), Lindlar’s catalyst (12.0 mg) and quinoline (21 μL, 0.18 
mmol) in MeOH (2.5 mL) was purged three times with H2 and then allowed to stir under 
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an atmosphere of H2 at 22 °C for 1 h. The reaction mixture was filtered through celite and 
the filtrate was concentrated under reduced pressure. Unpurified Z-allylic alcohol was used 
in the next step. 
Diisopropyl azodicarboxylate (89 μL, 0.45 mmol) was added to a solution of crude alcohol, 
phthalimide (53 mg, 0.36 mmol) and triphenylphosphine (118 mg, 0.45 mmol) in THF (4 
mL) at rt. The mixture was allowed to stir at 22 °C for 18 h, then concentrated under 
reduced pressure and triturated with Et2O. The precipitate was removed by filtration and 
the filtrate was concentrated under reduced pressure. The product was purified by silica gel 
chromatography on silica gel (20:1 hexane/Et2O) to afford a 93:7 mixture of 1.69 and over-
reduced (Z)-2-(8-phenyloct-3-en-2-yl)isoindoline-1,3-dione (74 mg, 69% yield by mass 
over 2 steps) as colorless oil. Rf = 0.46 (hexane/EtOAc, 9:1). 1H NMR (400 MHz, CDCl3): 
 7.78 (2H, dd, J = 5.5, 3.1 Hz), 7.66 (2H, dd, J = 5.5, 3.1 Hz), 7.31–7.19 (4H, m), 7.15 
(1H, tt, J = 7.0, 1.6 Hz), 6.35 (1H, d, J = 15.9 Hz), 6.16 (1H, dt, J = 15.9, 6.5 Hz), 6.00 
(1H, ddt, J = 10.7, 9.1, 1.5 Hz), 5.53 (1H, dtd, J = 10.7, 7.2, 1.0 Hz), 5.25 (1H, dqd, J = 
9.1, 7.0, 1.0 Hz), 2.37–2.29 (2H, m), 2.29–2.23 (2H, m), 1.52 (3H, d, J = 7.0 Hz); 13C 
NMR (101 MHz, CDCl3):  168.0, 137.6, 133.9, 132.1, 131.9, 130.7, 129.6, 129.2, 128.5, 
126.9, 126.0, 123.1, 43.7, 32.8, 27.4, 19.6; HRMS [M+H]+ calcd for C22H22NO2: 
332.16505; found: 332.16342. 
2-((3Z,7E)-8-Chloroocta-3,7-dien-2-yl)isoindoline-1,3-dione (1.70): Following the 
general procedure, a solution of Mo-6 in benzene (0.1 M, 25 L, 2.5 mol) was transferred 
by syringe to an oven-dried vial containing E-1,2-dichloroethene (78.9 mg, 0.814 mmol) 
and 1.69 (93% by mass, 29.0 mg, 0.0814 mmol). The resulting solution was allowed to stir 
for 1 h at 22 °C, after which time the reaction was quenched by the addition of wet CDCl3 
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and analysis of the unpurified mixture revealed >98% consumption of starting alkene. The 
resulting orange oil was purified by silica gel chromatography (5% EtOAc/hexanes) to 
afford a 83:17 mixture of 1.70 and unreacted (Z)-2-(8-phenyloct-3-en-2-yl)isoindoline-1,3-
dione  (26.9 mg, 0.0771 mmol, 95% yield by mass) in >98:2 E:Z ratio as yellow oil. 1H 
NMR (600 MHz, CDCl3): 7.81 (2H, dd, J = 5.4, 3.0 Hz), 7.69 (2H, dd, J = 5.4, 3.0 Hz), 
6.01 (1H, ddt, J = 10.9, 9.3, 1.6 Hz), 5.92 (1H, dt, J = 13.2, 1.3 Hz), 5.83 (1H, dt, J = 13.2, 
7.2 Hz, 0H), 5.44 (1H, dtd, J = 10.7, 7.5, 1.2 Hz), 5.19 (1H, dqd, J = 9.3, 7.0, 1.1 Hz), 
2.29–2.17 (2H, m), 2.12–2.07 (2H, m), 1.53 (3H, d, J = 6.9 Hz); 13C NMR (151 MHz, 
CDCl3): 168.1, 134.0, 132.8, 132.2, 131.1, 129.8, 123.3, 117.9, 43.6, 30.7, 27.0, 19.5; 
HRMS [M+H]+ calcd for C16H17ClNO2: 290.0948, found: 290.0956. 
1.7.7. E-Selective CM of Cinnarizine with Paraffin Pellets  
An oven-dried 5-mL Schlenk tube was charged with a paraffin tablet (4.4 wt% in Mo-1d, 
126.8 mg, 0.573 mmol, 5 mol %) and cinnarizine (42.6 mg, 0.116 mmol, 1.00 equiv). The 
tube was sealed with a rubber septum, then evacuated and back-filled with N2 three times 
to remove oxygen. E-1,2-Dichloroethene (90 mL, 1.17 mmol, 10.0 equiv) and 0.2 mL 
toluene were added via syringe and the resulting mixture was allowed to stir at 50 °C for 4 
h. At this time, the mixture was diluted with CH2Cl2 and the resulting residue (yellow oil) 
was purified by silica gel chromatography (100% CH2Cl2 to 1% MeOH/CH2Cl2) to afford 
3h (36.0 mg, 0.110 mmol, 95% yield) in >98:2 E:Z ratio as yellow oil. 
1.7.8. Synthesis of Cinnarizine Derivatives 
(E)-5-(3-(4-Benzhydrylpiperazin-1-yl)prop-1-en-1-yl)-1-methyl-1H-indole (1.72): An 
oven-dried vial with magnetic stir bar was charged with 1.71 (16.3 mg, 0.0499 mmol), 1-
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methylindole-5-boronic acid (13.1 mg, 0.0749 mmol) and CsF (11.4 mg, 0.0750 mmol). A 
mixture of Pd(OAc)2/SPhos (1:2 solution in i-PrOH, 0.01 M in Pd, 0.25 mL, 2.50 mol) 
was subsequently added. The vial was sealed and removed from the glove box. The mixture 
was allowed to stir at 85 °C for 12 h. The reaction was quenched by passing through a short 
plug of silica gel and washed with 5% MeOH/CH2Cl2 (3 x 2 mL). The filtrate was 
concentrated in vacuo to afford brown oil, which was purified by silica gel chromatography 
(100% CH2Cl2 to 2% MeOH/CH2Cl2) to afford 1.72 (18.2 mg, 0.0432 mmol, 86% yield) 
as yellow oil. IR (neat): 3024 (w), 2806 (m), 2764 (w), 1597 (w), 1489 (m), 1450 (m), 
1332 (m), 1244 (m), 1135 (m), 1005 (m), 966 (m), 907 (m), 727 (s), 704 (s); 1H NMR (600 
MHz, CDCl3): δ 7.56 (1H, d, J = 1.5 Hz), 7.41 (4H, dt, J = 8.0, 1.6 Hz), 7.31 (1H, dd, J = 
8.6, 1.6 Hz), 7.25 (5H, q, J = 7.6 Hz), 7.16 (2H, ddt, J = 7.8, 6.8, 1.3 Hz), 7.01 (1H, d, J = 
3.1 Hz), 6.62 (1H, d, J = 15.7 Hz), 6.44 (1H, dd, J = 3.1, 0.8 Hz), 6.21 (1H, dt, J = 15.7, 
6.9 Hz), 4.24 (1H, s), 3.77 (3H, s), 3.20 (2H, d, J = 6.4 Hz), 2.77 – 2.25 (8H, m); 13C NMR 
(151 MHz, CDCl3): δ 142.9, 136.6, 129.4, 128.8, 128.6, 128.1, 127.0, 109.4, 101.4, 76.3, 
61.4, 53.5, 51.9, 33.0; HRMS [M+H]+ calcd for C29H32N3: 422.2596, found: 422.2599. 
(E)-1-Benzhydryl-4-(3-(2,6-difluoropyridin-3-yl)allyl)piperazine (1.73): An oven-
dried vial with magnetic stir bar was charged with 1.71 (14.7 mg, 0.0450 mmol), 2,6-
difluoro-3-pyridineboronic acid (10.7 mg, 0.0675 mmol, 1.50 equiv) and CsF (12.3 mg, 
0.0810 mmol). Pd(OAc)2/SPhos (1:2 solution in i-PrOH, 0.01 M in Pd, 0.45 mL, 4.50 
mol) was subsequently added. The vial was sealed and removed from the glove box. The 
mixture was allowed to stir at 85 °C for 12 h, after which time the reaction was quenched 
by passing through a short plug of silica gel and washed with Et2O (3x2 mL). The filtrate 
was concentrated in vacuo to afford yellow oil, which was purified by silica gel 
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chromatography (100% CH2Cl2 to 1% MeOH/CH2Cl2) to afford 1.73 (12.7 mg, 0.0313 
mmol, 70% yield) as yellow oil. IR (neat): 2924 (m), 2852 (w), 2765 (w), 1602 (m), 1586 
(m), 1469 (s), 1452 (m), 1411 (m), 1302 (m), 1246 (w), 1136 (w), 993 (m); 1H NMR (400 
MHz, CDCl3): δ 7.91 (1H, dd, J = 17.0, 8.1 Hz), 7.427.39 (4H, m), 7.287.23 (4H, m), 
7.197.16 (2H, m), 6.78 (1H, dd, J = 8.1, 2.8 Hz), 6.55 (1H, d, J = 16.0 Hz), 6.396.28 
(1H, m), 4.24 (1H, s), 3.19 (2H, d, J = 5.8 Hz), 2.562.38 (8H, m); 13C NMR (101 MHz, 
C6D6): δ 143.3, 141.2 (dd, JC-F = 7.4, 4.5 Hz), 132.0, 131.6, 130.2, 128.8, 127.9, 127.2, 
122.4, 116.7 (d, JC-F = 18.9 Hz), 106.2 (dd, JC-F = 35.2, 5.5 Hz), 76.6, 60.7, 53.6, 52.3; 
HRMS [M+H]+ calcd for C25H26F2N3: 406.2095, found: 406.2114. 
(E)-4-(3-(4-Benzhydrylpiperazin-1-yl)prop-1-en-1-yl)-3,5-dimethylisoxazole (1.74): 
An oven-dried vial with magnetic stir bar was charged with 1.71 (16.3 mg, 0.0499 mmol), 
3,5-dimethylisoxazole-4-boronic acid pinacol ester (16.47 mg, 0.0749 mmol) and CsF 
(11.4 mg, 0.0750 mmol). Pd(OAc)2/SPhos (1:2 solution in i-PrOH, 0.01 M in Pd, 0.38 mL, 
3.8 mol) was subsequently added. The vial was sealed and removed from the glove box. 
The mixture was allowed to stir at 85 °C for 12 h, after which time the reaction was 
quenched by passing through a short plug of silica gel and washed with 5% MeOH/CH2Cl2 
(3x2 mL). The filtrate was concentrated in vacuo to afford brown oil, which was purified 
by silica gel chromatography (100% CH2Cl2 to 2% MeOH/CH2Cl2) to afford 1.74 13.9 mg, 
0.0359 mmol, 72% yield) as yellow oil. IR (neat): 2931 (w), 2806 (m), 2763 (w), 1671 
(w), 1598 (w), 1491 (w), 1450 (m), 1426 (w), 1136 (m), 1004 (m), 966 (m), 909 (m), 730 
(s), 705 (s); 1H NMR (400 MHz, CDCl3): δ 7.41 (4H, d, J = 8.3 Hz), 7.30–7.22 (4H, m), 
7.17 (2H, t, J = 7.3 Hz), 6.18 (1H, d, J = 16.3 Hz), 5.92 (1H, dt, J = 16.4, 6.8 Hz), 4.24 
(1H, s), 3.14 (2H, d, J = 6.8 Hz), 2.77–2.32 (8H, m), 2.38 (3H, s), 2.28 (3H, s); 13C NMR 
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(151 MHz, CDCl3): δ 165.5, 158.4, 142.8, 128.6, 128.0, 127.1, 120.8, 112.5, 76.3, 61.8, 
53.6, 51.9, 11.8, 11.6 ; HRMS [M+H]+ calcd for C25H30N3O: 388.2389, found: 388.2392. 
1.7.9. Kinetically E-Selective CM to Access E-Alkenyl Fluorides 
tert-Butyl (E)-3-(2-fluorovinyl)-1H-indole-1-carboxylate (1.82): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by 
syringe to an oven-dried vial containing a solution of E-1-chloro-2-fluoroethene in toluene 
(2.36 M in toluene, 215 L mmol, 0.507 mmol) and tert-butyl 3-vinyl-1H-indole-1-
carboxylate (12.3 mg, 0.0506 mmol). The resulting solution was allowed to stir for 2 h at 
22 °C. The reaction was then quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of tert-butyl 3-vinyl-1H-indole-1-
carboxylate that resulted in the formation of a mixture of F- and Cl-alkenes (89:11 F:Cl). 
The resulting red oil was purified by silica gel chromatography (50:1 pentane/Et2O) to 
afford 1.82 (10.9 mg, 0.0417 mmol, 82% yield) in >98:2 E:Z ratio as colorless oil. IR ( 
neat): 2981 (w), 2932 (w), 1732 (s), 1717 (s), 1454 (m), 1368 (s), 1253 (s), 1149 (s), 1090 
(s), 736 (s); 1H NMR (400 MHz, CDCl3): δ 8.15 (1H, d, J = 8.3 Hz), 7.57 – 7.50 (2H, m), 
7.29 (1H, ddd, J = 83.7, 11.5, 0.6 Hz), 7.34 (2H, ddd, J = 8.5, 7.2, 1.3 Hz), 7.28 (1H, d, J 
= 1.2 Hz), 7.28 – 7.25 (1H, m), 6.46 (1H, ddd, J = 19.3, 11.4, 0.9 Hz), 1.66 (9H, s); 19F 
NMR (376 MHz, CDCl3): δ –126.49 (1F, dd, J = 83.7, 19.3 Hz); 13C NMR (151 MHz, 
CDCl3): δ 150.1 (d, J = 258.2 Hz), 149.6, 135.9, 128.6, 125.0, 123.3, 123.1, 119.8, 115.6, 
113.1 (d, J = 12.9 Hz), 105.5 (d, J = 18.3 Hz), 84.1, 28.3; HRMS [M+H]+ calcd for 
C15H17FNO2: 262.1243, found: 262.1246. 
(E)-1-Bromo-4-(2-fluorovinyl)benzene (1.84): Following the general procedure, a 
solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by syringe to an 
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oven-dried vial containing E-1-chloro-2-fluoroethene (2.36 M in toluene, 110 L mmol, 
0.260) and 4-bromostyrene (9.4 mg, 0.0513 mmol). The solution was allowed to stir for 2 
h at 22 °C, after which the reaction was quenched with wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of styrene that resulted in the formation 
of a mixture of fluoro- and chloro-alkenes (89:11 F:Cl). The resulting orange oil was 
purified by silica gel chromatography (100% pentane) to afford 1.84 (6.1 mg, 0.0303 
mmol, 59% yield) in >98:2 E:Z ratio as colorless oil. The spectral data for this compound 
were in accordance with those reported previously.22   
(E)-4-(2-Fluorovinyl)phenyl acetate (1.85): Following the general procedure, a solution 
of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by syringe to an oven-dried 
vial containing E-1-chloro-2-fluoroethene (2.36 M in toluene, 105 L,  0.248 mmo) and 4-
acetoxystyrene (8.1 mg, 0.0499 mmol). The resulting solution was allowed to stir for 2 h 
at 22 °C, after which the reaction was quenched with wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of styrene that resulted in the formation 
of a mixture of fluoro- and chloro-alkenes (87:13 F:Cl). The resulting orange oil was 
purified by silica gel chromatography (10:1 pentane/Et2O) to afford 1.85 (6.4 mg, 0.0355 
mmol, 71% yield) in >98:2 E:Z ratio as needle-like crystalline solid. Mp: 57–59 C; IR 
(neat): 3096 (w), 1740 (s), 1656 (m), 1603 (w), 1508 (m), 1362 (m), 1209 (s), 1185 (s), 
1165 (s), 1080 (s), 1007 (m), 918 (s), 668 (m), 530 (s); 1H NMR (500 MHz, CDCl3): δ 
7.25 (2H, d, J = 8.6 Hz), 7.13 (1H, dd, J = 83.0, 11.3 Hz), 7.04 (2H, d, J = 8.6 Hz), 6.38 
(1H, dd, J = 19.1, 11.3 Hz), 2.30 (3H, d, J = 0.6 Hz); 13C NMR (151 MHz, CDCl3): δ 
169.6, 150.3 (d, J = 259.5 Hz), 127.3, 122.10, 113.24 (d, J = 16.6 Hz), 21.26; 19F NMR 
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(376 MHz, CDCl3): δ –129.42 (1F, dd, J = 83.0, 19.1 Hz); HRMS [M+H]+ calcd for 
C10H10FO2: 181.0664, found: 181.0661. 
(E)-2-(4-(2-Fluorovinyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.86): 
Following the general procedure, a solution of Mo-1 in benzene (0.1 M, 22 L, 2.2 mol) 
was transferred by syringe to an oven-dried vial containing a solution of E-1-chloro-2-
fluoroethene in toluene (2.36 M, 185 μL, 0.435 mmol) and 4,4,5,5-tetramethyl-2-(4-
vinylphenyl)-1,3,2-dioxaborolane (10.0 mg, 0.0435 mmol). The resulting solution was 
allowed to stir for 2 hours at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed >98% consumption of 4,4,5,5-tetramethyl-
2-(4-vinylphenyl)-1,3,2-dioxaborolane that resulted in the formation of a mixture of fluoro- 
and chloro-alkenes (88:12 F:Cl). The resulting red oil was purified by silica gel 
chromatography (2% Et2O/hexanes) to afford 1.86 (7.9 mg, 0.0318 mmol, 73% yield) in 
>98:2 E:Z ratio as colorless oil. IR (neat): 2980 (w), 1657 (w), 1610 (w), 1360 (m), 1264 
(m), 1092 (m), 912 (w); 1H NMR (400 MHz, CDCl3): δ 7.74 (2H, d, J = 8.0 Hz), 7.25 
(2H, d, J = 8.3 Hz), 7.22 (1H, dd, J = 83.0, 11.3 Hz), 6.39 (1H, dd, J = 19.3, 11.3 Hz), 1.34 
(12H, s); 19F NMR (376 MHz, CDCl3): δ –128.46 (1F, dd, J = 83.1, 19.3 Hz); 13C NMR 
(101 MHz, CDCl3): δ 150.9 (d, J = 260.6 Hz), 135.4, 125.6, 125.5, 114.2, 114.0, 84.0, 
25.0; HRMS [M+H]+ calcd for C14H19BFO2: 249.1462, found: 249.1462. 
(E)-3-(2-Fluorovinyl)benzo[b]thiophene (1.87): Following the general procedure, a 
solution of Mo-1 in benzene (0.1 M, 31 L, 3.1 mol) was transferred by syringe to an 
oven-dried vial containing a solution of E-1-chloro-2-fluoroethene in toluene (2.36 M, 265 
μL, 0.624 mmol) and 3-vinylbenzo[b]thiophene (10.0 mg, 0.0624 mmol). The resulting 
solution was allowed to stir for 2 h at 22 °C. The reaction was quenched by addition of wet 
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CDCl3 and analysis of the unpurified mixture revealed 95% consumption of 3-
vinylbenzo[b]thiophene that resulted in the formation of a mixture of fluoro- and chloro-
alkenes (88:12 F:Cl). The resulting red oil was purified by silica gel chromatography (2% 
Et2O/hexanes) to afford 1.87 (7.3 mg, 0.0410 mmol, 66% yield) in >98:2 E:Z ratio as 
colorless oil. IR (neat): 3057 (w), 2921 (w), 1657 (m), 1426 (w), 1264 (m), 1111 (m), 908 
(w); 1H NMR (400 MHz, CDCl3): δ 7.89 ̶ 7.85 (1H, m), 7.80 ̶ 7.76 (1H, m), 7.45 ̶ 7.36 
(2H, m), 7.30 (1H, s), 7.23 (1H, dd, J = 83.5, 11.3 Hz), 6.63 (1H, ddd, J = 18.1, 11.3, 1.0 
Hz); 19F NMR (376 MHz, CDCl3): δ –125.14 (1F, dd, J = 83.5, 18.1 Hz); 13C NMR (101 
MHz, CDCl3): δ 150.8 (d, J = 261.9 Hz), 124.8, 124.6, 123.1, 122.0, 122.0, 122.0, 107.2, 
107.0; HRMS [M+H]+ calcd for C10H8FS: 179.0331, found: 179.0335. 
(E)-tert-Butyl(8-fluoro-2,6-dimethyl-7-octen-2-yloxy)dimethylsilane (1.88): Following 
the general procedure, a solution of Mo-1 in benzene (0.1 M, 18 L, 1.8 mol) was 
transferred by syringe to an oven-dried vial containing a solution of E-1-chloro-2-
fluoroethene in toluene (2.36 M, 78 μL, 0.185 mmol) and tert-butyl(2,6-dimethyl-7-octen-
2-yloxy)dimethylsilane (10.0 mg, 0.0370 mmol). The resulting solution was allowed to stir 
for 2 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed 95% consumption of tert-butyl(2,6-dimethyl-7-octen-2-
yloxy)dimethylsilane that resulted in the formation of a mixture of fluoro- and chloro-
alkenes (90:10 F:Cl). The resulting red oil was purified by silica gel chromatography 
(100% pentane) to afford 1.88 (8.2 mg, 0.0284 mmol, 77% yield) in >98:2 E:Z ratio as 
colorless oil. IR (neat): 2956 (m), 2930 (m), 2856 (w), 1672 (w), 1462 (w), 1252 (m), 1039 
(s), 917 (m), 833 (s), 770 (s); 1H NMR (400 MHz, CDCl3): δ 6.48 (1H, ddd, J = 86.3, 
11.1, 0.8 Hz), 5.22 (1H, ddd, J = 20.0, 11.1, 9.0 Hz), 2.05 (1H, qt, J = 10.9, 7.3 Hz), 
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2.011.99 (1H, m), 1.371.23 (6H, m), 1.17 (6H, s), 1.00 (3H, s), 0.85 (9H, s), 0.05 (6H, 
s); 19F NMR (376 MHz, CDCl3): δ  ̶ 133.34 (1F, dd, J = 86.3, 20.0 Hz); 13C NMR (100 
MHz, CDCl3): δ 148.0 (d, J = 252.3 Hz), 117.7, 73.6, 45.1, 37.9, 30.8, 30.0, 26.0, 22.0, 
21.2, 18.3, -1.9; HRMS [M+H]+ calcd for C16H34FOSi: 289.2363, found: 289.2371. 
Methyl (1R,4aR,4bS,7S,10aR)-7-((E)-2-fluorovinyl)-1,4a,7-trimethyl-
1,2,3,4,4a,4b,5,6,7, 8,10,10a-dodecahydrophenanthrene-1-carboxylate (1.90): 
Following the general procedure, a solution of Mo-1 in benzene (0.1 M, 14 L, 1.4 mol) 
was transferred by syringe to an oven-dried vial containing a solution of E-1-chloro-2-
fluoroethene in toluene (2.36 M, 30 µL, 0.0711 mmol) isopimaric acid methyl ester (4.5 
mg, 0.0142 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction 
was quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 
94% consumption of alkene precursor that resulted in the exclusive formation of fluoro-
alkene. The resulting orange oil was purified by silica gel chromatography (10 mL of 1:1 
hexanes/benzene then 15 mL of 20:1 hexanes/Et2O) to afford 1.90 (3.7 mg, 0.0111 mmol, 
78% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 2916 (m), 2868 (m), 2847 (m), 
1724 (s), 1667 (m), 1432 (m), 1385 (m), 1241 (s), 1184 (m), 1143 (m), 1069 (s), 920 (s).; 
1H NMR (400 MHz, CDCl3): δ 6.47 (1H, dd, J = 86.1, 11.2 Hz), 5.37 (1H, dd, J = 22.9, 
11.2 Hz), 5.32 (1H, m), 3.64 (3H, s), 2.03–1.69 (8H, m), 1.64–1.47 (6H, m), 1.42–1.23 
(5H, m), 1.17–1.06 (1H, m), 0.89 (3H, s), 0.88 (3H, s).; 13C NMR (101 MHz, CDCl3): δ 
179.3, 149.1, 146.6, 135.0, 123.9, 123.87, 121.7, 52.1, 51.9, 46.8, 46.8, 46.7, 45.4, 39.0, 
37.1, 36.8, 36.8, 35.2, 33.6, 33.5, 25.3, 22.2, 19.9, 18.1, 17.6, 15.4.; 19F NMR (376 MHz, 
CDCl3): δ –138.07 (1F, dd, J = 86.1, 22.8 Hz).; HRMS [M+H]+ calcd for C21H32FO2: 
335.2386, found: 335.2382.  
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(3aR,5S,6aR)-5-((E)-2-Fluorovinyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole 
(1.91): Following the general procedure, a solution of Mo-1 in benzene (0.1 M, 42 L, 4.2 
mol) was transferred by syringe to an oven-dried vial containing a solution of E-1-chloro-
2-fluoroethene in toluene (2.36 M, 90 µL, 0.212 mmol) and   (3aR,5S,6aR)-2,2-dimethyl-
5-vinyltetrahydrofuro[2,3-d][1,3]dioxole18,58 (7.1 mg, 0.0422 mmol). The resulting 
solution was allowed to stir for 12 h at 40 °C. The reaction was quenched by addition of 
wet CDCl3 and analysis of the unpurified mixture revealed 94% consumption of alkene 
precursor that resulted in the exclusive formation of fluoro-alkene (>98:2 F:Cl). The 
resulting orange oil was purified by silica gel chromatography (100 mL of 20:1 
pentane/Et2O then 100 mL of 10:1 pentane/Et2O) to afford 1.91 (4.3 mg, 0.0228 mmol, 
54% yield) in >98:2 E:Z ratio as colorless oil. The spectral data for this compound were 
identical to those previously reported.18 
1.7.10. NMR Spectra 
 
 
 
 
 
 
 
 
                                                 
(58) Merayala, H. B.; Goud, P. M.; Radikota, R. R.; Reddy, K. R. J. Carbohydr. Chem. 2000, 19, 1211–1222. 
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1H NMR of Mo-6 
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1H NMR of S6 
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13C NMR of S6 
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1H NMR of 1.43 
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13C NMR of 1.43 
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1H NMR of 1.44 
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13C NMR of 1.44 
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1H NMR of 1.45 
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13C NMR of 1.45 
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1H NMR of 1.48 
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13C NMR of 1.48 
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1H NMR of 1.49 
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13C NMR of 1.49 
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1H NMR of 1.50
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13C NMR of 1.50 
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1H NMR of 1.51 
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13C NMR of 1.51 
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1H NMR of 1.52 
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13C NMR of 1.52 
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1H NMR of 1.53
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13C NMR of 1.53 
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1H NMR of 1.54 
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13C NMR of 1.54 
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1H NMR of 1.63 
 
Page 72 
1H NMR of 1.70
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13C NMR of 1.70 
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1H NMR of 1.71 
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13C NMR of 1.71
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1H NMR of 1.72 
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13C NMR of 1.72 
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1H NMR of 1.73 
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13C NMR of 1.73 
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1H NMR of 1.74 
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13C NMR of 1.74 
 
Page 82 
1H NMR of 1.82 
 
 
Page 83 
13C NMR of 1.82 
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19F NMR of 1.82 
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1H NMR of 1.85 
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13C NMR of 1.85 
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19F NMR of 1.85 
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1H NMR of 1.86 
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13C NMR of 1.86 
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19F NMR of 1.86 
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1H NMR of 1.87 
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13C NMR of 1.87
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19F NMR of 1.87
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1H NMR of 1.88
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13C NMR of 1.88 
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19F NMR of 1.88 
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1H NMR of 1.90 
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13C NMR of 1.90 
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13C NMR of 1.90 
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1H NMR of 1.91 
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Chapter Two 
Development of Efficient and Kinetically E-Selective 
Macrocyclic Ring-Closing Metathesis 
2.1. Introduction 
Macrocyles recently emerge as an exciting chemical space for therapeutic agents 
because of the favorable biological and physiochemical properties that the macrocyclic 
scaffold could impart to medicinal compounds.1 Among various strategies to construct a 
macrocycle, ring-closing metathesis2 (RCM) is frequently used in the pharmaceutical 
industry for discovery as well as process scale-up purposes due to its versatility and 
reliability in formation of various ring sizes.3 More often than not, the geometry of the  
 
macrocyclic alkene products is critical for biological activity (e.g. the E isomer of pacritinib 
                                                 
(1) E. Marsault, M. K. Peterson,  J. Med. Chem. 2011, 54, 1961–2004. 
(2) P. R. Hanson, S. Maitram, R. Chegondi, J. L. Markley in Handbook of Metathesis Vol. 2 (eds Grubbs, R. 
H. & O’Leary, D. J.) 1–170 (Wiley–VCH, 2014). For a recent review on ring-closing metathesis in drug 
development, see: M. Yu, S. Lou, F. Gonzales-Bobes. Org. Process. Res. Dev. 2018 DOI: 
10.1021/acs.oprd.8b00093 
(3) C. S. Higman, J. A. M. Lummiss, D. E. Fogg, Angew. Chem. Int. Ed. 2016, 55, 3552–3565. 
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isomer of pacritinib,4 an 18-membered ring tyrosine kinase inhibitor shown in Scheme 
2.1.1, is more potent than the Z isomer) as well as for the stereochemical outcome of 
subsequent transformations [e.g. stereoselective dihydroxylation of the E-macrocyclic 
alkene moiety in the total synthesis of amphidinolide T2 (Scheme 2.1.1).5 Kinetically Z-
selective RCM reactions that allow access to Z-macrocyclic alkene from bis--olefin 
(containing two terminal alkene moieties) precursors have been reported6 but the 
kinetically E-selective variant remained unknown. Instead, pure E-macrocyclic alkenes can 
be obtained from a two-step procedure that involves RCM of a bis--olefin substrate to 
generate a mixture that is usually more enriched in the E- macrocyle; ensuing Z-selective  
 
                                                 
(4) William, A. D.; Lee, A. C.-H.; Blanchard, S.; Poulsen, A.; Teo, E. L.; Nagaraj, H.; Tan, E.; Chen, D.; 
Williams, M.; Sun, E. T.; Goh, K. C.; Ong, W. C.; Goh, S. K.; Hart, S.; Jayaraman, R.; Pasha, M. K.; 
Ethirajulu, K.; Wood, J. M.; Dymock, B. W. J. Med. Chem. 2011, 54, 4638–4658. 
(5) Li, H.; Wu, J.; Luo, J.; Dai, W.-M. Chem. Eur. J. 2010, 16, 11530–11534. 
(6) (a) Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature 
2011, 479, 8893. (b) Wang, C.; Yu, M.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. 
H. Chem. Eur. J. 2013, 19, 27262740. For more recent Z-selective RCM studies, see: (c) Zhang, H.; Yu, E. 
C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 1649316494. (d) Xu, C.; Shen, 
X.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 10919–10928. (e) Ahmed, T. S.; Montgomery, T. P.; 
Grubbs, R. H. Chem. Sci. 2018, 9, 35803583. 
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ethenolysis7 (cross-metathesis of internal olefins with ethylene gas as the cross-partner)  
then selectively converts the undesired Z isomer back to starting material (i.e. 2.1, Scheme 
2.1.2) leaving the E-alkene in high isomeric purity. Without catalyst control, 
stereoselectivity of the RCM step can vary significantly with subtle changes in the 
substrates (e.g. 46% vs. 77% E selectivity in RCM of 16-membered rings with different 
position of alkene moiety8 or induced conformational change through protonation 
 
                                                 
(7) Marx, V. M.; Herbert, M. B.; Keitz, B. K.; Grubbs, R. H. J. Am. Chem. Soc. 2013, 135, 94−97.  For Z-
selective ethenolysis of acyclic internal alkenes, see: Marinescu, S. C.; Schrock, R. R.; Müller, P.; Hoveyda, 
A. H. J. Am. Chem. Soc. 2009, 131, 10840–10841. For a recent review on ethenolysis, see: Bidange, J.; 
Fischmeister, C.; Bruneau, C. Chem. Eur. J. 2016, 22, 1222612244.  
(8) Fürstner, A.; Langemann, K. J. Org. Chem. 1996, 61, 3942–3943. 
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of amine functional groups9 as exemplified in Scheme 2.1.3) and such variations in 
stereoselectivity are hard to predict a priori. Moreover, macrocyclic RCM is often 
performed at a late stage in a synthetic route;10 thus, degradation of a significant fraction 
of valuable products especially in cases where there is little to no preference for the E 
isomer can be costly. Last but not least, use of ethylene gas entails the formation of 
methylidene species which are prone to decomposition, thus requiring higher catalyst 
loadings to maintain reaction efficiency. 
There are methods that convert cycloalkynes, prepared from ring-closing alkyne 
metathesis11 (RCAM), to E-macrocyclic alkenes through trans-selective hydrosilylation of 
alkynes12 promoted by [Cp*Ru(CH3CN)3]PF6 (Cp* = pentamethylcyclopentadienyl) 
followed by stereoretentive protodesilylation with excess silver fluoride in methanol.   
 
                                                 
(9) Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632–16633. 
(10)Hughes, D.; Wheeler, P.; Ene, D. Org. Process. Res. Dev. 2017, 21, 1938–1962. 
(11) For a recent review on ring-closing alkyne metathesis, see: Fürstner, A. Angew. Chem. Int. Ed. 2013, 
52, 2794–2819. 
(12) Fürstner, A.; Radkowski, K. Chem. Commun. 2002, 2182–2183. 
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Cp*RuCl(cod) (cod = 1,5-cyclooctadiene) under an elevated pressure of H2 gas (Scheme 
2.1.4). Other than the use of precious transition-metal catalysts, the former approach can 
only deliver the desired E-macrocyclic alkenes in three steps starting from acetylene 
(compared to terminal alkenes).6b The latter approach, although more concise than the 
hydrosilylation/protodesilylation sequence, is often accompanied by over-reduction to 
difficult-to-remove alkane byproducts. 
Hence, the development of an E-selective macrocyclic RCM reaction that can 
deliver E-macrocyclic alkenes efficiently and in high isomeric purity would not only be a 
substantial advancement in the field of stereoselective olefin metathesis but also allow 
direct access to E-macrocycles from more abundant and readily available alkene starting 
materials (vs. alkyne metathesis). 
2.2. Design Principles for Kinetically E-Selective Ring-Closing Metathesis 
In chapter 1, a kinetically controlled E-selective cross-metathesis (CM) of terminal 
olefins and trans-β-alkyl styrenes with E-1,2-dihaloethenes was described with 
monoaryloxide monopyrrolide  (MAP) Mo-alkylidene complex Mo-1 (Scheme 2.2.1).13 
Development of an E-selective RCM reaction, however, poses several distinct challenges 
compared to a CM counterpart. Whereas an excess amount of cross partner is usually 
employed in CM reactions to favor product formation,14 the same practice is not possible 
in RCM. In addition, undesired homocoupling of unhindered terminal alkenes in CM can 
be minimized with a large excess of the cross partner. Meanwhile, formation of oligomers 
                                                 
(13) Nguyen, T. T.; Koh, M. J.; Shen, X.; Romiti, F.; Schrock, R. R.; Hoveyda, A. H. Science 2016, 352, 
569–575. 
(14) Chatterjee, A. K. in Handbook of Metathesis; Grubbs, R. H., Ed; Wiley-VCH, 2003; Vol. 1, pp 246–
295. 
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resulting from CM of bis--olefin substrates often preceeds macrocyclic RCM even at mM 
concentration15 and productive RCM most likely operates through a sequence of steps 
involving oligomerization followed by backbiting.16 Thus, in considering a strategy to 
achieve high stereoselectivity as well as to minimize competitive oligomer formation 
during E-selective RCM, we envisioned that a diene precursor that contains a terminal 
alkene and an E-1,2-disubstituted alkene with a suitable substituent R (2.10, Scheme 2.2.1) 
could induce facile and selective formation of metallacyclobutane (mcb) 2.12 while 
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(15) Conrad, J. C.; Edelman, M. D.; Duarte Silva, J. A.; Monfette, S.; Parnas, H. H.; Snelgrove, J. L.; Fogg, 
D. E. J. Am. Chem. Soc. 2007, 129, 1024-1025. 
(16) Monfette, S.; Fogg, D. E. Chem. Rev. 2009, 109, 3783–3816. 
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oligomerization of 2.10 should be relatively slow (compared to bis--olefin precursor) in 
the presence of a 1,2-disubstituted alkene moiety. As in the case of E-selective CM17 with 
Mo-1, mcb 2.12 should be more favored than its isomer 2.13 due to the increased eclipsing 
interaction (the involved C-alkyl and C-alkyl groups are highlighted by two shaded 
circles in 2.12, Scheme 2.2.1) and severe steric repulsion between C-R and the peripheral 
ring of the aryloxide ligand (both in shaded circles) present in the latter. Furthermore, 
cycloreversion of 2.13 would produce anti-alkylidene species 2.14anti which is typically 
higher in energy compared to the syn-alkylidene counterpart (see 2.14syn, Scheme 2.2.1).18  
A practical, efficient, and stereoselective macrocyclic RCM utilizing diene 
substrates such as 2.10 would be feasible if the E-disubstituted alkene portion meets the 
following requirements. First, it must be readily accessed in pure E form in an efficient, 
inexpensive, and reliable manner. Second, the substituent R should be large enough to 
disfavor adventitious isomerization of the E-alkene but not too large so that RCM is 
inhibited. Third, the E-alkene should be polarized in such a way that there is a greater 
electron density at the carbon adjacent to R to induce a favorable electronic match19 
between the E-alkene and the electron-deficient Mo center (see 2.11, Scheme 2.2.1). 
Finally, the Mo-alkylidene species derived from R after each productive RCM event (i.e. 
2.14syn) should be reactive so that RCM can occur at a reasonable rate even at high dilution 
condition typically employed in macrocyclic RCM.16 Yet, such intermediate should be  
                                                 
(17) For a more detailed discussion on the stereochemical model of kinetically E-selective CM with Mo-1, 
see Chapter 1, Section 1.2. 
(18) Schrock, R. R.;  Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4592−4633. 
(19) For discussion on how the electronic match between an incoming alkene and Mo-alkylidene can 
influence CM efficiency as well as regioselectivity of alkene products, see: (a) Crowe, W. E.; Zhang, Z. J. J. 
Am. Chem. Soc. 1993, 115, 1099810999. (b) Koh, M.-J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; 
Hoveyda, A. H. Nature 2016, 531, 459–465. 
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sufficiently stable to presumably avoid decomposition of catalyst. 
We first explored several E-alkene substrates that would lead to the 16-membered 
ring 2.4 (Scheme 2.2.2); the RCM was typically performed in toluene (1.0 mM 
concentration) at ambient temperature under reduced pressure (28 torr). Bis--olefin 2.15a 
was completely consumed within 2 hours, and macrocycle 2.4 was formed in 80% with 
moderate E selectivity (70:30 E:Z), which was similar to those reported with Ru carbene 
complex8 (cf. 2.4, Scheme 2.1.3). We next examined 2.15b because E-chloroalkenes can 
now be accessed through efficient and highly E-selective CM and control experiments have 
shown that such entities are resistant to isomerization. RCM of 2.15b afforded only 5% of 
2.4. This outcome might be because chloro-subsituted alkylidene species derived from  
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MAP complexes19b are more reactive than the aliphatic counterpart. The enhanced 
reactivity of chloro-substituted alkylidene could be translated productively to high turnover 
numbers in CM where the concentration of alkene reactants is high. In contrast, its 
encounter with another alkene under highly diluted RCM condition is much less frequent 
and catalyst decomposition could become competitive. Attempts to cyclize trans--alkyl 
styrene 2.15c, a motif that we have used successfully for E-selective CM, proved to be 
equally ineffective. Although 90% of the starting diene was consumed, only about 15% of 
which was converted to macrocycle 2.4. Out of the complicated product mixture, we could 
detect trans-stilbene (from 1H NMR analysis) among several oligomeric products (detected 
by high-resolution mass spectrometry). The ability of Mo-benzylidene derived from Mo-1 
(cf. 2.14syn where R = Ph, Scheme 2.2.1) to efficiently engage trans--alkyl styrene in CM 
allowed for oligomerization of 2.15c to take place more readily than RCM. Although 
longer reaction time may improve RCM efficiency15, the oligomers formed could undergo 
facile isomerization to generate a mixture of E-and Z-disubstituted alkenes,13 which could 
erode E selectivity.  
At this point we thought that attenuating the reactivity of the propagating Mo 
alkylidene species (cf. 2.14syn, Scheme 2.2.1) could lead to a more chemoselective turnover 
event (i.e. reaction would occur more preferentially at the terminal alkene site rather than 
at the E-disubstituted alkene moiety), thus rendering oligomerization less competitive. We 
turned to E-alkenylsilane (2.15d) and E-alkenylboronates (2.15e and 2.15f) because the 
silyl-and boryl-substituted alkylidene derived from MAP complexes have been shown to 
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be less reactive than an aliphatic alkylidene;20 moreover, both alkenylsilane and 
alkenylboronate possess the desired polarization of C=C bond (as depicted in 2.11, Scheme 
2.2.1) due to the donation of electron density from the  bonding pair into the low-lying 
*Si-C orbital in the former or the partially vacant p orbital of boron in the latter. Whereas 
RCM of 2.15d was not efficient (<5% formation of 2.4), the results with 2.15e and 2.15f 
were promising (44% conv. to 2.4 in 96:4 E:Z and 37% conv. to 2.4 in 93:7 E:Z, 
respectively). Previous investigations have shown that pinacolatoboryl [B(pin)] MAP 
alkylidene complexes are more active than those with a trimethylsilyl group.20 Although 
RCM with 2.15f was also E-selective, the hexylene glycolatoboryl group is less robust than 
B(pin) and not as practical to use. Therefore, we decided to further explore RCM with 
substrate bearing a terminal alkene and an E-alkenylB(pin).  
2.3. Kinetically E-Selective Macrocyclic RCM 
The required E-alkenylB(pin) moiety is stable to air and moisture and can be 
prepared by several E-selective and broadly applicable protocols starting from readily 
available catalysts/reagents.21 For instance, subjecting alkyne 2.16, which has an 
unprotected hydroxy group, to 20 mol % Schwartz’s reagent (Cp2ZrHCl), 4.0 equiv. of 
pinacolborane, and 10 mol % triethylamine21f (all are commercially available) followed by 
routine esterification afforded 2.15e in 70% yield as a single alkene isomer (>98% E) 
                                                 
(20) Townsend, E. M.; Kilyanek, S. M.; Schrock, R. R.; Müller, P.; Smith, S. J.; Hoveyda, A. H. 
Organometallics 2013, 32, 4612–4617. 
(21) (a) Tucker, C. E.; Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482–3485. (b)  Pereira, S.; Srebnik, 
M. Organometallics 1995, 14, 3127–3128. (b) Wang, Y. D.; Kimball, G.; Prashada, A. S.; Wanga, Y. 
Tetrahedron Lett. 2005, 46, 87778780. (c) Shirakawa, K.; Arase, A.; Hoshi, M. Synthesis, 2004, 
18141820. (d) Zhang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7859–
7871. (e) Coombs, J. R.; Zhang, L.; Morken, J. P. Org. Lett. 2015, 17, 1708–1711. (f) Hong, S.; Zhang, W.; 
Liu, M.; Yao, Z.-J.; Deng, W. Tetrahedron Lett. 2016, 57, 1–4. 
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(Scheme 2.3.1). Treatment of 2.15e with 5.0 mol % Mo-1 under similar conditions as 
described in Scheme 2.2.2 but with longer reaction time (6 hours vs. 2 hours) furnished 2.4  
in 60% yield and 96:4 E:Z. 
Twelve- to nineteen-membered macrocyclic lactones (2.6, 2.17-2.20, Scheme 
2.3.1) were obtained in yields similar to when bis--olefin substrates were used with Ru-1 
complex but in much higher E selectivity (91:9 to >98:2 E:Z). Although RCM efficiency  
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with Ru-1 and bis--olefin precursors may at times produce a higher yield, a significant 
fraction of the macrocycle (24% to 42% Z) was the undesired Z isomer, which is difficult 
to remove by routine purification methods. Meanwhile, the present protocol delivered the 
macrocyclic alkenes in substantially higher E selectivity. The moderate yields of the 
macrolactones in Scheme 2.3.1 could be attributed to a lack of conformational constraint.22 
Homocoupling of the terminal alkene site became competitive with macrocyclic RCM, 
thus accounting for the differences between conversion (consumption of starting diene) 
and formation of macrocycles. Unlike RCM with bis--olefin substrates where two 
reactive terminal alkene moieties are still present in the oligomeric products, self-
metathesis products generated from RCM of a diene containing a terminal alkene and a 
1,2-disubstituted alkene would generate intermediates that contain only disubstituted 
alkenes whose steric hindrance would slow down productive macrocyclization through a 
‘backbiting’ mechanism.16 The higher yields of macrocyclic products obtained from RCM 
of bis--olefin precursors in some cases (2.19 and 2.20) may reflect these differences. 
E-alkenylB(pin) may alternatively be prepared through NHC-Cu catalyzed E-and 
regio-selective protoboration21d of terminal alkynes. Reaction of alkyne 2.21 with 
bis(pinacolato)diboron [B2(pin)2], methanol and the NHC-Cu complex in situ generated 
from CuCl and imidazolium salt 2.22 (all are commercially available) furnished 2.23 in 
>98% chemoselectivity (i.e. <2% protoboration of the terminal alkene) and >98% E-
selectivity (Scheme 2.3.2). The RCM of 2.23 afforded 16-membered lactam 2.24 in 44% 
yield as a single alkene isomer, which compared well with the result obtained from RCM 
                                                 
(22) Martí-Centelles, V.; Pandey, M. D.; Burguete, M. I.; Luis, S. V. Chem. Rev. 2015, 115, 87368834. 
Page 114 
of bis--olefin substrate with Ru-123 (44% yield in >98% E:Z vs. 47% yield but as a near 
equal mixture of E and Z isomers). The same protoboryl addition/RCM led to the formation 
of 14-membered lactam 2.25 in 38% yield in similarly high E selectivity. Interestingly, 
RCM of bis--olefin substrate with 5.0 mol % Ru-1 (slowly added over 3 hours) afforded 
2.25 in higher efficiency (71% vs. 38% yield) but the Z isomer predominated (80% Z) 
probably due to substrate control. 
Boc
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2.4. Application to E-selective Synthesis of Recifeiolide and Pacritinib 
After establishing the optimal condition for E-selective macrocyclic RCM, we then 
explored the stereoselective synthesis of recifeiolide24 (antibiotic) and pacritinib4 (tyrosine 
                                                 
(23) Goldring, W. P. D.; Hodder, A. S.; Weiler, L. Tetrahedron Lett. 1998, 39, 4955–4958.  
(24) Vesonder, R. F.; Stodola, F. H.; Wickerham, L. J.; Ellis J. J.; Rohwedder, W. K. Can. J. Chem. 1971, 
49, 2029-2032. 
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kinase inhibitor) (Scheme 2.1.1) using this method. Synthesis of recifeiolide through RCM 
has been reported before:25 slow addition of a solution of 2.26 and another of 3.0 mol % 
Ru-3 into third vessel containing refluxing dichloromethane over 20 hours, followed by 12 
hours of reaction time at ambient temperature afforded recifeiolide in 80% yield as an 82:18 
E/Z mixture. In contrast, subjection of diene 2.28 obtained from the hydroboration and  
 
esterification described in Scheme 2.3.1 to our E-selective RCM protocol furnished 
recifeiolide in 65% yield and as a single alkene isomer. Moreover, the RCM was 
conveniently performed in only 6 hours (vs. 32 hours as reported) in a single vessel without 
the need to use a syringe pump (for slow addition of substrate and catalyst solutions). With 
                                                 
(25) Fürstner, A.; Langemann, K. Synthesis 1997, 792–803. 
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a paraffin pellet containing 5.0 mol % of Mo-1, recifeiolide can be obtained in 55% yield 
and >98% E selectivity. 
Pacritinib presents a particularly interesting target for E-selective RCM not only 
because of its exceptional biological activity4 but also due to the presence of two electron-
deficient allylic ethers and several Lewis basic functional groups. Previous attempt to 
synthesize 2.30, a precursor to pacritinib, required 10 mol % of Ru-4 under acidic condition 
(pH = 2.0-2.2) to effect complete protonation of the Lewis basic nitrogen atoms presumably 
to avoid decomposition of Ru-4.26 The macrocyclic product 2.30 was obtained in 74% 
yield as an inseparable 85:15 E:Z mixture of alkenes.  
We first looked at the model substrate 2.31 which did not have the 2-chloroethoxy 
group on the aniline ring. RCM of 2.31 with 5.0 mol % of Mo-1 was inefficient (25% conv. 
of 2.29, 17% formation of 2.32) in the presence of the 2-amino pyrimidine group although 
E selectivity was high (93:7 E:Z). The reduced RCM efficiency with Mo-1 was most likely 
derived from the formation of a stable and unreactive Mo-amine adduct27 rather than 
deprotonation of a metallacyclobutane intermediate as in the case of Ru carbene26. If that 
was true, the reactivity of Mo-1 would be resumed by adding a suitable aprotic Lewis acid 
to mask the Lewis basic 2-aminopyrimidine.27b Inspired by a previous study by Schrock 
and coworkers28 in which tris(pentafluorophenyl)borane [B(C6F5)3] was used to abstract 
neutral dimethylphenylphosphine ligand from a W-alkylidene complex, we decided to 
                                                 
(26) Lummiss, J. A. M.; Ireland, B. J.; Sommers, J. M.; Fogg, D. E. ChemCatChem 2014, 6, 459–463. 
(27) For examples of stable bipyridine adducts of Mo alkylidene complexes, see: (a) Lichtscheidl, A. G.; Ng, 
V. W. L.; Müller, P.; Takase, M. K.; Schrock, R. R.; Malcolmson, S. J.; Meek, S. J.; Li, B.; Kiesewetter, E. 
T.; Hoveyda, A. H. Organometallics 2012, 31, 4558−4564. (b) Heppekausen, J.; Fürstner, A. Angew. Chem. 
Int. Ed. 2011, 50, 7829–7832. 
(28) Peryshkov, D. V.; Schrock, R. R.; Takase, M. K.; Müller, P.; Hoveyda, A. H. J. Am. Chem. 
Soc. 2011, 133, 20754–20757. 
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probe the possibility of using B(C6F5)3 to disrupt the Mo-amine adduct. When the RCM 
was performed with 1.0 equiv. of B(C6F5)3 added, 2.32 was isolated in considerably higher 
yield (60% vs. 17% yield, Scheme 2.4.2) and 95:5 E:Z selectivity. Notably, the 
transformation was carried out at much more concentrated condition than when a Ru 
carbene was used (20 mM in toluene with Mo-1 vs. 1 mM in CH2Cl2 with Ru-4) and 
removal of volatile byproducts by vacuum was not needed. The reason for this distinction 
is that homocoupling of primary allylic ethers is slower with a Mo alkylidene compared to 
a Ru carbene.29 Consequently, generation of ethylene gas from the reaction mixture was  
 
minimal. For example, we found that there was 47% conv. to homocoupling product of 
allyl benzyl ether within 10 minutes when 2.0 mol % of Ru-4 was used as the catalyst 
                                                 
(29) Chatterjee, A. K.;  Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 
11360−11370. 
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whereas less than 5% of the same product was detected with 2.0 mol % Mo-1 as the 
catalyst.  
We then examined the E-selective RCM of diene 2.33 that would lead to 2.30, the 
actual precursor to pacritinib. However, RCM efficiency was not as high as with the model 
substrate (34% yield of 2.30 vs. 60% yield of 2.32) even with added B(C6F5)3 (Scheme 
2.4.3). The decrease in yield was most likely due to the additional Lewis basic phenoxy 
group in 2.33 which together with the allylic ether oxygen could chelate to the Lewis acidic 
Mo center to cause reduced catalyst activity. The Lewis acid B(C6F5)3, although effective 
in masking the 2-aminopyrimidine moiety, could not prevent chelation at the same time. 
We therefore investigated the Boc-protected variant (2.34, Scheme 2.4.3) thinking that the 
newly-introduced carbamate group could simultaneously decrease the Lewis basicity of  
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the 2-aminopyrimidine and the phenoxy groups. Gratifyingly, subjecting 2.34 to the same 
RCM conditions at ambient temperature and pressure furnished 2.30 in 73% yield and 92:8 
E:Z selectivity after ensuing Boc removal with trifluoroacetic acid. 
2.5. Conclusions 
In summary, we devised a strategy to achieve high E selectivity in RCM to afford 
E-macrocyclic alkenes of various ring sizes regardless of the associated thermodynamic 
preferences.  The key findings revealed that E-alkenylB(pin), widely recognized for its 
broad use in catalytic cross-coupling chemistry, possesses the appropriate steric and 
electronic attributes to serve as a suitable cross-partner in RCM with Mo alkylidenes. 
Synthetic utility was demonstrated through RCM at a late stage of a multi-step route. The 
investigation described above offers a practical solution to a compelling problem in olefin 
metathesis, further elevating the utility of this widely used transformation. 
2.6. Experimental Section 
2.6.1. General 
Unless otherwise noted, transformations were performed with distilled and degassed 
solvents under an atmosphere of dry N2, in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum line techniques. 1H NMR spectra were recorded on a Varian 
Unity INOVA 400 (400 MHz), 500 (500 MHz) or a 600 (600 MHz) spectrometer. 
Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance 
resulting from incomplete deuterium incorporation as the internal standard (CDCl3: δ 7.26 
ppm, C6D6: δ 7.16 ppm). Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), and 
coupling constants (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 400 
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(100 MHz), 500 (125MHz), or 600 (151 MHz) spectrometers with complete proton 
decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance as the internal standard (CDCl3: δ 77.16 ppm, C6D6: δ 128.00 ppm). High-
resolution mass spectrometry was performed on a Micromass LCT ESI-MS and JEOL 
Accu TOF Dart (positive mode) at the Boston College Mass Spectrometry Facility. Melting 
points were determined using a Thomas Hoover Uni-melt capillary melting point 
apparatus. Infrared (IR) spectra were recorded on a Bruker FTIR Alpha (ATR Mode) 
spectrometer, vmax in cm-1. Bands are characterized as broad (br), strong (s), medium (m), 
or weak (w). Values for E:Z ratios of products were determined by analysis of 1H NMR 
spectra. 
Solvents 
Solvents (CH2Cl2, benzene and toluene) were purified under a positive pressure of dry 
argon gas by a modified Innovative Technologies purification system. Tetrahydrofuran 
(THF) was distilled from Na/benzophenone. All purification procedures of RCM products 
were carried out with reagent grade solvents (purchased from Fisher) under bench-top 
conditions. 
Reagents 
The RCM substrates were dried by azeotropic distillation (with benzene) prior to use. 
Bis(cyclopentadienyl)zirconium(IV) chloride hydride (Cp2ZrHCl, Aldrich), pinacolborane 
(HBpin, Alfa Aesar), triethylamine (Et3N, Aldrich), N,N'-dicyclhexylcarbodiimide (DCC, 
Advanced ChemTech), 4-dimethylaminopyridine (DMAP, Advanced ChemTech), N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, Advanced ChemTech), 
di-tert-butyl dicarbonate (Boc2O, Advanced ChemTech), CuCl (Strem), NaOt-Bu (Strem), 
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anhydrous methanol (Aldrich), 1,3-bis(1-adamantyl)imidazolium tetrafluoroborate 
(Aldrich), hex-5-enoic acid (Aldrich), oct-7-enoic acid (Aldrich), non-8-enoic acid 
(Aldrich), undec-10-enoic acid (Aldrich), hex-5-ynoic acid (Aldrich), undec-10-ynoic acid 
(Aldrich), pent-4-yn-1-ol (Aldrich), hex-5-yn-1-ol (Aldrich), dec-9-yn-1-ol, undec-10-en-
1-ol (Aldrich), pent-4-yn-2-ol (Aldrich), undec-10-en-1-amine (GFS Chemicals), 1-
butanol (Aldrich), diisopropylethylamine  (iPr2NEt, Aldrich), propargyl bromide (80 wt. % 
in toluene, Alfa Aesar), KOH (Aldrich), (n-Bu)4NHSO4 (Aldrich), B(C6F5)3 (Alfa Aesar) 
were used as received.  
Bis(pinacolato)diboron (Frontier Scientific) was recrystallized from pentane prior to use. 
Undec-10-en-1-yl hex-5-enoate (from hex-5-enoic acid (Aldrich) and undec-10-en-1-ol 
(Aldrich)) was prepared by esterification according to a reported procedure.7 (E)-11-
Phenylundec-10-en-1-yl hex-5-enoate (from hex-5-enoic acid (Aldrich) and (E)-11-
phenylundec-10-en-1-ol30) were prepared by esterification in analogy to a reported 
procedure31. (E)-11-Chloroundec-10-en-1-yl hex-5-enoate (from hex-5-enoic acid 
(Aldrich) and (E)-11-chloroundec-10-en-1-ol) was prepared by esterification in analogy to 
a reported procedure31. (E)-11-Chloroundec-10-en-1-ol was prepared from undec-10-yn-
1-ol (Aldrich) in analogy to a reported procedure32. (E)-11-(4,4,6-Trimethyl-1,3,2-
dioxaborinan-2-yl)undec-10-en-1-yl hex-5-enoate (from hex-5-enoic acid (Aldrich) and 
(E)-11-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)undec-10-en-1-ol) were prepared by 
esterification in analogy to a reported procedure31. (E)-11-(4,4,6-Trimethyl-1,3,2-
dioxaborinan-2-yl)undec-10-en-1-ol was prepared from protoboration21d of undec-10-yn-
                                                 
(30) Werner, E. W.; Sigman,  M. S. J. Am. Chem. Soc. 2010, 132, 1398113983. 
(31) Dhaon, M. K.; Olsen, R. K.; Ramasamy, K. J. Org. Chem. 1982, 47, 19621965. 
(32) Mlynarski, S. N.; Schuster,  C. H.; Morken,  J. P. Nature 2014, 505, 386390. 
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1-ol in analogy to a reported procedure. (E)-11-(Dimethyl(phenyl)silyl)undec-10-en-1-yl 
hex-5-enoate was prepared from undec-10-yn-1-yl hex-5-enoate by protosilylation in 
analogy to a reported procedure.33 
Organometallic Complexes 
Mo monoaryloxide pyrrolide (MAP) complexes Mo-1 were prepared in situ from Mo 
bispyrrolide precursor and the corresponding terphenol according to a previously reported 
procedure.13 Mo complexes were manipulated under an atmosphere of N2 in a glove box. 
Ru-1 (Aldrich), Ru-2 (Aldrich), Ru-3 (Aldrich), Ru-4 (Aldrich) were used as received. 
Paraffin pellets were obtained from XiMo, AG. 
2.6.2. Synthesis of and analytical data for the RCM substrates 
 
Representative hydrozirconation-boryl trapping/ester formation procedure: 
(E)-11-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-10-en-1-yl hex-5-enoate 
(2.15e). In a N2-filled glove box, an oven-dried vial was charged with undec-10-yn-1-ol 
(444 mg, 2.70 mmol), pinacolborane (1.40 g, 10.94 mmol), Et3N (27.3 mg, 40 uL, 0.27 
mmol) and Cp2ZrHCl (140 mg, 0.54 mmol) in sequence at 22 °C. The vial was sealed and 
the mixture was allowed to heat to 60 °C for 17 h, after which the mixture was purified by 
                                                 
(33) Meng, F.; Jang, H.; Hoveyda, A. H. Chem. Eur. J. 2013, 19, 32043214. 
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silica gel chromatography (20% EtOAc in hexanes) to afford the desired alkenyl–(pin) 
compound as colorless oil (617 mg, 2.08 mmol, 77% yield). To the mixture of the obtained 
alkenyl B(pin) (148.2 mg, 0.50 mmol), 5-hexenoic acid (85.5 mg, 0.75 mmol) and 4 mL 
of dichloromethane in an oven-dried vial, was added N,N'-dicyclohexylcarbodiimide 
(DCC, 206.0 mg, 1.00 mmol) and 4-dimethylaminopyridine (DMAP, 12.2 mg, 0.10 mmol) 
in sequence at 0 °C, and the mixture was allowed to warm to 22 °C and stir for 3 h. At this 
time, the mixture was allowed to cool to 4 °C (freezer) and after 2 h, the resulting solid was 
removed by filtration and washed with cold hexanes (10 mL). The filtrate was collected, 
concentrated and purified by silica gel chromatography (2% EtOAc in hexanes) to afford 
2.15e as colorless oil (176.5 mg, 0.45 mmol, 90% yield). The overall yield for the two 
steps: 69%. IR (neat): 2977 (m), 2926 (s), 2855 (m), 1735 (s), 1638 (s), 1459 (m), 1361 
(s), 1318 (s), 1146 (s), 996 (m), 849 (m), 805 (m); 1H NMR (600 MHz, CDCl3): δ 6.60 
(dt, J = 17.9, 6.3 Hz, 1H), 5.75 (ddt, J = 13.4, 10.1, 6.7 Hz, 1H), 5.39 (d, J = 17.9 Hz, 1H), 
5.00 (d, J = 17.1 Hz, 1H), 4.95 (d, J = 10.2 Hz, 1H), 4.03 (t, J = 6.6 Hz, 2H), 2.28 (t, J = 
7.5 Hz, 2H), 2.16–2.02 (m, 4H), 1.76–1.66 (m, 2H), 1.61–1.55 (m, 2H), 1.33–1.21 (m, 
24H); 13C NMR (151 MHz, CDCl3): δ 173.7, 154.8, 137.8, 154.4, 83.0, 64.5, 35.9, 33.7, 
33.2, 29.5, 29.5, 29.3, 29.2, 28.7, 28.3, 26.0, 24.8, 24.2; HRMS[M+H]+: Calcd for 
C23H42B1O4: 393.31761; found: 393.31854.  
(E)-5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl oct-7-enoate 
(precursor to macrocycle 2.17; prepared through hydrozirconation-boryl trapping/ester 
formation sequence): IR (neat): 2977 (m), 2930 (s), 2858 (m), 1736 (s), 1639 (s), 1461 
(m), 1363 (s), 1321 (s), 1166 (s), 1145 (s), 995 (m), 971 (m), 910 (m), 638 (w); 1H NMR 
(600 MHz, CDCl3): δ 6.62 (dt, J = 18.0, 6.4 Hz, 1H), 5.78 (ddt, J = 17.0, 10.2, 6.7 Hz, 
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1H), 5.42 (d, J = 18.0 Hz, 1H), 5.02 (d, J = 17.1 Hz, 1H), 4.98 (d, J = 10.2 Hz, 1H), 4.05 
(t, J = 6.7 Hz, 2H), 2.30 (t, J = 7.5 Hz, 2H), 2.14 (q, J = 7.9 Hz, 2H), 2.09 (q, J = 7.2 Hz, 
2H), 1.73 (p, J = 7.5 Hz, 2H), 1.64–1.57 (m, 2H), 1.46–1.37 (m, 2H), 1.35–1.28 (m, 2H), 
1.28–1.25 (m, 12H); 13C NMR (151 MHz, CDCl3): δ 174.0, 152.9, 139.0, 114.6, 83.3, 
63.8, 34.4, 33.7, 32.2, 28.8, 28.7, 27.4, 25.0, 24.9; HRMS[M+H]+: Calcd for C19H34B1O4: 
337.25501; found: 337.25596.  
(E)-5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl non-8-enoate 
(precursor to macrocycle 2.18; prepared through hydrozirconation-boryl trapping/ester 
formation sequence). IR (neat): 2977 (m), 2928 (s), 2856 (m), 1736 (s), 1639 (s), 1464 
(m), 1363 (s), 1320 (s), 1165 (s), 1144 (s), 995 (m), 970 (m), 909 (m), 638 (w); 1H NMR 
(600 MHz, CDCl3): δ 6.59 (dt, J = 17.9, 6.4 Hz, 1H), 5.85 – 5.65 (m, 1H), 5.44 (d, J = 
17.9 Hz, 1H), 4.97 (d, J = 17.1 Hz, 1H), 4.91 (d, J = 10.2 Hz, 1H), 4.05 (t, J = 6.5 Hz, 2H), 
2.26 (t, J = 7.5 Hz, 2H), 2.20 (q, J = 6.9 Hz, 2H), 2.02 (q, J = 6.6 Hz, 2H), 1.78–1.71 (m, 
2H), 1.67–1.57 (m, 2H), 1.41–1.26 (m, 6H), 1.26 (s, 12H); 13C NMR (151 MHz, CDCl3): 
δ 173.9, 152.9, 139.1, 114.4, 83.2, 63.8, 34.4, 33.8, 32.1, 29.1, 28.9, 28.8, 27.3, 25.1, 24.9; 
HRMS[M+H]+: Calcd for C20H36B1O4: 351.27066, Found: 351.27101. 
Representative ester formation/protoboryl addition procedure: 
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(E)-6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-en-1-yl non-8-enoate 
(precursor to macrocycle 2.19). To a mixture of hex-5-yn-1-ol (98.0 mg, 1.00 mmol), non-
8-enoic acid (234.0 mg, 1.50 mmol) in CH2Cl2 (5 mL) was added N,N'-
Dicyclohexylcarbodiimide (DCC, 412.0 mg, 2.00 mmol) and 4-dimethylaminopyridine 
(DMAP, 366.0 mg, 3.00 mmol, 3.00 equiv.) in sequence at 0 °C. The mixture was allowed 
to warm to 22 °C and stir for 3 h, after which the mixture was placed in a freezer (4 °C) for 
2 h during which time a solid was formed, which was filtered and washed with cold hexane 
(10 mL). The filtrate was collected, volatiles were removed and the remaining residue was 
purified by silica gel chromatography (2% EtOAc in hexane) to afford the desired 
carboxylic ester (205.1 mg, 0.87 mmol, 87% yield) as colorless oil. In a N2-filled box, an 
oven-dried vial was charged with 1,3-bis(1-adamantyl)imidazolium tetrafluoroborate 2.22 
(10.6 mg, 0.025 mmol), CuCl (2.5 mg, 0.025 mmol), NaOt-Bu (9.6 mg, 0.10 mmol) and 
THF (1 mL). The mixture was allowed to stir at 22 °C for 1 h, after which B2(pin)2 (123.0 
mg, 0.50 mmol) was added. After an additional hour, a solution of the carboxylic ester 
(118.0 mg, 0.50 mmol) in THF (1.5 mL) was added, followed by MeOH (40.5 L, 1.00 
mmol). The solution was allowed to stir at 22 °C for 16 h after which diethyl ether was 
added (60 mL) and the mixture was washed with H2O (10 mL) and brine (10 mL). The 
organic phase was collected, dried over anhydrous MgSO4, filtered, concentrated in vacuo 
and the residue was purified by silica gel chromatography (2% EtOAc in hexanes) to afford 
the desired product (101.0 mg, 0.28 mmol, 56% yield) as colorless oil along with the 
recovery of un-reacted ester (24.7 mg, 0.10 mmol, 20% yield). The yield based on 
recovered starting material is 75%. IR (neat): 2977 (m), 2930 (s), 2858 (m), 1735 (s), 1638 
(s), 1459 (m), 1360 (s), 1318 (s), 1144 (s), 997 (m), 849 (m); 1H NMR (400 MHz, CDCl3): 
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δ 6.61 (dt, J = 18.0, 6.4 Hz, 1H), 5.80 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 5.44 (d, J = 18.0 
Hz, 1H), 4.99 (d, J = 17.1 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 4.05 (t, J = 6.5 Hz, 2H), 2.28 
(t, J = 7.5 Hz, 2H), 2.18 (q, J = 7.0 Hz, 2H), 2.04 (q, J = 6.8 Hz, 2H), 1.77–1.55 (m, 4H), 
1.55–1.43 (m, 2H), 1.43–1.29 (m, 6H), 1.26 (s, 12H); 13C NMR (151 MHz, CDCl3): δ 
173.9, 153.8, 139.1, 114.4, 83.1, 64.2, 35.3, 34.4, 33.8, 29.1, 28.8, 28.7, 28.3, 25.0, 24.9, 
24.7; HRMS[M+H]+: Calcd for C21H38B1O4: 365.28631, Found: 365.28621.  
(E)-6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-en-1-yl undec-10-enoate 
(precursor to macrocycle 2.6; prepared through hydrozirconation-boryl trapping/ester 
formation sequence). IR (neat): 2977 (m), 2928 (s), 2856 (m), 1736 (s), 1639 (s), 1459 
(m), 1362 (s), 1320 (s), 1145 (s), 997 (m), 850 (m); 1H NMR (600 MHz, CDCl3): δ 6.58 
(dt, J = 18.2, 6.1 Hz, 1H), 5.88–5.71 (m, 1H), 5.42 (d, J = 18.2 Hz, 1H), 4.96 (d, J = 17.1 
Hz, 1H), 4.90 (d, J = 10.2 Hz, 1H), 4.04 (t, J = 6.5 Hz, 2H), 2.30–2.22 (m, 2H), 2.21–2.12 
(m, 2H), 2.06–1.97 (m, 2H), 1.65–1.53 (m, 4H), 1.52–1.41 (m, 2H), 1.33 (t, J = 11.0 Hz, 
2H), 1.31–1.25 (m, 8H), 1.24 (s, 12H); 13C NMR (151 MHz, CDCl3): δ 174.0, 153.8, 
139.3, 114.2, 83.1, 64.2, 35.4, 34.5, 33.9, 29.4, 29.3, 29.2, 29.1, 29.0, 28.3, 25.1, 24.9, 24.7; 
HRMS[M+H]+: Calcd for C23H42B1O4: 393.31761, Found: 393.31753.  
(E)-11-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)undec-10-en-1-yl non-8-enoate 
(precursor to macrocycle 2.20; prepared through hydrozirconation-boryl trapping/ester 
formation sequence): IR (neat): 2977 (m), 2925 (s), 2854 (m), 1736 (s), 1638 (m), 1464 
(m), 1361 (s), 1319 (m), 1145 (s), 996 (m), 910 (m), 850 (m); 1H NMR (400 MHz, CDCl3): 
δ 6.63 (dt, J = 18.0, 6.4 Hz, 1H), 5.80 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 5.42 (d, J = 18.0 
Hz, 1H), 4.99 (d, J = 17.1 Hz, 1H), 4.93 (d, J = 10.2 Hz, 1H), 4.05 (t, J = 6.7 Hz, 2H), 2.29 
(t, J = 7.5 Hz, 2H), 2.18–2.10 (m, 2H), 2.08–2.00 (m, 2H), 1.66–1.55 (m, 4H), 1.45–1.35 
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(m, 4H), 1.34–1.25 (m, 26H); 13C NMR (151 MHz, C6D6): δ 173.1, 154.9, 139.1, 114.6, 
82.9, 64.4, 36.2, 34.5, 34.1, 29.8, 29.8, 29.6, 29.5, 29.3, 29.2, 29.1, 28.8, 26.3, 25.3, 25.0; 
HRMS[M+H]+: Calcd for C26H48B1O4: 435.36456, Found: 435.36590. 
Representative amide formation/protoboryl addition procedure: 
 
(E)-tert-Butyl (6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-enoyl)(undec-10-
en-1-yl) carbamate (2.23; prepared through amide formation/protoboryl addition 
sequence). IR (neat): 2977 (m), 2926 (s), 2854 (m), 1731 (s), 1695 (m), 1679 (m), 1639 
(m), 1457 (m), 1362 (s), 1320 (m), 1142 (s), 995 (m), 907 (m), 850 (m); 1H NMR (600 
MHz, CDCl3): δ 6.61 (dt, J = 18.0, 6.4 Hz, 1H), 5.81 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H), 
5.45 (d, J = 18.0 Hz, 1H), 4.99 (d, J = 17.1 Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 3.62  (t, J 
= 7.7 Hz, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.29–2.14 (m, 2H), 2.07–2.00 (m, 2H), 1.81–1.71 
(m, 2H), 1.51 (s, 9H), 1.50–1.46 (m, 2H), 1.40–1.33 (m, 2H), 1.27 (s, 10H), 1.26 (s, 12H); 
13C NMR (151 MHz, CDCl3): δ 175.6, 153.8, 153.4, 139.3, 114.2, 83.1, 82.7, 44.6, 37.9, 
35.3, 33.9, 29.6, 29.5, 29.4, 29.2, 29.0, 28.8, 28.2, 27.0, 24.9, 23.9; HRMS[M+H]+: Calcd 
for C28H51B1NO5: 492.38603, Found: 492.38386.  
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(E)-tert-Butyl non-8-en-1-yl(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-
enoyl) carbamate (precursor to 2.25, prepared through amide formation/protoboryl 
addition sequence). IR (neat): 2977 (m), 2929 (s), 2857 (m), 1732 (s), 1696 (m), 1680 (m), 
1639 (m), 1457 (m), 1366 (s), 1321 (m), 1145 (s), 997 (m), 908 (m), 850 (m); 1H NMR 
(600 MHz, CDCl3): δ 6.61 (dt, J = 18.0, 6.4 Hz, 1H), 5.80 (ddt, J = 17.1, 10.2, 6.7 Hz, 
1H), 5.45 (d, J = 18.0 Hz, 1H), 4.98 (d, J = 17.1 Hz, 1H), 4.92 (d, J = 10.2 Hz, 1H), 3.62 
(d, J = 7.6 Hz, 2H), 2.81 (d, J = 7.5 Hz, 2H), 2.22–2.17 (m, 2H), 2.08–1.99 (m, 2H), 1.51 
(s, 9H), 1.50–1.45 (m, 2H), 1.39–1.32 (m, 2H), 1.32–1.27 (m, 8H), 1.25 (s, 12H); 13C NMR 
(151 MHz, CDCl3): δ 175.7, 153.8, 153.4, 139.2, 114.3, 83.1, 82.7, 44.6, 37.9, 35.3, 33.9, 
29.3, 29.1, 28.9, 28.8, 28.2, 27.0, 24.9, 23.9; HRMS[M+H]+: Calcd for C26H47B1NO5: 
464.35473, Found: 464.35687.  
2.6.3. E-Selective macrocyclic RCM reactions 
General Procedure: In a N2-filled glove box, an oven-dried 50 mL round-bottom flask 
equipped with a magnetic stir bar was charged with an alkene substrate (1.0 equiv.) and 
anhydrous toluene. This mixture was then charged with a solution of Mo-1 in benzene and 
the vessel was then connected to a 28 torr vacuum generated from a diaphragm pump. The 
solution was allowed to stir for 4-12 h at 22 C under vacuum, after which the reaction was 
quenched by the addition of “wet” ether (% conversion was determined by 1H NMR 
analysis of the unpurified mixture). Purification was performed through silica gel 
chromatography.  
(E)-Oxacyclohexadec-6-en-2-one (2.4). In a N2-filled glove box, a solution of Mo-1 in 
benzene (0.10 M, 12.5 L, 1.25 mol) was transferred by syringe to an oven-dried flask 
containing (E)-11-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)undec-10-en-1-yl hex-5-enoate 
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1e (9.8 mg, 0.025 mmol) and toluene (25 mL). The mixture was allowed to stir for 6 h at 
22 °C under 28 torr vacuum. At this time the reaction was quenched by the addition of 
“wet” Et2O and the mixture was concentrated in vacuo. The resulting residue was purified 
by silica gel chromatography (1% EtOAc in hexanes) to afford macrocyclic alkene 2.4 (3.6 
mg, 0.015 mmol, 60% yield) in 96:4 E:Z selectivity as colorless oil. The characterization 
data are consistent with those previously reported.8 
(E)-Oxacyclododec-8-en-2-one (2.17). The same procedure as described above was used. 
Purification of the crude product mixture by silica gel chromatography (1% EtOAc in 
hexane) afforded macrocyclic alkene 2.17 (2.6 mg, 0.014 mmol, 57% yield) in 96:4 E:Z 
ratio as colorless oil. IR (neat): 2923 (s), 2853 (m), 1732 (s), 1450 (m), 1354 (m), 1285 
(s), 1145 (m), 1071 (m), 969 (m); 1H NMR (400 MHz, CDCl3): δ 4.50 (dt, J = 14.5, 7.2 
Hz, 1H), 4.18 (dt, J = 14.5, 7.2 Hz, 1H), 3.12–3.06 (m, 2H), 1.34–1.27 (m, 2H), 1.25–1.17 
(m, 2H), 1.14–1.07 (dd, J = 13.0, 6.6 Hz, 2H), 0.86–0.76 (m, 2H), 0.61–0.49 (m, 2H), 0.48–
0.40 (m, 2H), 0.31–0.18 (m, 2H); 13C NMR (101 MHz, CDCl3): δ 173.9, 133.4, 127.3, 
66.4, 35.3, 32.6, 29.7, 28.2, 25.2, 25.0, 21.1; HRMS[M+H]+: Calcd for C11H19O2: 
183.13850; found: 183.13784.  
(E)-Oxacyclotridec-9-en-2-one (2.18). The same procedure as described above was used. 
Purification of the crude product mixture by silica gel chromatography (1% EtOAc in 
hexane) afforded macrocyclic alkene 2.18 (2.0 mg, 0.010 mmol, 40% yield) in 91:9 E:Z 
selectivity as colorless oil. IR (neat): 2926 (s), 2854 (m), 1732 (s), 1442 (m), 1358 (m), 
1205 (m), 1149 (m), 1047 (m), 967 (m); 1H NMR (400 MHz, CDCl3): δ 5.44 (dt, J = 14.0, 
7.0 Hz, 1H), 5.28 (dt, J = 14.0, 7.0 Hz, 1H), 4.13–4.09 (m, 2H), 2.33–2.27 (m, 2H), 2.23–
2.14 (m, 2H), 2.03 (dd, J = 11.9, 6.0 Hz, 2H), 1.87–1.78 (m, 2H), 1.73–1.63 (m, 2H), 1.48–
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1.37 (m, 2H), 1.35–1.26 (m, 4H); 13C NMR (101 MHz, CDCl3): δ 174.9, 131.0, 130.1, 
65.8, 34.2, 32.3, 31.3, 27.7, 27.1, 26.6, 26.0, 25.1; HRMS[M+H]+: Calcd for C12H21O2: 
197.15415; found: 197.15471.  
(E)-Oxacyclotetradec-9-en-2-one (2.19). The same procedure as described above was 
used. Purification of the crude product mixture by silica gel chromatography (1% EtOAc 
in hexane) afforded macrocyclic alkene 2.19 (2.1 mg, 0.010 mmol, 40% yield) in 94:6 E:Z 
selectivity as colorless oil. The characterization data are consistent with those previously 
reported.Error! Bookmark not defined. 
(E)-Oxacyclohexadec-11-en-2-one (2.6). The same procedure as described above was 
used. Purification of the crude product mixture by silica gel chromatography (1% EtOAc 
in hexane) afforded macrocyclic alkene 2.6 (3.5 mg, 0.015 mmol, 59% yield) in >98:2 E:Z 
selectivity as colorless oil. The characterization data are consistent with those previously 
reported.23 
(E)-Oxacyclononadec-9-en-2-one (2.20). The same procedure as described above was 
used. Purification of the crude product mixture by silica gel chromatography (1% EtOAc 
in hexane) afforded macrocyclic alkene 2.20 (2.8 mg, 0.010 mmol, 40% yield) in 91:9 E:Z 
selectivity as colorless oil. IR (neat): 2925 (s), 2854 (m), 1736 (s), 1460 (m), 1247 (s), 
1179 (m), 1078 (m), 969 (m); 1H NMR (400 MHz, CDCl3): δ 5.42–5.28 (m, 2H), 4.10 (t, 
J = 5.7 Hz, 2H), 2.29 (t, J = 7.3 Hz, 2H), 2.00 (s, 4H), 1.63 (dd, J = 14.5, 7.3 Hz, 4H), 
1.45–1.22 (m, 18H); 13C NMR (101 MHz, CDCl3): δ 174.1, 131.2, 130.8, 64.6, 34.9, 32.1, 
32.0, 29.5, 29.0, 28.9, 28.8, 28.6, 28.5, 28.4, 28.0, 27.9, 26.7, 25.5. HRMS[M+H]+: Calcd 
for C18H33O2: 281.24805; found: 281.24929. 
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tert-butyl (E)-2-oxoazacyclohexadec-6-ene-1-carboxylate (2.24). The same procedure 
as described above was used. Purification of the crude product mixture by silica gel 
chromatography (1% EtOAc in hexane) afforded macrocyclic alkene 2.24 (3.0 mg, 0.009 
mmol, 44% yield) as colorless oil. Compound 2.24 was dissolved in 0.5 mL CH2Cl2 in a 4 
mL vial, and then 0.1 mL CF3COOH was added. After 4 h, MeOH (2 mL) was added and 
the solvent was removed in vacuo. The residue was purified by silica gel chromatography 
(20% EtOAc in hexane) to afford the unprotected amide (previously reported compound6b; 
2.1 mg, 0.009 mmol, 44% yield over two steps) in >98:2 E:Z selectivity as white solid. IR 
(neat): 3304 (m), 3038 (w), 2926 (s), 2852 (m), 1640 (s), 1550 (m), 1438 (m), 1250 (m), 
1172 (m), 971 (m), 712 (m); 1H NMR (600 MHz, CDCl3) δ 5.44–5.28 (m, 3H), 3.41–3.24 
(m, 2H), 2.21 (t, J = 6.9 Hz, 2H), 2.12–2.01 (m, 2H), 1.81–1.71 (m, 2H), 1.56–1.48 (m, 
2H), 1.43–1.22 (m, 14H); 13C NMR (101 MHz, CDCl3): δ 172.8, 131.9, 129.9, 38.8, 34.5, 
31.7, 30.6, 28.4, 28.3, 27.5, 26.7, 26.6, 26.0, 25.4, 24.3; HRMS[M+H]+: Calcd for 
C15H28NO: 238.21709, found: 238.21802. 
(E)-tert-Butyl 2-oxoazacyclotetradec-6-ene-1-carboxylate (2.25). The same procedure 
as described above was used. Purification of the crude product mixture by silica gel 
chromatography (1% EtOAc in hexane) afforded macrocyclic alkene 2.25 (2.9 mg, 0.0094 
mmol, 38% yield) in >98:2 E:Z selectivity as colorless oil. IR (neat): 2927 (s), 2855 (m), 
1728 (s), 1700 (m), 1459 (m), 1368 (s), 1350 (m), 1143 (s), 971 (m), 776 (m), 805 (m) cm–
1; 1H NMR (600 MHz, CDCl3): δ 5.40 (dt, J = 15.1, 7.1 Hz, 1H), 5.30 (dt, J = 15.1, 7.1 
Hz, 1H), 3.72 (t, J = 6.3 Hz, 2H), 2.78 (t, J = 6.5 Hz, 2H), 2.19–2.15 (m, 2H), 2.01–1.96 
(m, 2H), 1.85–1.77 (m, 2H), 1.58–1.52 (m, 2H), 1.51 (s, 9H), 1.39–1.20 (m, 8H); 13C NMR 
(101 MHz, CDCl3): δ 175.8, 153.8, 132.2, 130.0, 82.5, 44.2, 36.2, 31.6, 31.5, 28.2, 27.4, 
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26.7, 26.6, 25.6, 24.7, 22.7; HRMS[M+H]+: Calcd for C18H32NO3: 310.23822, found: 
310.23925. 
2.6.4. Application to synthesis of Recifeiolide 
(E)-5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-ol. In a N2-filled glove 
box, to an oven-dried vial was added pent-4-yn-2-ol (100.8 mg, 1.20 mmol), pinacolborane 
(614.0 g, 697 L, 4.80 mmol), Et3N (12.1 mg, 16.7 L, 0.12 mmol), and Cp2ZrHCl (62.0 
mg, 0.24 mmol, 0.20 equiv.) in sequence at 22 °C. The vessel was sealed and allowed to 
stir at 60 °C for 20 h, after which the mixture was purified by silica gel chromatography 
(20% EtOAc in hexane) to afford a residue that was dissolved in MeOH (2 mL) and 4 M 
HCl (dioxane solution, 1 mL) was added. The resulting residue was allowed to stir at 22 
oC for one h and purified by silica gel chromatography (20% EtOAc in hexanes) to afford 
the desired alkenyl–B(pin) product as colorless oil (208 mg, 0.98 mmol, 82% yield). IR 
(neat): 3427 (b), 2976 (s), 2929 (m), 1638 (s), 1457 (m), 1360 (s), 1319 (s), 1143 (s), 996 
(m), 849 (m), 638 (m); 1H NMR (400 MHz, CDCl3): δ 6.57 (dt, J = 18.0, 6.9 Hz, 1H), 
5.50 (d, J = 18.0 Hz, 1H), 3.92–3.82 (m, 1H), 2.46–2.18 (m, 2H), 1.81 (s, 1H), 1.23 (s, 
12H), 1.18 (d, J = 6.2 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 150.1, 83.3, 66.8, 45.0, 
24.9, 23.1; HRMS[M-H2O+H]+: Calcd for C11H20BO2 [M-H2O+H]+: 195.15563, found: 
195.15588.  
(E)-5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-yl non-8-enoate 
(2.28). To a mixture of the aforementioned alkenyl–B(pin) compound (275.6 mg, 1.30 
mmol) and non-8-enoic acid (304.0 mg, 1.55 mmol) in CH2Cl2 (4 mL) in an oven-dried 
vial, was added N,N'-dicyclohexylcarbodiimide (DCC, 536.5 mg, 2.60 mmol) and 4-
dimethylaminopyridine (DMAP, 31.7 mg, 0.26 mmol) in sequence at 0 °C. The solution 
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was then allowed to warm to 22 °C and stir for 3 h. The mixture was then placed in a freezer 
(4 °C) and kept there for 2 h. During this time an white solid was formed, which was 
removed by filtration and washed with cold hexane (10 mL). The liquid phase was 
concentrated in vacuo and the resulting residue was purified by silica gel chromatography 
(2% EtOAc in hexanes) to afford diene 2.28 as colorless oil (405.3 mg, 1.16 mmol, 89% 
yield).  IR (neat): 2978 (m), 2929 (s), 2857 (m), 1732 (s), 1640 (s), 1458 (m), 1363 (s), 
1322 (s), 1144 (s), 995 (m), 849 (m), 805 (m); 1H NMR (400 MHz, CDCl3): δ 6.52 (dt, J 
= 17.9, 6.8 Hz, 1H), 5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.49 (d, J = 17.9 Hz, 1H), 5.01–
4.94 (m, 2H), 4.92 (d, J = 10.2 Hz, 1H), 2.49–2.31 (m, 2H), 2.25 (t, J = 7.5 Hz, 2H), 2.03 
(q, J = 6.9 Hz, 2H), 1.66–1.52 (m, 2H), 1.43–1.33 (m, 2H), 1.33–1.27 (m, 4H), 1.25 (s, 
12H), 1.21 (d, J = 6.3 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 173.4, 148.8, 139.1, 114.4, 
83.3, 69.5, 42.4, 34.8, 33.8, 29.1, 28.9, 28.8, 25.1, 24.9, 24.8, 19.8. HRMS[M+H]+: Calcd 
for C20H36BO4: 351.27066, found: 351.26923.  
Recifeiolide. In a N2-filled glove box, a solution of Mo-1 in benzene (0.10 M, 75.0 L, 
7.50 mol) was transferred by syringe to an oven-dried flask containing diene 17 (52.5 mg, 
0.15 mmol) and toluene (120 mL). The mixture was allowed to stir for 6 h at 22 °C under 
28 torr vacuum. At this time the reaction was quenched by the addition of “wet” Et2O and 
the mixture was concentrated in vacuo. Purification of the crude product mixture by silica 
gel chromatography (1% EtOAc in hexane) afforded recifeiolide (19.1 mg, 0.097 mmol, 
65% yield) with >98:2 E:Z selectivity as colorless oil. The characterization data are 
consistent with those previously reported.34 
                                                 
(34) Okuma, K.; Hirabayashi, S.-i.; Ono, M.; Shioji, K.; Matsuyama, H.; Bestmann, H. J. Tetrahedron 1998, 
54, 42434250. 
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2.6.5. Application to Synthesis of Pacritinib 
Synthesis of E-Alkene 2.31 
O
O
N
N
N
H
B(pin)
2.5 equiv. KOH,
10 mol % (n-Bu)4NHSO4,
22 ºC, 12 h
OH
N
N
Cl
Br
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O
N
N
Cl
O
H2N
4 N aq. HCl,
n-BuOH, 80 ºC, 4 h
1.2 equiv.
O
O
N
N
N
H
1.20equiv. HB(pin),
10 mol % Et3N,
60ºC, 22h
20 mol % Cp2ZrHCl
2.31
S1
S2  
2-Chloro-4-(3-((prop-2-yn-1-yloxy)methyl)phenyl)pyrimidine (S1): To an oven-dried 
vial was added (3-(2-chloropyrimidin-4-yl)phenyl)methanol4 (660 mg, 3.00 mmol), (n-
Bu)4NHSO4, 102 mg, 0.3 mmol), KOH (85% purity, 500 mg, 7.50 mmol), 5 mL of dried 
toluene and propargyl bromide (80 wt. % in toluene, 4.0 mL, 37.0 mmol) in sequence at 
22 °C. The mixture was allowed to stir for 12 h, after which the reaction was quenched by 
the addition of water (15 mL). The mixture was then washed with CH2Cl2 (3 x 20 mL). 
The organic layers were combined and dried over anhydrous Na2SO4. Filtration and 
removal of the volatiles in vacuo afforded an oily residue that was purified by silica gel 
chromatography (25% EtOAc in hexanes) to afford S1 as white solid (661 mg, 2.56 mmol, 
85% yield). M.p.: 6465 °C; IR (neat): 3289 (m), 2855 (m), 1566 (s), 1535 (m), 1422 (m), 
1343 (s), 1185 (m), 1028 (s), 790 (m), 696 (m), 629 (m); 1H NMR (600 MHz, CDCl3): δ 
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8.65 (d, J = 5.2 Hz, 1H), 8.09 (s, 1H), 8.04 (d, J = 7.7 Hz, 1H), 7.67 (d, J = 5.2 Hz, 1H), 
7.56 (d, J = 7.6 Hz, 1H), 7.52 (t, J = 7.6 Hz, 1H), 4.71 (s, 2H), 4.24 (d, J = 2.4 Hz, 2H), 
2.50 (t, J = 2.4 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ 167.0, 161.9, 160.0, 138.7, 135.3, 
131.4, 129.3, 127.0, 126.9, 115.3, 79.5, 75.1, 71.2, 57.6; HRMS[M+H]+: Calcd for 
C14H12ClN2O: 259.06327, Found: 259.06290. 
N-(3-((Allyloxy)methyl)phenyl)-4-(3-((prop-2-yn-1-yloxy)methyl)phenyl)pyrimidin-
2-amine (S2): To a mixture of 2-chloro-4-(3-((prop-2-yn-1-
yloxy)methyl)phenyl)pyrimidine (166 mg, 0.64 mmol) and 3-((allyloxy)methyl)aniline 
(125.0 mg, 0.77 mmol, 1.20 equiv.) in 1-butanol (3 mL) was added a solution of 4N HCl 
(0.90 mL, 3.20 mmol). The mixture was allowed to heat to 80 °C for 4 h, after which the 
reaction was quenched by the addition of water (10 mL). The mixture was then washed 
with CH2Cl2 (3 x 20 mL). The organic layers were combined and washed with a saturated 
solution of aqueous NaHCO3 (10 mL) and brine (10 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated in vacuo, affording a residue that was purified by silica gel 
chromatography (15% EtOAc in hexanes) to obtain S2 as yellow oil (168.0 mg, 0.44 mmol, 
68% yield). IR (neat): 3283 (m), 3079 (m), 2853 (m), 1561 (s), 1537 (m), 1490 (m), 1437 
(s), 1355 (m), 1196 (m), 1078 (s), 824 (s), 695 (m), 634 (m); 1H NMR (600 MHz, CDCl3): 
δ 8.48 (d, J = 5.2 Hz, 1H), 8.08 (s, 1H), 8.06–8.01 (m, 1H), 7.74 (s, 1H), 7.66 (d, J = 7.8 
Hz, 1H), 7.57–7.48 (m, 2H), 7.34 (t, J = 7.8 Hz, 1H), 7.18 (d, J = 5.2 Hz, 1H), 7.04 (d, J = 
7.5 Hz, 1H), 6.05–5.93 (m, 1H), 5.33 (ddd, J = 17.2, 3.2, 1.6 Hz, 1H), 5.24–5.18 (m, 1H), 
4.71 (s, 2H), 4.57 (s, 2H), 4.24 (d, J = 2.4 Hz, 2H), 4.12–4.05 (m, 2H), 2.50 (t, J = 2.4 Hz, 
1H); 13C NMR (151 MHz, CDCl3): δ 164.7, 160.4, 158.6, 140.0, 139.2, 138.1, 137.4, 
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134.9, 130.4, 129.0, 128.9, 126.7, 121.7, 118.5, 117.1, 108.4, 79.6, 75.0, 72.2, 71.4, 71.2, 
57.4; HRMS[M+H]+: Calcd for C24H24N3O2: 386.18685; found: 386.18689.  
(E)-N-(3-((Allyloxy)methyl)phenyl)-4-(3-(((3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2 yl)allyl)oxy)me thyl)phenyl)pyrimidin-2-amine (2.31). In a N2-filled 
glove box, an oven-dried vial was charge with the aforementioned enyne (56.0 mg, 0.15 
mmol), pinacolborane (55.0 L, 0.38 mmol), Et3N (2.2 L, 0.015 mmol), and Cp2ZrHCl 
(3.9 mg, 0.015 mmol) in sequence at 22 °C. The vessel was sealed and the mixture was 
allowed to heat at 60 °C for 18 h, after which mixture was directly purified by silica gel 
chromatography (20% EtOAc in hexanes) to afford alkenyl–B(pin) compound 2.31 as 
colorless oil (53.2 mg, 0.90 mmol, 60% yield). IR (neat): 3268 (w), 2977 (m), 2856 (m), 
1644 (m), 1560 (s), 1539 (m), 1490 (m), 1438 (s), 1357 (m), 1196 (m), 1165 (m), 1143 (s), 
1006 (s), 826 (s), 698 (m), 634 (m); 1H NMR (600 MHz, CDCl3): δ 8.48 (d, J = 5.1 Hz, 
1H), 8.05 (s, 1H), 8.01 (d, J = 7.2 Hz, 1H), 7.73 (s, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.54 (s, 
1H), 7.52–7.44 (m, 2H), 7.34 (t, J = 7.8 Hz, 1H), 7.17 (d, J = 5.2 Hz, 1H), 7.04 (d, J = 7.4 
Hz, 1H), 6.71 (dt, J = 18.1, 4.6 Hz, 1H), 6.02–5.93 (m, 1H), 5.80 (d, J = 18.1 Hz, 1H), 5.33 
(d, J = 17.2 Hz, 1H), 5.21 (d, J = 10.4 Hz, 1H), 4.62 (s, 2H), 4.56 (s, 2H), 4.16 (s, , 2H), 
4.07 (s, 2H), 1.28 (s, 12H); 13C NMR (151 MHz, CDCl3): δ 164.9, 160.4, 158.6, 149.1, 
139.9, 139.3, 139.1, 137.3, 134.9, 130.0, 129.0, 126.5, 126.3, 121.7, 118.6, 117.2, 108.6, 
83.4, 72.3, 72.2, 72.0, 71.2, 24.9; HRMS[M+H]+: Calcd for C30H37BN3O4: 514.28771; 
found: 514.28721. 
Macrocyclic E-alkene 2.32.  In a N2-filled glove box, an oven-dried vial was charged with 
2.31 (7.7 mg, 0.015 mmol), B(C6F5)3 (7.7 mg, 0.015 mmol) and toluene (0.75 mL). After 
10 min, a solution of complex Mo-1 in benzene (0.1 M, 15.0 L, 1.50 mol) was added by 
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syringe and the resulting solution was allowed to stir for 12 h at 22 °C. The reaction was 
quenched by the addition of “wet” Et2O and the volatiles were removed in vacuo. The 
resulting oil was purified by silica gel chromatography (30% EtOAc in hexanes) to afford 
macrocyclic product 2.32 as yellow solid (3.6 mg, 0.009 mmol, 60% yield). Mp: 158160 
°C; IR (neat): 3273 (w), 3062 (w), 2925 (w), 2853 (m), 1600 (m), 1562 (s), 1538 (m), 
1482 (m), 1408 (s), 1370 (m), 1198 (w), 1068 (m), 1006 (s), 978 (m), 787 (m), 730 (m), 
690 (m), 633 (m); 1H NMR (600 MHz, CDCl3): δ 8.77 (t, J = 1.7 Hz, 1H), 8.46 (d, J = 5.2 
Hz, 1H), 8.40 (t, J = 1.6 Hz, 1H), 7.84 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.6 Hz, 1H), 7.50 
(t, J = 7.6 Hz, 1H), 7.34–7.28 (m, 2H), 7.22 (d, J = 5.2 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 
6.86 (d, J = 8.0 Hz, 1H), 5.92–5.82 (m, 2H), 4.64 (s, 2H), 4.60 (s, 2H), 4.17 (s, 1H), 4.16 
(s, 1H), 4.09 (s, 1H), 4.08 (s, 1H); 13C NMR (151 MHz, CDCl3): δ 164.2, 160.2, 159.1, 
140.1, 139.1, 138.9, 137.2, 131.8, 131.2, 130.8, 129.1, 129.1, 128.1, 126.4, 122.1, 118.8, 
118.1, 108.3, 71.0, 69.9, 69.7, 68.5; HRMS[M+H]+: Calcd for C22H22N3O2: 360.17120; 
found: 360.17292.  
Synthesis of E-alkene 2.34 
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N-(3-((Allyloxy)methyl)-4-(2-chloroethoxy)phenyl)-4-(3-((prop-2-yn-1-
yloxy)methyl)phenyl)pyrimidin-2-amine (S3): To a mixture of the propargyl ether 
(516.0 mg, 2.00 mmol) and 3-((allyloxy)methyl)-4-(2-chloroethoxy)aniline (723.0 mg, 
3.00 mmol) in n-butanol (12.0 mL) at 22 °C was added a 4N solution of HCl (2.5 mL, 
10.00 mmol). The resulting mixture was then allowed to heat to 80 °C and stir at that 
temperature for 4 h. The mixture was then allowed to cool to 0 °C and the reaction 
quenched by the addition of water. The mixture was washed with CH2Cl2 (3 x 30 mL) and 
the combined organic layers were washed with a saturated solution of aqueous NaHCO3 
(10 mL) and brine (10 mL) and dried over anhydrous Na2SO4. Filtration followed by 
removal of the volatiles in vacuo yielded a residue that was purified by silica gel 
chromatography (25% EtOAc in hexanes) to afford the desired enyne as yellow solid 
(580.0 mg, 1.25 mmol, 63% yield). Mp: 8283 °C; IR (neat): 3285 (w), 3067 (w), 2856 
(w), 1608 (m), 1561 (s), 1498 (s), 1425 (s), 1356 (s), 1217 (s), 1193 (m), 1074 (m), 887 
(w), 788 (m), 633 (m); 1H NMR (600 MHz, CDCl3): δ 8.45 (d, J = 5.2 Hz, 1H), 8.06 (s, 
1H), 8.02 (d, J = 6.7 Hz, 1H), 7.75 (s, 1H), 7.71–7.62 (m, 2H), 7.47 (q, J = 7.1 Hz, 2H), 
7.12 (d, J = 5.0 Hz, 1H), 6.85 (d, J = 8.6 Hz, 1H), 5.99 (ddd, J = 17.2, 10.4, 5.5 Hz, 1H), 
5.34 (d, J = 17.2 Hz, 1H), 5.20 (d, J = 10.4 Hz, 1H), 4.69 (s, 2H), 4.64 (d, J = 16.1 Hz, 
2H), 4.26–4.21 (m, 4H), 4.12 (d, J = 5.4 Hz, 2H), 3.81 (t, J = 5.4 Hz, 2H), 2.49 (t, J = 2.3 
Hz, 1H); 13C NMR (151 MHz, CDCl3): δ 164.6, 160.5, 158.6, 151.3, 138.0, 137.4, 135.0, 
135.0, 133.7, 130.3, 129.0, 128.2, 126.7, 121.2, 121.1, 120.0, 120.0, 116.9, 116.9, 112.7, 
112.7, 108.1, 108.0, 79.6, 79.6, 75.0, 74.9, 71.6, 71.4, 69.0, 66.8, 57.3, 42.2; 
HRMS[M+H]+: Calcd for C26H27Cl1N3O3: 464.17409; found: 464.17293. 
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(E)-N-(3-((Allyloxy)methyl)-4-(2-chloroethoxy)phenyl)-4-(3-(((3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)methyl)phenyl)pyrimidin-2-amine 
(2.33). In a N2-filled glove box, an oven-dried vial was charged with the above enyne 
(250.0 mg, 0.54 mmol), pinacolborane (278.0 L, 1.90 mmol), THF (0.5 mL), Et3N (7.8 
L, 0.054 mmol), and Cp2ZrHCl (14.0 mg, 0.054 mmol) at 22 °C, respectively. The vessel 
was then sealed and the mixture was allowed to heat to 60 °C and let stand at this 
temperature for 24 h. At this time, the mixture was purified (no extractive workup) by silica 
gel chromatography (2033% EtOAc in hexanes) to afford 2.33 as yellow oil (183 mg, 
0.31 mmol, 57% yield). IR (neat): 3268 (w), 2977 (m), 2928 (w), 2856 (w), 1724 (m), 
1565 (s), 1501 (s), 1429 (s), 1358 (s), 1143 (s), 1040 (m), 889 (w), 849 (m), 790 (m), 634 
(w); 1H NMR (600 MHz, CDCl3): δ 8.43 (d, J = 5.2 Hz, 1H), 8.07–7.96 (m, 2H), 7.71–
7.63 (m, 2H), 7.51–7.42 (m, 2H), 7.30 (s, 1H), 7.13 (d, J = 5.2 Hz, 1H), 6.87 (d, J = 8.1 
Hz, 1H), 6.70 (dt, J = 18.1, 4.7 Hz, 1H), 6.02–5.94 (m, 1H), 5.79 (d, J = 18.1 Hz, 1H), 5.33 
(d, J = 17.3 Hz, 1H), 5.19 (d, J = 10.5 Hz, 1H), 4.62 (s, 4H), 4.26 (t, J = 5.8 Hz, 2H), 4.15 
(d, J = 4.7 Hz, 2H), 4.12 (d, J = 5.6 Hz, 2H), 3.82 (t, J = 5.8 Hz, 2H), 1.27 (s, 12H); 13C 
NMR (151 MHz, CDCl3): δ 164.9, 160.6, 158.6, 151.5, 149.1, 139.1, 137.4, 135.1, 133.7, 
130.0, 129.0, 128.3, 126.5, 126.3, 121.2, 120.1, 117.0, 112.8, 108.3, 83.4, 72.3, 72.0, 71.7, 
69.2, 66.9, 42.3, 24.9; HRMS[M+H]+: Calcd for C32H40BClN3O5: 592.27495, found: 
592.27374.  
tert-Butyl(3-((allyloxy)methyl)-4-(2-chloroethoxy)phenyl)(4-(3-((prop-2-yn-1-
yloxy)methyl)phenyl)pyrimidin-2-yl)carbamate (S4): To a mixture of  S3 (324 mg, 0.70 
mmol), DMAP (20 mg, 0.16 mmol) in CH3CN (3 mL) was added Boc2O (262 mg, 1.20 
mmol) and the mixture was allowed to stir at 22 °C for 12 h. Subsequent removal of the 
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volatiles in vacuo and purification of the resulting residue by silica gel chromatography 
(2033% EtOAc in hexanes) afforded S4 as yellow oil (391 mg, 0.69 mmol, 99% yield). 
IR (neat): 3292 (w), 2978 (w), 2934 (w), 2858 (w), 1714 (s), 1610 (w), 1547 (s), 1500 (s), 
1424 (m), 1368 (m), 1251 (s), 1159 (s), 1081 (s), 927 (w), 775 (m), 633 (m); 1H NMR (400 
MHz, CDCl3): δ 8.66 (d, J = 5.2 Hz, 1H), 8.02 (s, 1H), 7.97 (d, J = 7.2 Hz, 1H), 7.51–7.43 
(m, 3H), 7.37 (s, 1H), 7.21 (d, J = 8.6 Hz, 1H), 6.85 (d, J = 8.7 Hz, 1H), 5.92 (ddt, J = 17.2, 
10.4, 5.6 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 5.15 (d, J = 10.4 Hz, 1H), 4.67 (s, 2H), 4.58 
(s, 2H), 4.26 (t, J = 5.8 Hz, 2H), 4.21 (d, J = 2.4 Hz, 2H), 4.05 (d, J = 5.5 Hz, 2H), 3.83 (t, 
J = 5.8 Hz, 2H), 2.49 (t, J = 2.4 Hz, 1H), 1.48 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 
164.9, 161.7, 158.9, 154.3, 153.8, 138.3, 136.7, 135.0, 135.0, 130.8, 129.2, 128.7, 128.3, 
128.1, 126.9, 126.9, 117.0, 112.7, 111.9, 81.9, 79.6, 75.0, 71.6, 71.4, 68.6, 66.8, 57.5, 42.1, 
28.3; HRMS[M+H]+: Calcd for C31H35ClN3O5: 564.22652, found: 564.22533.  
(E)-tert-Butyl (3-((allyloxy)methyl)-4-(2-chloroethoxy)phenyl)(4-(3-(((3-(4,4,5,5-
tetramethyl-1,3,2- dioxaborolan-2-yl)allyl)oxy)methyl)phenyl)pyrimidin-2-
yl)carbamate (2.34). In a N2-filled glove box, an oven-dried vial was charged with S4 
(46.0 mg, 0.08 mmol), pinacolborane (14.4 L, 0.008 mmol), THF (0.5 mL), Et3N (1.2 L, 
0.008 mmol), and Cp2ZrHCl (2.0 mg, 0.008 mmol) in sequence at 22 °C. The vessel was 
sealed and the mixture allowed to heat (60 °C) and stir at the same temperature for 22 h. 
Purification by silica gel chromatography (no aqueous workup; 2033% EtOAc in 
hexanes) afforded 2.34 as yellow oil (36.0 mg, 0.052 mmol, 65% yield). IR (neat): 2977 
(m), 2928 (w), 2855 (w), 1717 (s), 1645 (m), 1573 (s), 1547 (m), 1500 (m), 1367 (s), 1335 
(s), 1252 (s), 1161 (s), 1120 (m), 1038 (m), 892 (w) 849 (m), 776 (w), 631 (w); 1H NMR 
(600 MHz, CDCl3): δ 8.65 (d, J = 5.2 Hz, 1H), 7.99 (s, 1H), 7.95 (d, J = 7.6 Hz, 1H), 7.51–
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7.40 (m, 3H), 7.37 (d, J = 2.2 Hz, 1H), 7.22 (dd, J = 8.6, 2.4 Hz, 1H), 6.85 (d, J = 8.7 Hz, 
1H), 6.69 (dt, J = 18.2, 4.6 Hz, 1H), 6.00–5.84 (m, 1H), 5.76 (d, J = 18.2 Hz, 1H), 5.26 (d, 
J = 16.4 Hz, 1H), 5.14 (d, J = 10.3 Hz, 1H), 4.59 (s, 2H), 4.58 (s, 2H), 4.26 (t, J = 5.8 Hz, 
2H), 4.13 (d, J = 3.5 Hz, 2H), 4.04 (d, J = 5.5 Hz, 2H), 3.82 (t, J = 5.8 Hz, 2H), 1.48 (s, 
9H), 1.27 (s, 12H); 13C NMR (151 MHz, CDCl3): δ 165.0, 161.7, 158.9, 154.3, 153.8, 
149.0, 139.2, 136.6, 135.0, 130.3, 129.1, 128.7, 128.2, 128.0, 126.6, 126.3, 117.0, 112.7, 
111.9, 83.4, 81.8, 72.2, 72.1, 71.5, 68.6, 66.7, 42.1, 28.3, 24.9; HRMS[M+H]+: Calcd for 
C37H48BClN3O7: 692.33409, found: 692.32994. 
Macrocyclic E-alkene 2.30. In a N2-filled glove box, a solution of Mo-1 in benzene (0.10 
M in benzene, 37.0 L, 3.70 mol) was transferred by syringe to an oven-dried vial 
containing diene 2.34 (25.4 mg, 0.037 mmol) and toluene (1.85 mL). The resulting solution 
was allowed to stir for 12 h at 22 °C, after which the reaction was quenched by the addition 
of wet ether, and the mixture was concentrated under vacuum. The residue purified by 
silica gel chromatography (40% EtOAc in hexanes) to afford a mixture which was 
dissolved in toluene (1.0 mL) and CF3COOH (0.5 mL) and the resulting mixture was 
allowed to stir for 4 h at 22 °C. MeOH (5 mL) was added and the volatiles were removed 
in vacuo. Purification of the resulting residue by silica gel chromatography (30% EtOAc 
in hexanes) afforded macrocyclic E-alkene 2.30 in 92:8 E:Z selectivity as yellow solid 
(11.6 mg, 0.027 mmol, 73% yield). 1H NMR (600 MHz, CDCl3): δ 8.70 (d, J = 2.3 Hz, 
1H), 8.43 (d, J = 5.2 Hz, 1H), 8.30 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.60 (d, J = 7.6 Hz, 
1H), 7.50 (t, J = 7.6 Hz, 1H), 7.17 (d, J = 5.2 Hz, 2H), 6.89–6.81 (m, 2H), 5.90–5.80 (m, 
2H), 4.66 (s, 2H), 4.65 (s, 2H), 4.27 (t, J = 5.9 Hz, 2H), 4.17 (d, J = 5.5 Hz, 2H), 4.07 (d, 
J = 5.3 Hz, 2H), 3.84 (t, J = 5.9 Hz, 2H); HRMS[M+H]+: Calcd for C24H25ClN3O3: 
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438.15844, found: 438.15756. The spectroscopic data of this compound are consistent with 
those reported previously.4  
2.6.6. E-Selective RCM with air- and moisture-resistant paraffin tablets 
Under N2, an oven-dried 50 mL round-bottom flask equipped with a magnetic stir bar was 
charged with diene 2.28 (8.7 mg, 0.025 mmol) and a paraffin tablet (4.4 wt % in Mo-1, 
27.7 mg, 1.25 mol). Anhydrous toluene (25 mL) was added and the vessel was connected 
to a 28 torr vacuum generated from a diaphragm pump. The mixture was allowed to stir 
for 6 h at 22 °C under 28 torr vacuum. At this time the reaction was quenched by addition 
of wet ether, and the volatiles were removed in vacuo. MeCN (5.0 mL) was added and the 
mixture was allowed to stir at 22 °C for 10 min. The slurry was filtered through a short 
plug of silica gel and eluted with MeCN (5.0 mL) and then the filtrate was concentrated in 
vacuo. Silica gel chromatography (1% EtOAc in hexanes) of the unpurified residue 
afforded recifeiolide (2.7 mg, 0.014 mmol, 55% yield) with >98:2 E:Z selectivity as 
colorless oil. 
2.6.7. NMR Spectra 
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1H NMR of 2.15e 
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13C NMR of 2.15e 
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1H NMR of the precursor to 2.17  
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13C NMR of the precursor to 2.17 
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1H NMR of the precursor to 2.18 
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13C NMR of the precursor to 2.18 
 
 
Page 149 
1H NMR of the precursor to 2.19 
 
 
Page 150 
13C NMR of the precursor to 2.19 
 
 
Page 151 
1H NMR of the precursor to 2.6 
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13C NMR of the precursor to 2.6 
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1H NMR of the precursor to 2.20 
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13C NMR of the precursor to 2.20 
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1H NMR of 2.23 
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13C NMR of 2.23 
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1H NMR of the precursor to 2.24 
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13C NMR of the precursor to 2.24 
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1H NMR of 2.17 
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13C NMR of 2.17 
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1H NMR of 2.18 
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13C NMR of 2.18 
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1H NMR of 2.20 
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13C NMR of 2.20
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1H NMR of the precursor to 2.28 
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13C NMR of the precursor to 2.28
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1H NMR of 2.28 
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13C NMR of 2.28
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1H NMR of S1 
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13C NMR of S1 
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1H NMR of S2 
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13C NMR of S2 
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1H NMR of 2.31
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13C NMR of 2.31
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1H NMR of 2.32 
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13C NMR of 2.32
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1H NMR of S3
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13C NMR of S3
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1H NMR of 2.33
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13C NMR of 2.33
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1H NMR of S4 
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13C NMR of S4 
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1H NMR of 2.34 
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Chapter Three 
Stereoselective Synthesis of E- and Z-Trisubstituted Alkenes by 
Combining Stereoretentive Catalytic Cross-Metathesis and 
Catalytic Cross-Coupling 
3.1. Introduction 
Linear E- and Z-trisubstituted alkenes occur widely in nature and are commonly 
used in chemical synthesis1 (catalytic hydrogenation2, allylic substitution3, conjugate 
addition4, etc.). Several broadly applicable approaches have been developed for preparation 
of stereo-defined trisubstituted alkenes but these methods are not without shortcomings. 
Wittig-type olefination of ketones generally proceeds with poor stereoselectivity5 unless 
-alkoxy ketones are involved.6,7 Zirconocene-catalyzed 1,2-addition of 
trimethylaluminum to terminal alkynes8 followed by reacting the resulting 
alkenylaluminum intermediates with an electrophilic halogen reagent (I2, N-
bromosuccinimide, etc.) delivered E-trisubstituted alkenyl halides as the only alkene 
                                                 
(1) Negishi, E.; Huang, Z.; Wang, G.; Mohan, S.; Wang, C.; Hattori, H. A.  Acc. Chem. Res. 2008, 41, 1474–
1485. 
(2) Shang, G.; Li, W.; Zhang X. In Catalytic Asymmetric Synthesis; Ojima, I., Ed; Wiley, 2010; pp 344–436. 
(3) Baslé, O.;  Denicourt-Nowicki, A.; Crévisy, C.; Mauduit M. In Copper-Catalyzed Asymmetric Synthesis; 
Alexakis, A., Krause, N.; Woodward, S., Eds; Wiley, 2014; pp 85–119. 
(4) Alexakis, A., Krause, N.; Woodward, S. In Copper-Catalyzed Asymmetric Synthesis; Alexakis, A., 
Krause, N.; Woodward, S., Eds; Wiley, 2014; 33–68. 
(5) Sreekumar, C.; Darst, K. P.; Still, W. C. J. Org. Chem. 1980, 45, 4260–4262. 
(6) Maryanoff, B. E.; Reitz, A. B. Chem. Rev. 1989, 89, 863–927.  
(7) For stereoselective synthesis of trisubstituted alkenes starting from carbonyl compounds, see: (a) Corey, 
E. J.; Lee, J.; Roberts, B. E. Tetrahedron Lett. 1997, 38, 8915−8918. (b) Hodgson, D. M.; Arif, T. J. Am. 
Chem. Soc. 2008, 130, 16500–16501.  
(8) Negishi, E., van Horn, D. E.; Yoshida, T. J. Am. Chem. Soc. 1985, 107, 6639–6647. 
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isomer (Scheme 3.1.1). However, the required trimethylaluminum reagent is pyrophoric 
and incompatible with a number of organic functional groups (e.g. carboxylic esters, 
epoxides9, Boc-protected indoles10). The Z isomers can be preferred if a directing hydroxyl  
  
group is present at the propargylic or homopropargylic position.11 Hydrometallation of 
internal alkynes generally suffers from poor regioselectivity12 unless the two alkynyl  
 
                                                 
(9) Miyazawa, M.; Ishibashi, N.; Ohnuma, S.; Miyashita, M. Tetrahedron Lett. 1997, 38, 3419–3422. 
(10) Anantoju, K. K.; Mohd, B. S.; Maringanti, T. C. Tetrahedron Lett. 2017, 58, 1499–1500. 
(11) Ma, S.; Negishi, E. J. Org. Chem. 1997, 62, 784–785. For Cu-catalyzed anti-carbometallation of 
propargylic alcohols, see: Lu, Z., Ma, S. J. Org. Chem. 2006, 71, 2655–2660. 
(12) Trost, B. M.; Ball, Z. T. Synthesis 2005, 853–887.  
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substituents are well-differentiated (either by steric or electronic factors), 13 a propargylic  
hydroxyl group is present,14 or the addition occurs intramolecularly.15, 16 Although syn- and 
anti-hydrosilylation of internal alkynes 3.7 (Scheme 3.1.2) afforded the cyclic 
allkenylsilanes in high stereoselectivity and the products can be further transformed by 
Hiyama coupling, a directing alkoxysilane group at the homopropargylic position is 
required. Catalytic reductive coupling of internal alkynes and aldehydes17 proceeded with 
high stereo- and/or regioselectivity18 but these methods are limited to silyl-protected  
 
                                                 
(13) (a) Erver, F.; Hilt, G. J. Org. Chem. 2012, 77, 5215–5219. (b) Trost, B. M.; Koester, D. C.; Herron, A. 
N. Angew. Chem. Int. Ed. 2015, 54, 15863–15866. 
(14) Huwyler, N.; Radkowski, K.; Rummelt, S. M.; Fürstner, A. Chem. Eur. J.  2017, 23, 12412–12419. 
(15) Pan, W.; Denmark, S. E. Org. Lett. 2001, 3, 61–64. 
(16) Pan, W.; Denmark, S. E. Org. Lett. 2002, 4, 4163–4166. 
(17) Huang, W.-S.; Chan, J.; Jamison, T. F. Org. Lett. 2000, 2, 4221−4223.  
(18) Malik, H. A.; Sormunen, G. J.; Montgomery, J. J. Am. Chem. Soc. 2010, 132, 6304−6305.  
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trisubstituted allylic alcohols. Geminal dichloroalkenes such as 3.11 could be transformed 
to stereodefined trisubstituted alkenes by two consecutive Pd-catalyzed cross-coupling 
reactions.19,20 Bromoboration of propyne (3.14) with boron tribromide21 followed by 
trapping the resulting dibromoalkylborane with pinacol afforded trisubstituted alkenyl 
iodide 3.16 which can be further funtionalized once more by cross-coupling; however, the 
scope of this method is severely limited by the exceeding Lewis acidity of boron 
tribromide. Alternatively, copper-boron22 or copper-silyl23 addition to terminal alkynes 
delivered trisubstituted alkenylcopper intermediates that could be trapped with excess 
methyl iodide; however, these methods are limited to only one alkene isomer. Thus, there 
are no broadly applicable method that can deliver trisubstituted alkenes efficiently in either 
isomeric form. Protocols that can furnish E- or Z-trisubstituted alkenyl chlorides and 
bromides are particularly desirable as these moieties are found in biologically active natural  
 
                                                 
(19) Minato, A.; Suzuki, K.; Tamao, K. J. Am. Chem. Soc. 1987, 109, 1257–1258. 
(20) Tan, Z.; Negishi, E. Angew. Chem. Int. Ed. 2006, 45, 762–765. 
(21) Wang, C.; Tobrman, T.; Xu, Z.; Negishi, E. Org. Lett. 2009, 11, 4092–4095. 
(22) Mun, B.; Kim, S.; Yoon, H.; Kim, K. H.; Lee, Y. J. Org. Chem. 2017, 82, 6349–6357. 
(23) Fleming I.; Newton, T. W.; Roessler, F. J. Chem. Soc. Perkin Trans. I 1981, 2527–2532. 
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products24 (Scheme 3.1.4) and may be converted to other alkenes through catalytic cross-
coupling. 
3.2. The Challenges in Developing Efficient and Stereoselective Cross-Metathesis 
of Trisubstituted Alkenes 
Alkene cross-metathesis (CM) represents a complementary retrosynthetic 
disconnection to the existing approaches that utilizes more abundant and stable alkene  
starting material (compared to terminal alkynes). Moreover, synthetic routes involving 
alkenes intermediates are usually more concise than those with alkyne.25 However, there  
 
                                                 
(24) Gribble, G. W. Mar. Drugs 2015, 13, 4044–4136. 
(25) Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 
479, 8893. 
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are only a few reports on synthesis of trisubstituted alkenes through catalytic CM(Scheme 
3.2.1).26,27,28,29 Reactions either proceeded with minimal stereoselectivity27 or the E isomers 
were generated preferentially owing to substrate control.28 In one case, homocoupling of 
the less hindered terminal alkene cross-partner outcompeted CM29 so use of a bulky cross-
partner such as 3.29 (instead of a terminal alkene) to prevent self-metathesis together with 
a large excess of 1,1-disubstituted alkene 3.20 (30 equivalents), as well as forcing 
conditions (100 oC, 24 h) was needed to afford the desired products as a mixture of alkene 
isomers. 
Design of kinetically E- or Z-selective trisubstituted alkene CM is challenging 
because of several reasons. Self-metathesis of the less hindered alkene cross-partner may 
at times be considerably more facile than CM,29 thus causing low reaction efficiency. The 
metallacyclobutane (mcb) intermediates in trisubstituted alkene CM are more congested 
and, as a result, higher in energy compared to the disubstituted counterparts. Last but not 
least, the energy difference between E- and Z-trisubstituted alkenes, especially those with 
all aliphatic substituents, is smaller than those in 1,2-disubstituted alkenes.30,31 Therefore, 
reactions would be at best minimally selective without catalyst control. 
At the outset of this study, we first looked at the CM of 1,1-disubstituted alkene 
3.32 with Z- and E-1,2-dichloroethene (Z-3.33 and E-3.33, Scheme 3.2.2) using the 
                                                 
(26) Chatterjee, A. K.; Grubbs, R. H. Org. Lett. 1999, 1, 1751–1753. 
(27) Chatterjee, A. K.; Sanders, D. P.; Grubbs R. H. Org. Lett. 2002, 4, 1939–1942. 
(28) Morrill, C. M.; Funk, T. W.; Grubbs, R. H. Tetrahedron Lett. 2004, 45, 7733–7736. 
(29) Wang, Z. J.; Jackson, W. R.; Robinson, A. J. Org. Lett. 2013, 15, 3006–3009. 
(30) Cuvigny, T.; du Penhoat, H.; Julia, M. Tetrahedron Lett. 1980, 21, 1331–1334. 
(31) Wiberg, K. B.; Wang, Y. G.; Petersson, G. A.; Bailey, W. F. J. Chem. Theory Comput. 2009, 5, 1033–
1037. 
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corresponding optimal catalyst for each chloroalkene cross-partner (Mo-132 and Mo-2, 
respectively)33. The reaction of 3.32 typically required 10 mol% of Mo alkylidene and long 
reaction time (12 h) to proceed to completion (>98% conv. of 3.32). Unexpectedly, the E 
isomer of the trisubstituted chloroalkene 3.34 was formed predominantly in both cases 
(70:30 E:Z with Mo-1 and Z-3.33, 80:20 E:Z with Mo-2 and E-3.33).  
Detailed analysis of each CM reaction revealed the following results: There was 
minimal isomerization of product 3.34 and the corresponding cross-partner (Z-3.33 and E-
3.33) in each case. In both cases, the initial alkylidene complex reacted with 3.32 in 
 
                                                 
(32) Koh, M.-J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; Hoveyda, A. H. Nature 2016, 531, 459–465. 
(33) Nguyen, T. T.; Koh, M. J.; Shen, X.; Romiti, F.; Schrock, R. R.; Hoveyda, A. H. Science 2016, 352, 
569–575. 
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preference to the dichloroalkenes to generate 3.35 that was observed in the unpurified 
product mixture (Scheme 3.2.3). Lastly, stoichiometric reaction between 3.32 and Mo-2 
proceeded to only about 30% conv. after 24 h. Combined, these experimental results 
allowed us to propose the catalytic pathway as illustrated with Mo-1 in Scheme 3.2.3. 
Initiation of Mo-1 generated the 1,1-disubstituted alkylidene 3.36 which in turn reacted 
with Z-3.33 to form chloro-alkylidene 3.37. We argued that 3.36 was not an intermediate 
within the catalytic cycle; otherwise, reaction of 3.36 with Z-3.33 and E-3.33 would lead 
to opposite senses of stereoselectivity.34 Moreover, 3.37 probably would not react with 
3.32 via mcb 3.40 due to the destabilizing repulsion between the methyl group and the 
 
                                                 
(34) For detailed discussion on the stereochemical models in CM of Z-3.33 and E-3.33, see reference 23 and 
24. 
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aryloxide ligand33 (highlighted in gray circles). Reaction of the resulting chloro-alkylidene 
3.37 with 3.32 furnished product 3.34 and the unstable methylidene35 3.39 after 
cycloreversion. Chloro-alkylidene 3.37 would then be regenerated from the reaction of 
3.39 and Z-3.33 to complete the catalytic cycle.  
The proposed pathway above could account for the inferior efficiency and 
stereoselectivity observed. Firstly, initiation of Mo-1 would be difficult due to steric 
repulsion similar to that found in 3.40. Secondly, the size difference between a –CH3 and 
a –CH2CH2Ph group in the stereo-determining step (3.38 vs. 3.38’ in the box, Scheme 
3.2.3) was not sufficient to ensure high stereoselectivity. Lastly, methylidene 3.39 is 
relatively unstable and is susceptible to bimolecular decomposition pathway especially at 
the relatively high concentration that CM was carried out at (>1 M in benzene), which 
explained the observed low turnover numbers. 
We decided to address problems within the catalytic cycle first, namely the short 
lifetime of methylidene 3.39. Use of a trisubstituted alkene substrate such as E-3.41 could 
improve reaction efficiency and stereoselectivity. Cycloreversion of mcb 3.42, generated 
from reaction of E-3.41 and chloro-alkylidene 3.37 (cf. 3.37, Scheme 3.2.2), would form 
ethylidene 3.44 which is more stable than methylidene 3.39.35  Furthermore, the competing 
pathway (mcb 3.43, Scheme 3.2.3) leading to the undesired Z isomer would be destabilized 
due to the newly introduced steric repulsion between the methyl group and the aryloxide 
ligand (highlighted in gray circles). This additional interaction between the aryloxide 
ligand and trisubstituted alkene substrates would not be available if 1,1-disubstituted 
alkenes (cf. 3.32, Scheme 3.2.2) were used. If successful, a solution would emerge from a 
                                                 
(35) Schrock, R. R.;  Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4592−4633. 
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counterintuitive principle that more sterically hindered trisubstituted alkenes (compared to 
1,1-disubstituted alkenes) could improve CM efficiency as well as stereoselectivity.  
 
Nevertheless, the solution proposed in Scheme 3.2.4 may seem counterproductive at first 
because stereoselective preparation of trisubstituted alkene substrates would be critical for 
the ensuing stereoretentive trisubstituted alkene CM. Although synthesis of trisubstituted 
alkenes with three different substituents can be difficult, E-3.41 was readily prepared from 
catalytic cross-coupling as demonstrated in Scheme 3.2.5. For instance, alkyl borabicycle 
3.46, prepared from hydroboration of styrene with 9-BBN, underwent Suzuki cross-
coupling with the commercially available E-3.45 to furnish E-3.44 in 85% yield as a single 
stereoisomer.36 CM of E-3.41 in the presence of only 1.0 mol% Mo-1 (vs. 10 mol% with  
3.32) and 5.0 equiv. of E-3.33 reached completion within 4 h (vs. 12 h with 3.32) and the  
trisubstituted alkenyl chloride E-3.34 was isolated in 81% yield and in 95:5 E:Z ratio  
(Scheme 3.2.5). Not only was CM efficiency and selectivity improved considerably but 
                                                 
(36) Chemler, S. R.; Trauner, D.; Danishefsky, S. J. Angew. Chem. Int. Ed. 2001, 40, 4544–4568. 
Page 195 
chloroalkene 3.47 was the only detectable initiation product in the unpurified product 
mixture, which indicated that Mo-1 reacted preferentially with the disubstituted E-3.33 
rather than the more sterically hindered trisubstituted 3.41. This unexpected change in 
initiation of Mo-1 thus provided a direct entrance to the putative catalytic cycle. 
 
3.3. Synthesis of E- and Z-Trisubstituted Alkenyl Chlorides 
E-Trisubstituted alkenyl chlorides 3.48-3.56 (Scheme 3.3.1) were obtained in 56–
91% yield and 93:7 to >98:2 E:Z selectivity. The aforementioned zirconocene-catalyzed 
carbometallation approach (Scheme 3.1.1) is not compatible with an epoxide9 (3.51; lower  
yield due to difficult purification), a carboxylic ester (3.48), a boronic acid pinacol ester 
(pin, pinacolato) group (3.49 and 3.50) or a Boc-protected (Boc, tert-butoxycarbonyl) 
indole moiety10 (3.52). A number of observations is noteworthy: Z-3.33 and E-3.33 (both 
are commercially available) can be used interchangeably in most cases. The combination 
of Mo-1 and Z-3.33 presents a well-behaved catalytic system that proved optimal for when 
differentiation between a more hindered yet electron-rich trisubstituted alkene and an 
electron-deficient disubstituted α,β-unsaturated ester (3.48) or alkenylboronate (3.49 and 
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3.50) is desired. For more challenging substrates such as the sterically bulky α,β-
dialkylstyrenes (3.52-3.54), electron-deficient allylic ethers (3.55), or α-branched 
trisubstituted alkenes (3.56), a less hindered catalyst Mo-2 (vs. Mo-1) and fast-reacting 
cross-partner E-3.3333 (vs. Z-3.33) is needed for more efficient turnover. 
 
Z-Trisubstituted alkenyl chlorides can be synthesized by a sequence similar to that 
with E- trisubstituted alkenyl chlorides (Scheme 3.3.2); as noted before, such compounds 
cannot be accessed through zirconocene-catalyzed alkylaluminum addition approach 
unless propargylic or homopropargylic  hydroxyl group is present.11 By using 
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commercially available Z-3.45, we prepared Z-3.41 in 75% yield as a single stereoisomer37 
(>98% Z). Cross-metathesis with Z-3.33 and 3.0 mol % Mo-1 afforded Z-3.34 in 86% yield 
and 91% Z selectivity after four hours. Notable examples include 3.58 that contains a Lewis 
basic tertiary amine group as well as 3.59 with a ferrocene moiety (Scheme 3.3.2). CM 
reactions that furnish Z-trisubstituted alkenyl chlorides are generally less selective (86-91% 
Z) compared to the E-trisubsituted alkene cases (≥ 95% E, Scheme 3.3.1). For sterically 
demanding aryl substrates (Z-3.54), Z selectivity was even more diminished (79% Z) 
although we were able to isolate pure Z-alkene product through routine silica gel 
chromatography. 
 
The lower Z selectivity in CM of Z-trisubstituted alkene substrates can be explained 
by considering the mcb intermediates (3.62 and 3.65, Scheme 3.3.3) leading to each 
                                                 
(37) Fall, Y.; Doucet, H.; Santelli, M. Appl. Organometal. Chem. 2008, 22, 503–509. 
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isomeric product in the case of Z-3.34 (Scheme 3.3.2). Similar to the stereochemical model 
discussed in CM of E-trisubstituted alkenes (cf. 3.42 and 3.43, Scheme 3.2.4), formation 
of mcb 3.62 leading to the undesired E isomers would be less favored than mcb 3.63 due 
to the steric interaction between the methyl group and the aryloxide ligand in this 
intermediate (highlighted in gray circles in 3.62, Scheme 3.3.3). However, mcb 3.63 would 
also be destabilized by having the larger alkene substituent (-CH2CH2Ph) in close 
proximity to chlorine (both highlighted in gray circles in 3.63), now that the geometry of 
the trisubstituted alkene substrate had been reversed. Therefore, the energy difference 
between 3.62 and 3.63 is smaller than that between 3.42 and 3.43, which translates to 
diminished Z selectivity in CM of Z-trisubstituted alkenes. To probe the validity of the 
above rationale, we synthesized allylboronate 3.64 which had a butyl group at the less 
hindered carbon of the alkene moiety. We reasoned that replacing the methyl group in mcb 
3.62 with a larger butyl group would destabilize such intermediate, thus rendering the  
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undesired pathway less competitive. In the event, CM of 3.64 with 3.0 mol% of Mo-1 and 
5.0 equiv. of Z-3.33 afforded γ-chloroallylboronate in 83% yield and 95:5 Z:E ratio, which 
supported our stereochemical model. 
3.4. Synthesis of E- and Z-Trisubstituted Alkenyl Bromides 
CM of various E- or Z-trisubstituted alkenes with 1,2-dibromoethene 
(commercially available as an inseparable mixture of isomer, 64:36 Z:E) was inefficient 
(<10% conv.) probably due to the increased steric bulk of 1,2-dibromoethene (vs. 
dichloroethene E-3.33 and Z-3.33) Based on our previous investigations regarding  
 
Page 200 
regioselective CM of dissymmetric 1,2-dihaloalkenes,32,33 use of Z-1-bromo-2-
fluoroethene 3.66 could lead to a regioselective and stereoselective CM to access E- and 
Z-trisubstituted alkenyl bromides. In agreement with the stereochemical model proposed 
in previous study,32 Mo-1 reacted with 3.66 to generate fluoroalkene 3.68 (observed by 1H 
NMR analysis) and the putative bromo-alkylidene 3.69 (Scheme 3.4.1). The ensuing CM 
of 3.69 and E-3.41 proceeded readily in the presence of 1.0 mol% of Mo-1 affording E-
3.67 in 90% yield and as a single alkene isomer. Additional examples of E-trisubstituted 
alkenyl bromides are shown in Scheme 3.4.1. Similar to cases with Z-trisubstituted alkenyl 
chlorides (Scheme 3.3.2), CM reactions involving Z-trisubstituted alkenes and 3.66 are 
typically less stereoretentive (~90% Z across most substrates vs. >98% E in all cases, 
Scheme 3.4.1) and selectivity towards formation of bromo-alkene products (83:17-89:11 
Br:F vs. 92:8-97:3 Br:F with E-trisubstituted alkenes, Scheme 3.3.4) was slightly 
diminished. 
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3.5. Synthesis of E- and Z-Trisubstituted Aliphatic Alkenes 
The present approach was applicable to stereoretentive synthesis of non-
halogenated trisubstituted olefins (Scheme 3.5.1). With 3.0 equiv. trans-5-decene 3.76 and 
3.0 mol% Mo-3, 3.77 was obtained in 69% yield as a single stereoisomer (>98% E). 
Because of the increased steric size of the alkene cross partner 3.76 (i.e. butyl vs. chloro in 
E-3.33), use of a slightly less sterically congested complex with mesityl-substituted 
(mesityl, 2,4,6-trimethylphenyl) aryloxide ligand led to higher efficiency (i.e. Mo-3 instead  
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of Mo-1). Mo-3 offers a well-balanced reactivity and stereoretention profile as the less 
sterically encumbered Mo-2 delivered 3.77 in inferior selectivity (86:14 E:Z). Reaction of 
E-3.41 with a 61:39 E:Z mixture of 1,2- disubstituted homoallylic ether 3.78 and 5.0 mol 
% Mo-3 led to the formation of 3.79 in 52% yield and 93:7 E:Z selectivity after four hours 
at 40 °C (Fig. 4b). Additionally, since the Mo catalyst readily reacts with either isomer of 
a 1,2-disubstituted alkene to generate the same syn-alkylidene, the 1,2-disubstituted cross-
partner needs not be stereoisomerically pure. 
Z-Trisubstituted alkene 3.80 (Scheme 3.5.1) was accessed similarly. As already 
noted, this CM proceeded via more congested metallacycles (cf. mcb 3.63 in Scheme 3.3.3 
where chloro is replaced by a butyl group). Accordingly, 3.80 was isolated in 28% yield 
when Mo-3 was used. More reactive monoaryloxide chloride species Mo-438 led to 
improved efficiency (64% yield); although Z selectivity was improved (86% Z vs. 67% Z 
with Mo-3), it was not as high as that obtained with 3.77 (>98% E isomer). 
3.6. Applications to Synthesis of Biologically Active Compounds 
Concise and stereoselective synthesis of naturally occurring anti-fungal agent 
indiacen B39, 10, 40 was demonstrated (Scheme 3.6.1). Diene E-3.82 was prepared from α,β-
unsaturated aldehyde 3.81 and bis[(pinacolato)boryl]methane41 (both are commercially  
                                                 
(38) Koh, M.-J.; Nguyen, T. T.; Lam, J. K.; Hyvl, J.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. Nature 
2017, 542, 80–85. 
(39) Steinmetz, H.; Mohr, K. I.; Zander, W.; Jansen, R.; Gerth, K.; Müller, R. J. Nat. Prod. 2012, 75, 1803–
1805. 
(40) For non-selective synthesis of indiacen B, see: Marsch, N.; Jones, P. G.; Lindel, T. Beilstein J. Org. 
Chem. 2015, 11, 1700–1706. 
(41) Coombs, J. R.; Zhang, L.; Morken, J. P. Org. Lett. 2015, 17, 1708–1711. 
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available). Chemo- and stereoretentive CM of 3.82 furnished 3.50 in 91% yield and 95% 
E selectivity. The natural product was obtained after a Suzuki cross-coupling in 65% yield 
with no loss in E selectivity of the chloroalkene moiety. The three-step route, affording 
indiacen B in 54% overall yield, compares favorably to a previously reported six-step  
synthesis10, which involved zirconocene-catalyzed addition of trimethylaluminum to an 
alkyne, and provided the target molecule in 16% overall yield. 
 
Stereoselective preparation of the carboxylic acid fragment of kimbeamide A42 
(anti-tumor) was accomplished in five steps (Scheme 3.6.2). Stereoisomerically pure 
skipped diene 3.85 was accessed by a two-step procedure involving hydroboration of 
commercially available 2-butyne and cross-coupling of the resulting alkenylboronic acid 
3.84 with 4-methoxycinnamyl alcohol43. Compound 3.49 was then synthesized via E-
alkenyl–B(pin) intermediate 3.85 through two chemo- and stereoretentive CM reactions.  
                                                 
(42) Nunnery, J. K.; Engene, N.; Byrum, T.; Cao, Z.; Jabba, S. V.; Pereira, A. R.; Matainaho, T.; Murray, T. 
F.; Gerwick, W. H. J. Org. Chem. 2012, 77, 4198–4208. 
(43) Tsukamoto, H.; Uchiyama, T.; Suzuki, T.; Kondo, Y. Org. Biomol. Chem. 2008, 6, 3005–3013. 
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The first was the conversion of 3.85 to 3.86 by a transformation carried out with 3.0 mol% 
Mo-3 and vinylB(pin) and the less hindered aryl alkene underwent reaction exclusively. A 
second CM was performed with 3.0 mol% Mo-2 and Z-3.33 (5.0 equiv.), delivering 3.49   
in 59% yield and 97:3 E:Z selectivity. Despite being more hindered, the more electron-rich 
trisubstituted alkene (vs. alkenylboronate moiety in 3.86) reacted preferentially in the CM 
reaction. Next, dienoate 3.88, a compound applicable to synthesis of kimbeamide A, was 
synthesized in 76% yield after another efficient and chemoselective cross-coupling 
reaction.44 The amine fragment of this compound had been previously synthesized by 
kinetically E-selective CM.33 
 Stereoselective synthesis of the anti-leishmanial agent, coibacin D,45 started from 
the same sequence that was used to prepare 3.49 (Scheme 3.6.2). Catalytic cross coupling 
                                                 
(44) Wang, G.; Mohan, S.; Negishi, E. Proc. Natl. Acad. Sci. 2011, 108, 11344−11349. 
(45) Balunas, M. J.; Grosso, M. F.; Villa, F. A.; Engene, N.; McPhail, K. L.; Tidgewell, K.; Pineda, L. M.; 
Gerwick, L.; Spadafora, C.; Kyle, D. E.; Gerwick, W. H. Org. Lett. 2002, 14, 3878−3881. 
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of 3.49 with homoallylic alcohol 3.8946 afforded triene 3.90 in 76% yield. The synthetic 
route continued with a third (the first two chemoselective CM reactions were performed 
with Mo complexes, Scheme 3.6.2) kinetically controlled chemoselective CM involving 
Z-2-butene-1,4-diol (3.91) and dithiolate carbene Ru-347 (94:6 Z:E with no detectable loss  
 
of stereochemistry at the other alkene sites). The resulting Z-allylic alcohol was then 
directly transformed to racemic coibacin D through oxidative cyclization with 
TEMPO/PhI(OAc)2 (57% yield over two steps). The target molecule was thus obtained in 
seven steps, 12% overall yield, and as a single alkene isomer, which compares favorably 
                                                 
(46) Kirchhoff, J. H.; Netherton, M. R.; Hills, I. D.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 13662–13663. 
(47) Koh, M.-J.; Khan, R. K. M.; Torker, S.; Yu, M.; Mikus, M. S.; Hoveyda, A. H. Nature 2015, 517, 181–
186. 
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with the previous synthesis that afforded racemic coibacin D in 4% overall yield after six 
steps and as a 75:25 mixture of alkene isomers.48 
Cross-coupling of E-trisubstituted alkenyl chlorides can be inefficient. Our 
attempts to synthesize propargylic alcohol 3.96, a synthetic intermediate en route to anti-
cancer agent pateamine A,49 by various Sonogashira cross-coupling conditions were not 
 
                                                 
(48) Kolská, K.; Ghavre, M.; Pour, M.; Hybelbauerová, S.; Kotora, M. Asian J. Org. Chem. 2016, 646–651. 
(49) (a) Northcote, P. T.; Blunt, J. W.; Munro, M. H. G. Tetrahedron Lett. 1991, 32, 6411−6414. (b) Dang, 
Y.; Low, W.-K.; Xu, J.; Gehring, N. H.; Dietz, H. C.; Romo, D.;  Liu, J. O. J. Biol. Chem. 2009, 284, 
23613−23621. 
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successful. As a result, we prepared E-trisubstituted alkenyl bromide 3.97 by stereorentive 
and regioselective CM of 3.94, which was accessed from ring-opening of the 
enantiomerically pure epoxide 3.93 followed by silyl protection of the resulting alcohol. 
CM between 3.94 and Z-1-bromo-2-fluoroethene 3.66 (3.0 equiv.) with 5.0 mol% Mo-5 
afforded 3.97 in 88:12 bromide:fluoride selectivity and as a single bromo-alkene isomer 
(>98% E). A catalyst with a smaller aryloxide ligand was needed for higher efficiency 
because a substrate with a β substituent (3.94) had to be accommodated (for example, 63% 
conv. of 3.94 with Mo-2 under otherwise identical conditions). Compound 3.97 was used 
directly in the ensuring cross-coupling with 3,3-diethoxy-1-propyne50 without the need to 
separate the fluoro-alkene byproduct. Unmasking the diethyl acetal group led to 3.98 (41% 
overall yield for three steps). The target fragment was thus synthesized by a shorter route 
(five compared to eight steps) and in similar yield (34% compared to 33% overall yield as 
previously reported).51 
3.7. Regio- and Stereoselective CM of Unhindered Terminal Alkenes 
 The counterintuitive finding that more hindered trisubstituted alkenes can undergo 
CM with higher efficiency and stereoretention led us to revisit a previously unsolved 
problem which pertains to the Z-selective and regioselective CM of terminal alkene 3.99 
with 3.66 (Scheme 3.7.1).32 Although both products 3.101 and 3.102 were obtained with 
excellent stereoselectivity (both >98% Z), the fluoro:bromo-alkene ratio was far from 
desired (72:28 F:Br), which decreased the yield of fluoro-alkene as well as complicated its 
                                                 
(50) The Sonogashira cross-coupling condition was modified from: Soheili, A.; Albaneze-Walker, J.; Murry, 
J. A.; Dormer, P. G.; Hughes, D. L. Org. Lett. 2003, 5, 4191−4194. 
(51) Romo, D.; Rzasa, R. M.; Shea, H. A.; Park, K.; Langenhan, J. M.; Sun, L.; Akhiezer, A.; Liu, J. O. J. 
Am. Chem. Soc. 1998, 120, 12237–12254. 
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isolation. The undesired alkenyl bromide product was most likely derived from CM of the 
self-metathesis product 3.103 and the bromo-alkylidene from cycloreversion of 3.107.52 
Although higher F:Br ratio (96:4 F:Br) could be obtained when sterically hindered allylic-
branched alkene 3.104 was used, self-metathesis of 3.104 was  not competitive53 with CM 
due to the increased steric constraints of this substrate. Whether the increase in selectivity  
 
                                                 
(52) For the complete catalytic cycle in CM of 3.63 with terminal alkenes, see reference 23. 
(53) Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360−11370. 
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for the formation of alkenyl fluorides was derived from destabilization of the pathway 
leading to bromoalkene or simply from slowing down homocoupling of terminal alkenes 
could not be unambiguously answered at the time. 
 In light of the latest results in CM of trisubstituted alkenyl halides, we envision that 
1,1-dimethyl trisubstituted alkenes (isoprenoids) could potentially serve as a surrogate for 
terminal alkenes. Isoprenoids represent an attractive and large subset of naturally-occurring 
alkenes that are derived from plant-based materials. Moreover, terminal alkenes can be 
readily converted to isoprenoid products by efficient CM of 2-methylpropene or 2-methyl-
2-butene as reported earlier.27 Importantly, isoprenoid alkenes such as 3.110 (Scheme 
3.7.2) do not undergo self-metathesis as confirmed by control experiment. To probe the 
possibility of our proposal, we carried out CM of silyl-protected citronellol 3.110 with 3.66 
using 1.0 mol% Mo-3 (optimal catalyst for isoprenoid substrates after screening) as the 
catalyst, respectively (Scheme 3.7.2). Indeed, considerably higher selectivity for 
fluoroalkene (92:8 F:Br vs. 72:28 F:Br with 3.99, Scheme 3.7.1) was obtained. This 
observation strongly indicated that homocoupling of unhindered terminal alkenes (cf. 3.99, 
Scheme 3.7.1) in CM with 3.66 was most likely responsible for the erosion of 
regioselectivity. 
It is worth mentioning that CM reactions with the more sizeable isoprenoid 
substrates (compared to monosubstituted alkenes) was even more efficient as illustrated by 
the example shown in Scheme 3.7.2. This could be attributed to the suppression of self-
metathesis as well as the absence of a pathway leading to formation of short-living 
methylidene species (cf. 3.39, Scheme 3.2.2). For instance, CM of allylboronate 3.112 with 
5.0 equiv. of 3.66 was moderately regioselective (73% F) and required 10 mol% Mo-2 to 
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fully consume 3.112. Meanwhile, reaction of prenylboronate 3.114 reached completion 
with just 1.3 mol% Mo-3 and a slight excess of 3.66 (2.0 equiv.), affording 3.113 in 83% 
isolated yield and 98:2 Z:E. To the best of our knowledge, this example was the first 
efficient synthesis of Z-γ-fluoroallylboronate 3.113, an important yet elusive fluorine-
containing building block for allylation methods. The synthetic utility of 3.113 is being 
currently explored in our laboratory. 
 
 A number of isoprenoids derived from commercially available and/or medicinal 
compounds can be converted through CM with 3.66 (Scheme 3.7.3) to afford Z-
fluoroalkenes. In certain cases, uncommonly high CM efficiency was achieved with as low 
as 0.6 mol% of Mo-3 (98% conv., 76% yield of 3.116) or high chemoselectivity between 
two trisubstituted alkenes was observed (3.118 and 3.119, the unreacted trisubstituted 
alkene moieties are highlighted in bold). Substrates bearing Lewis basic functional groups 
such as pyrazole 3.120 and imidazole 3.121 could be effectively masked with a slight 
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excess (1.1 equiv.) of commercially available and cost-effective triphenylborane 
[compared to B(C6F5)3].54 CM was inefficient (<10% conv.) in these cases without 
triphenylborane. Compound 3.121 represents an interesting fluorinated analog of 
enilconazole, an agricultural fungicide and veterinary medicine. 
 
 
                                                 
(54) (a) Peryshkov, D. V.; Schrock, R. R.; Takase, M. K.; Müller, P.; Hoveyda, A. H. J. Am. Chem. 
Soc. 2011, 133, 20754–20757. (b) Shen, X.; Nguyen, T. T.; Koh, M. J.; Xu, D.; Speed, A. W. H.; Schrock, 
R. R.; Hoveyda, A. H. Nature 2017, 541, 380−385. 
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 3.8. Conclusions 
In summary, we introduced a general solution to a longstanding and compelling 
problem in olefin metathesis: a broadly applicable strategy for reliable and efficient 
synthesis of acyclic E- and Z-trisubstituted alkenyl halides. Complications resulted from 
formation of an unstable methylidene species or less reactive disubstituted alkylidene 
complexes can be addressed by utilizing a stereo-defined E- or Z-trisubstituted alkene and 
a 1,2-disubstituted olefin as substrates. By merging two central catalytic transformations 
in organic synthesis, cross-coupling and CM, various E- or Z-trisubstituted alkenyl chloride 
and bromides were readily accessed by the same catalytic system without the need for 
directing groups. The synthetic utility of the present protocol was demonstrated through 
several concise and efficient synthesis of biologically active natural products/synthetic 
precursors. Notably, the E- or Z-trisubstituted alkenyl halides prepared by CM may be 
readily converted to other trisubstituted olefins with complete retention of stereochemical 
purity by means of a second cross-coupling reaction. Based on the new findings, we 
revisited previously unaddressed problems and establish that readily available isoprenoid 
alkenes can serve as suitable surrogate for unhindered terminal alkenes in CM. 
3.9. Experimental Section 
3.9.1. General 
Unless otherwise noted, transformations were performed with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum line techniques. Infrared (IR) spectra were recorded on a 
Bruker FTIR Alpha (ATR Mode) spectrometer, vmax in cm-1. Bands are characterized as 
broad (br), strong (s), medium (m), or weak (w). 1H NMR spectra were recorded on a 
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Varian Unity INOVA 400 (400 MHz), 500 (500 MHz), or 600 (600MHz_ spectrometer. 
Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance 
resulting from incomplete deuterium incorporation as the internal standard (CDCl3: δ 7.26 
ppm, C6D6: δ 7.16 ppm, CD2Cl2: δ 5.32 ppm, CD3OD: δ 3.31 ppm). Data are reported as 
follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR spectra were 
recorded on a Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometers with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 ppm, 
C6D6: δ 128.00 ppm, CD2Cl2: δ 54.00 ppm, CD3OD: δ 49.00 ppm). 19F NMR spectra were 
recorded on a Varian Unity INOVA 400 (376 MHz) spectrometer. High-resolution mass 
spectrometry was performed on a Micromass LCT ESI-MS and JEOL Accu TOF Dart 
(positive mode) at the Boston College Mass Spectrometry Facility. Melting points were 
determined using a Thomas Hoover Uni-melt capillary melting point apparatus. Values for 
E:Z ratios of products were determined by 1H NMR analysis of unpurified mixtures. 
Solvents: 
Solvents (CH2Cl2, Et2O, pentane, benzene and toluene) were purified under a positive 
pressure of dry argon gas by a modified Innovative Technologies purification system. 
Tetrahydrofuran was distilled from Na/benzophenone. Methanol was distilled over Mg. 
Acetone, N,N-dimethylformamide (anhydrous), 1,2-dimethoxyethane (anhydrous) and 1,4-
dioxane (anhydrous) were used as received. All purification procedures of CM products 
were carried out with reagent grade solvents (purchased from Fisher) under bench-top 
conditions. 
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Reagents: 
(E)-5-Decene (Aldrich) and vinylboronic acid pinacol ester (Aldrich) were either distilled 
(from CaH2 or CaCl2) under vacuum or dried by azeotropic distillation (with anhydrous 
benzene) prior to use.  
(3-Methylbut-3-en-1-yl)benzene (from 4-phenyl-2-butanone (Aldrich)) and 1-(tert-butyl)-
4-(prop-1-en-2-yl)benzene (from 4'-tert-butylacetophenone (Aldrich)) were prepared by 
Wittig reaction in analogy to a reported procedure.55 
(E)-1-(But-2-en-2-yl)-4-(tert-butyl)benzene (from 4-tert-butylphenyl boronic acid 
(Combi-Blocks) and (E)-2-bromo-2-butene (Aldrich)), (Z)-1-(but-2-en-2-yl)-4-(tert-
butyl)benzene (from 4-tert-butylphenyl boronic acid (Combi-Blocks) and (Z)-2-bromo-2-
butene (Aldrich)), (E)-1-(but-2-en-2-yl)-3-methoxybenzene (from 3-methoxyphenyl 
boronic acid (Combi-Blocks) and (E)-2-bromo-2-butene (Aldrich)) and (E)-tert-butyl 5-
(but-2-en-2-yl)-1H-indole-1-carboxylate (from 1-Boc-indole-5-boronic acid pinacol ester 
(Combi-Blocks) and (E)-2-bromo-2-butene (Aldrich)) were prepared by cross-coupling in 
analogy to a reported procedure.56 
(E)-(3-Methylpent-3-en-1-yl)benzene (from styrene (Aldrich)), (E)-2-(9-methylundec-9-
en-1-yl)oxirane (from 1,2-epoxy-9-decene (Aldrich)), (E)-2-(3-methylpent-3-en-1-
yl)benzo[b]thiophene (from 2-vinylbenzo[b]thiophene),57 (E)-N,N-dibenzyl-12-
methyltetradec-12-en-1-amine (from N,N-dibenzyl-10-undecen-1-amine32) and (E)-2-(4-
methylhex-4-en-1-yl)isoindoline-1,3-dione (from 2-allylisoindoline-1,3-dione (Ark 
                                                 
(55) Pine, S. H.; Shen, G. S.; Hoang, H. Synthesis 1991, 165–167. 
(56) Fristrup, P.; Tanner, D.; Norrby, P.-O. Chirality 2003, 15, 360–368. 
(57) Falk, A.; Cavalieri, A.; Nichol, G. S.; Vogt, D.; Schmalz, H. Adv. Synth. Catal. 2015, 357, 3317–3320. 
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Pharm)) were prepared by hydroboration with 9-BBN dimer (Alfa Aesar) followed by 
cross-coupling with (E)-2-bromo-2-butene (Aldrich) in analogy to a reported procedure.56  
(Z)-(3-Methylpent-3-en-1-yl)benzene (from styrene (Aldrich)), (Z)-(3-methylpent-3-en-1-
yl)ferrocene (from vinylferrocene (Alfa Aesar)), (Z)-methyl 7-methylnon-7-enoate (from 
methyl oct-7-enoate),58 (Z)-benzyl 2-(dibenzylamino)-6-methyloct-6-enoate (from benzyl 
2-(dibenzylamino)pent-4-enoate),59 (Z)-4,4,5,5-tetramethyl-2-(3-(3-methylpent-3-en-1-
yl)phenyl)-1,3,2-dioxaborolane (from 2-(3-ethenylphenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (Combi-Blocks)), (Z)-tert-butyl 5-(3-methylpent-3-en-1-yl)-1H-indole-1-
carboxylate (tert-butyl 5-vinyl-1H-indole-1-carboxylate)60 and (2S,4aR,6S,7R,8S,8aS)-7-
(benzyloxy)-6-(4-methoxyphenoxy)-8-(((Z)-4-methylhex-4-en-1-yl)oxy)-2-
phenylhexahydropyrano[3,2-d][1,3]dioxine (from 4-methoxyphenyl 3-O-allyl-2-O-
benzyl-4,6-O-benzylidene-β-D-galactopyranoside (TCI America)) were prepared by 
hydroboration with 9-BBN dimer (Alfa Aesar) followed by cross-coupling with (Z)-2-
bromo-2-butene (Aldrich) in analogy to a reported procedure.61 
(E)-1-Methoxy-4-(((2-methylbut-2-en-1-yl)oxy)methyl)benzene (from (E)-2-methylbut-
2-en-1-ol)62 was prepared in analogy to a reported procedure.63 
                                                 
(58) Yun, J. I.; Kim, H. R.; Kim, S. K.; Kim, D.; Lee, J. Tetrahedron 2012, 68, 1177–1184. 
(59) Rodriquez, M.; Bruno, I.; Cini, E.; Marchetti, M.; Taddei, M.; Gomez-Paloma, L. J. Org. Chem. 2006, 
71, 103–107. 
(60) Duan, J.; Field, S.; Kobayashi, S. Patent WO2004/063336 A2 (2004). 
(61) Miyaura, N.; Ishiyama, T.; Sasaki, H.; Ishikawa, M.; Sato, M.; Suzuki, A. J. Am. Chem. Soc. 1989, 111, 
314–321. 
(62) Hazelden, I. R.; Ma, X.; Langer, T.; Bower, J. F Angew. Chem. Int. Ed. 2016, 55, 11198–11202. 
(63) Helliwell, M.; Karim, S.; Parmee, E. R.; Thomas, E. J. Org. Biomol. Chem. 2005, 3, 3636–3653. 
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(2E,6E)-Ethyl 6-methylocta-2,6-dienoate was prepared in analogy to reported 
procedures.64 
(E)-4-Methoxycinnamyl alcohol was prepared according to a reported procedure.65 
methyl (E)-3-bromopropenoate was prepared according to a reported procedure.66 
(Z)-4,4,5,5-tetramethyl-2-(2-methylhept-2-en-1-yl)-1,3,2-dioxaborolane was prepared as a 
93:7 mixture of 1,4- and 1,2-addition product in analogy to a reported procedure.67 
1-((but-2-en-1-yloxy)methyl)-4-methoxybenzene (95:5 E:Z) was prepared from crotyl 
alcohol (95:5 E:Z, Aldrich) in analogy to a reported procedure.68 
(Z)-but-2-en-2-ylboronic acid was prepared according to a reported procedure.69 
tert-butyl((3,7-dimethyloct-6-en-1-yl)oxy)dimethylsilane was prepared from (±)-
citronellol (TCI) in analogy to a reported procedure.70 
Indomethacin geranyl ester was prepared from indomethacin (AK Scientific) in analogy to 
a reported procedure.71 
Imperatorin was prepared from xanthotoxol (Combi-blocks) according to a reported 
procedure.72 
                                                 
(64) (a) Kobayashi, Y.; Yoshida, S.; Nakayama, Y. Eur. J. Org. Chem. 2001, 1873–1881. (b) Gemma, S.; 
Martí, F.; Gabellieri, E.; Campiani, G.; Novellino, E.; Butini, S. Tetrahedron Lett. 2009, 50, 5719–5722. 
(65) Maeda, H.; Matsuda, S.; Mizuno, K. J. Org. Chem. 2016, 81, 8544–8551. 
(66) Crombie, L.; Horsham, M. A.; Jarret, S. R. M. J. Chem. Soc., Perkin Trans. 1 1991, 1511−1524. 
(67) Ely, R. J.; Morken, J. P. Org. Synth. 2011, 88, 342−352. 
(68) Bourque, L. E.; Haile, P. A.; Loy, J. M. N.; Woerpel, K. A. Tetrahedron 2009, 65, 5608–5613. 
(69) Patil, A. S.; Mo, D.; Wang, H.; Mueller, D. S.; Anderson, L. L. Angew. Chem. Int. Ed. 2012, 51, 7799–
7803. 
(70) Aponick, A.; Li, C.-Y.; Palmes, J. A. Org. Lett. 2009, 11, 121–124. 
(71) Kalgutkar, A. S.; Marnett, A. B.; Crews, B. C.; Remmel, R. P.; Marnett, L. J. J. Med. Chem. 2000, 43, 
2860–2870. 
(72) Russo, M.; Torre, G.; Carnovale, C.; Bonaccorsi, I.; Mondello, L.; Dugo, P. Journal of Essential Oil 
Research 2012, 24, 119−129. 
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1-(2-(2,4-dichlorophenyl)-2-((3-methylbut-2-en-1-yl)oxy)ethyl)-1H-imidazole was 
prepare from 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol (Ark Pharm) in 
analogy to a reported procedure.72 
Methyl 5-allyl-2-hydroxy-3-methoxybenzoate was prepared from methyl 3-
methoxysalicylate (Combi-blocks) according to a reported procedure.73 
3-methyl-5-(3-methylbut-2-en-1-yl)-1-phenyl-1H-pyrazole was prepared according to a 
reported procedure.74 
(Z)-1,2-Dichloroethene (Aldrich), (E)-1,2-dichloroethene, (Z)-1-bromo-2-fluoroethene 
(Synquest), (Z)-2-butene-1,4-diol (Aldrich), methyl 5-bromovalerate (Aldrich), 
allylboronic acid pinacol ester (Frontier Scientific), diisobutylaluminum hydride solution 
(1.0 M in cyclohexane) (Aldrich), 4-bromoindole-3-carboxyaldehyde (Ark-Pharm), 1-
propenylmagnesium bromide 0.5 M solution in THF (Aldrich), ethylene oxide 2.5−3.3 M 
solution in THF (Aldrich), tetrakis(triphenylphosphine)palladium(0) (Strem), dichloro 
1,1'-bis(diphenylphosphino)ferrocene palladium (II) dichloromethane (Strem), 
bis[(pinacolato)boryl]methane (Aldrich), lithium 2,2,6,6-tetramethylpiperidide (Aldrich), 
dibromoborane dimethyl sulfide complex solution (1.0 M in dichloromethane) (Aldrich), 
palladium (II) acetate (Strem), di-tert-butylmethylphosphine (Aldrich), TEMPO (Aldrich), 
(diacetoxyiodo)benzene (Oakwood), tert-butyllithium solution (1.7 M in pentane) 
(Aldrich), cesium fluoride (Aldrich), dichloro[bis(2-
(diphenylphosphino)phenyl)ether]palladium(II) (Aldrich), (S)-propylene oxide (Aldrich), 
tert-butyldimethylsilyl trifluoromethanesulfonate (Aldrich), triethylamine (Aldrich), 
                                                 
(73) Kim, E.; Kim, J. Y.; Rhee, H. Bull. Korean Chem. Soc. 2004, 25, 1720−1722. 
(74) Yang, Y.; Buchwald, S. L. J. Am. Chem. Soc. 2013, 135, 10642−10645. 
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bis(tri-tert-butylphosphine)palladium(0) (Aldrich), copper (I) iodide (Aldrich), 1,4-
diazabicyclo[2.2.2]octane (Aldrich), 3,3-diethoxy-1-propyne (Aldrich) and oxalic acid 
dihydrate (Fisher) were used as received. 
Preparation of organometallic complexes 
Mo-1,32 Mo-2,33 Mo-3,75 and Mo-438 were prepared according to previously reported 
procedures. Mo complexes were manipulated under an atmosphere of N2 in a glove box. 
Ru-147 was prepared according to a previously reported procedure. 
General procedure for in situ preparation of Mo-5 for spectroscopic analysis: In a N2-
filled glove box, an oven-dried 4 mL vial equipped with a magnetic stir bar was charged 
with pentafluorophenylimido Mo bispyrrolide complex76 (16.7 mg, 0.0280 mmol), 4',5'-
diphenyl-[1,1':2',1''-terphenyl]-3'-ol77 (11.2 mg, 0.0280 mmol) and C6D6 (1 mL), resulting 
in a dark red solution. The vial was capped and the mixture was allowed to stir for 2 h at 
22 C, at which time it was transferred to a screw cap NMR tube by a pipette. The NMR 
tube was capped and sealed with Teflon tape. For in situ generated complexes, only the 
diagnostic α proton signal of the syn-alkylidene of Mo-5 is reported: 1H NMR (500 MHz, 
C6D6): δ 12.38 (1H, s). 
General procedure for in situ preparation of Mo-5 for use in reactions: In a N2-filled 
glove box, an oven-dried 4 mL vial equipped with a magnetic stir bar was charged with 
pentafluorophenylimido Mo bispyrrolide complex (59.8 mg, 0.100 mmol), 4',5'-diphenyl-
                                                 
(75) Zhang, H.; Yu, E. C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 16493–
16496. 
(76) Yuan, J.; Schrock, R. R.; Müller, P.; Axtell, J. C.; Dobereiner, G. E. Organometallics 2012, 31, 4650–
4653. 
(77) Townsend, E. M.; Kilyanek, S. M.; Schrock, R. R.; Müller, P.; Smith, S. J.; Hoveyda, A. H. 
Organometallics 2013, 32, 4612–4617. 
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[1,1':2',1''-terphenyl]-3'-ol (39.9 mg, 0.100 mmol) and C6H6 (1 mL), resulting in a dark red 
solution. The vial was capped and the mixture was allowed to stir for 2 h at 22 C, after 
which time the catalyst solution was transferred to the reaction mixture by syringe (dried 
at 65 °C). 
3.9.2. Cross-Metathesis (CM) Reactions 
General Procedure: In a N2-filled glove box, an oven-dried 8 mL vial equipped with a 
magnetic stir bar was charged with trisubstituted alkene substrate and the corresponding 
disubstituted alkene substrate (Z-1,2-dichloroethene, E-1,2-dichloroethene, Z-1-bromo-2-
fluoroethene, (E)-5-decene, tert-butyldimethyl(pent-3-en-1-yloxy)silane) or (E)-1-((but-2-
en-1-yloxy)methyl)-4-methoxybenzene). A solution of Mo-1, Mo-2, Mo-3, Mo-4 or Mo-
5 in benzene was then added. The resulting mixture was allowed to stir for 4 h at 22 C, 
after which time the reaction was quenched by the addition of wet (undistilled) CDCl3 
(percent conversion was determined by 1H NMR analysis of the unpurified mixture). 
Purification was performed through silica gel chromatography and/or preparative thin layer 
chromatography. 
(E)-(4-Chloro-3-methylbut-3-en-1-yl)benzene (E-3.34): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 10 L, 1.0 mol) was transferred by 
syringe to an oven-dried vial containing E-1,2-dichloroethene (48.5 mg, 0.500 mmol) and 
(E)-(3-methylpent-3-en-1-yl)benzene (16.0 mg, 0.100 mmol). The resulting solution was 
allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and 
analysis of the unpurified mixture revealed 98% consumption of (E)-(3-methylpent-3-en-
1-yl)benzene. The resulting orange oil was purified by silica gel chromatography (100% 
pentane) to afford E-3.34 (14.6 mg, 0.0808 mmol, 81% yield) in 95:5 E:Z ratio as colorless 
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oil. IR (neat): 3064 (w), 2926 (w), 2855 (w), 1641 (w), 1602 (w), 1454 (m), 1030 (m); 1H 
NMR (400 MHz, CDCl3): δ 7.32−7.26 (2H, m), 7.23−7.18 (1H, m), 7.18−7.14 (2H, m), 
5.81−5.78 (1H, m), 2.77−2.71 (2H, m), 2.40−2.34 (2H, m), 1.83 (3H, d, J = 1.4 Hz); 13C 
NMR (100 MHz, CDCl3): δ 141.4, 138.2, 128.6, 128.5, 126.2, 112.8, 39.2, 34.4, 16.8; 
HRMS [M+H]+ calcd for C11H14Cl: 181.0784, found: 181.0785. 
(2E,6E)-Ethyl 7-chloro-6-methylhepta-2,6-dienoate (3.48): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by 
syringe to an oven-dried vial containing E-1,2-dichloroethene (24.2 mg, 0.250 mmol) and 
(2E,6E)-ethyl 6-methylocta-2,6-dienoate (9.1 mg, 0.0499 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed 85% consumption of (2E,6E)-ethyl 6-
methylocta-2,6-dienoate. The resulting orange oil was purified by silica gel 
chromatography (2% Et2O in pentane) to afford 3.48 (6.6 mg, 0.0326 mmol, 65% yield) in 
96:4 E:Z ratio as pale yellow oil. IR (neat): 2917 (w), 2850 (w), 1716 (s), 1654 (m), 1265 
(s), 1152 (s), 1041 (s); 1H NMR (400 MHz, CDCl3): δ 6.90 (1H, dt, J = 15.6, 6.8 Hz), δ 
5.86−5.80 (2H, m), 4.19 (2H, q, J = 7.1 Hz), 2.38−2.30 (2H, m), 2.26−2.19 (2H, m), 1.78 
(3H, d, J = 1.3 Hz), 1.29 (3H, t, J = 7.1 Hz); 13C NMR (100 MHz, CDCl3): δ 166.6, 147.5, 
137.3, 122.2, 113.3, 60.4, 35.6, 30.4, 16.6, 14.4; HRMS [M+H]+ calcd for C10H16ClO2: 
203.0839, found: 203.0830. 
2-((1E,4E)-5-Chloro-4-methylpenta-1,4-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3.49): Following the general procedure, a solution of Mo-1 in benzene 
(0.1 M, 75 L, 7.5 mol) was transferred by syringe to an oven-dried vial containing Z-
1,2-dichloroethene (73 mg, 0.75 mmol) and 3.83 (55.5 mg, 0.250 mmol). The resulting 
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solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet 
CDCl3 and analysis of the unpurified mixture revealed 98% consumption of 3.83. The 
resulting red oil was purified by SiO2 gel chromatography (5% Et2O in pentane) to afford 
3.49 (35.7 mg, 0.147 mmol, 59% yield) in 97:3 E:Z ratio as colorless oil. IR (neat): 2978 
(m), 1636 (m), 1358 (s), 1321 (s), 1142 (s), 970 (m), 846 (m); 1H NMR (400 MHz, 
CDCl3): δ 6.53 (1H, dt, J = 17.9, 6.5 Hz), 5.84 (1H, q, J = 1.3 Hz), 5.48 (1H, dt, J = 17.9, 
1.5 Hz), 2.88 (2H, dt, J = 6.5, 1.5 Hz), 1.77 (3H, d, J = 1.4 Hz), 1.26 (12H, s); 13C NMR 
(100 MHz, CDCl3) δ 149.8, 136.4, 113.8, 83.4, 43.3, 24.9, 16.9; HRMS [M+H]+ calcd for 
C12H21BClO2: 243.1323, found: 243.1324. 
2-((1E,3E)-4-Chloro-3-methylbuta-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3.50): Following the general procedure, a solution of Mo-1 in benzene 
(0.1 M, 500 L, 50.0 mol) was transferred by syringe to an oven-dried vial containing Z-
1,2-dichloroethene (242 mg, 2.50 mmol) and 3.82 (104 mg, 0.500 mmol). The resulting 
solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet 
CDCl3 and analysis of the unpurified mixture revealed 96% consumption of 3.82. The 
resulting red oil was purified by silica gel chromatography (5% Et2O in pentane) to afford 
a mixture of 3.82, (1'r,3'r)-2,2'',4,4'',6,6''-hexaethyl-[1,1':3',1''-terphenyl]-2'-ol (protonated 
aryloxide ligand from Mo-2) and 3.50 (80% by weight accounting for the mass of unreacted 
3.82 and terphenol, 133 mg, 0.466 mmol, 93% yield) in 95:5 E:Z ratio as wet orange solid. 
IR (neat): 2978 (m), 2929 (w), 1615 (m), 1380 (m), 1340 (s), 1324 (s), 1270 (w), 1200 
(w), 1142 (s), 989 (m), 969 (m), 89 (m), 789 (m); 1H NMR (400 MHz, CDCl3): E-isomer 
(major): δ 6.98 (1H, d, J = 18.1 Hz), 6.35 – 6.30 (m, 1H), 5.61 (1H, dd, J = 18.1, 0.7 Hz), 
1.89 (3H, d, J = 1.3 Hz), 1.27 (12H, s); Z-isomer (resolved signals only): δ 7.57 (1H, d, J 
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= 18.2 Hz), 6.10 – 6.05 (1H, m), 5.74 (1H, dd, J = 18.2, 0.8 Hz), 1.85 (3H, d, J = 1.5 Hz); 
13C NMR (125 MHz, CDCl3) δ 148.6, 138.4, 123.6, 83.5, 24.9, 12.2; HRMS [M+H]+ 
calcd for C11H19BClO2: 229.1167, found: 229.1166. 
 (E)-2-(10-Chloro-9-methyldec-9-en-1-yl)oxirane (3.51): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.3 mg, 0.251 mmol) and 
(E)-2-(9-methylundec-9-en-1-yl)oxirane (10.5 mg, 0.0500 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed 83% consumption of starting material. The 
resulting red oil was purified by silica gel chromatography (1% Et2O in pentane) to afford 
3.51 (6.5 mg, 0.0282 mmol, 56% yield) in 94:6 E:Z ratio as colorless oil. IR (neat): 2925 
(s), 2854 (m), 1460 (w), 771 (m); 1H NMR (400 MHz, CDCl3): δ 5.78 (1H, h, J = 1.3 Hz), 
2.90 (1H, tdd, J = 5.3, 4.0, 2.7 Hz), 2.75 (1H, dd, J = 5.1, 4.0 Hz), 2.46 (1H, dd, J = 5.1, 
2.7 Hz), 2.05 (2H, td, J = 7.4, 1.3 Hz), 1.76 (3H, d, J = 1.3 Hz), 1.59–1.14 (14H, m); 13C 
NMR (100 MHz, CDCl3) δ 139.1, 111.8, 52.5, 47.3, 37.2, 32.6, 29.6, 29.5, 29.4, 29.2, 
27.6, 26.1, 16.5; HRMS [M+H]+ calcd for C14H24ClO: 231.1516, found: 231.1514. 
tert-Butyl (E)-5-(1-chloroprop-1-en-2-yl)-1H-indole-1-carboxylate (3.52): Following 
the general procedure, a solution of Mo-2 in benzene (0.1 M, 50 L, 5.0 mol) was 
transferred by syringe to an oven-dried vial containing E-1,2-dichloroethene (24.3 mg, 
0.251 mmol) and tert-butyl (E)-5-(but-2-en-2-yl)-1H-indole-1-carboxylate (13.6 mg, 0.501 
mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 91% 
consumption of tert-butyl (E)-5-(but-2-en-2-yl)-1H-indole-1-carboxylate. The resulting 
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red oil was purified by preparative thin layer chromatography (2% Et2O in pentane) to 
afford 3.52 (13.3 mg, 0.0456 mmol, 91% yield) in >98:2 E:Z ratio as clear colorless oil. IR 
(neat): 2977 (w), 2931 (w), 1731 (s), 1486 (m), 1364 (s), 1334 (s), 1231 (s), 1135 (s), 1083 
(s), 1022 (s), 782 (m), 764 (m), 724 (m); 1H NMR (400 MHz, CDCl3): E isomer (major): 
δ 8.09 (1H, d, J = 8.7 Hz), 7.60 (1H, d, J = 3.7 Hz), 7.52 (1H, dd, J = 1.9, 0.6 Hz), 7.30 
(1H, dd, J = 8.7, 1.9 Hz), 6.56 (1H, dd, J = 3.7, 0.8 Hz), 6.33 (1H, d, J = 1.4 Hz), 2.26 (3H, 
d, J = 1.4 Hz), 1.68 (9H, s); 13C NMR (100 MHz, CDCl3) δ 138.9, 135.2, 130.8, 126.7, 
122.5, 118.4, 115.2, 115.1, 107.5, 84.0; HRMS [M+H]+ calcd for C16H19ClNO2: 292.1104, 
found: 292.1103. 
(E)-1-(1-Chloroprop-1-en-2-yl)-3-methoxybenzene (3.53): Following the general 
procedure, a solution of Mo-2 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.2 mg, 0.250 mmol) and 
(E)-1-(but-2-en-2-yl)-3-methoxybenzene (8.1 mg, 0.0499 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed 90% consumption of (E)-1-(but-2-en-2-
yl)-3-methoxybenzene. The resulting orange oil was purified by silica gel chromatography 
(100% hexanes to 1% EtOAc in hexanes) to afford 3.53 (7.9 mg, 0.0433 mmol, 87% yield) 
in >98:2 E:Z ratio as colorless oil. IR (neat): 2953 (m), 2926 (s), 2855 (m), 1601 (m), 1577 
(m), 1457 (m), 1263 (s), 1048 (m); 1H NMR (400 MHz, CDCl3): δ 7.26−7.26(1H, m), 
6.95−6.90 (1H, m), 6.88−6.82 (2H, m), 6.35−6.31(1H, m), 3.82 (3H, s), 2.19 (3H, d, J = 
1.4 Hz); 13C NMR (100 MHz, CDCl3): δ 138.6, 129.6, 118.6, 116.1, 113.2, 112.1, 101.2, 
55.4, 31.1; HRMS [M]+ calcd for C10H11ClO: 182.0498, found: 182.0495. 
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(E)-1-(tert-Butyl)-4-(1-chloroprop-1-en-2-yl)benzene (E-3.54): Following the general 
procedure, a solution of Mo-2 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.2 mg, 0.250 mmol) and 
(E)-1-(but-2-en-2-yl)-4-(tert-butyl)benzene (9.4 mg, 0.0499 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed >98% consumption of (E)-1-(but-2-en-2-
yl)-4-(tert-butyl)benzene. The resulting orange oil was purified by silica gel 
chromatography (100% pentane) to afford E-3.54 (9.4 mg, 0.0450 mmol, 90% yield) in 
>98:2 E:Z ratio as colorless oil. IR (neat): 3034 (w), 2962 (m), 2867 (w), 1620 (w), 1363 
(m), 1245 (m), 1114 (m), 985 (m); 1H NMR (400 MHz, CDCl3): δ 7.38−7.34 (2H, m), 
7.30−7.26 (2H, m), 6.32−6.30 (1H, m), 2.20−2.19 (3H, m), 1.33 (9H, s); 13C NMR (100 
MHz, CDCl3): δ 151.0, 138.4, 137.5, 125.7, 125.6, 115.3, 34.7, 31.4, 16.9; HRMS 
[M+H]+ calcd for C13H18Cl: 209.1097, found: 209.1102. 
(E)-1-(((3-Chloro-2-methylallyl)oxy)methyl)-4-methoxybenzene (3.55): Following the 
general procedure, a solution of Mo-2 in benzene (0.1 M, 25 L, 2.5 mol) was transferred 
by syringe to an oven-dried vial containing E-1,2-dichloroethene (24.2 mg, 0.250 mmol) 
and (E)-1-methoxy-4-(((2-methylbut-2-en-1-yl)oxy)methyl)benzene (10.3 mg, 0.0499 
mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% 
consumption of starting trisubstituted alkene. The resulting orange oil was purified by silica 
gel chromatography (1% to 2% EtOAc in hexanes) to afford 3.55 (10.3 mg, 0.0454 mmol, 
91% yield) in 93:7 E:Z ratio as pale yellow oil. IR (neat): 3000 (w), 2917 (w), 2853 (w), 
1612 (m), 1512 (s), 1245 (s), 1077 (s), 1033 (s), 818 (s); 1H NMR (400 MHz, CDCl3): δ 
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7.25 (2H, d, J = 7.3 Hz), 6.88 (2H, d, J = 8.6 Hz), 6.12−6.09 (1H, m), 3.93 (2H, s), 3.81 
(3H, s), 1.82 (3H, d, J = 1.1 Hz); 13C NMR (100 MHz, CDCl3): δ 136.0, 130.1, 129.5, 
115.9, 114.0, 101.2, 72.7, 71.7, 55.4, 14.6; HRMS [M-H]+ calcd for C12H14ClO2: 
225.0682, found: 225.0692. 
(S,E)-tert-butyl((5-chloro-4-methylpent-4-en-2-yl)oxy)dimethylsilane (3.56): 
Following the general procedure, a solution of Mo-2 in benzene (0.1 M, 100 L, 10 mol) 
was transferred by syringe to an oven-dried vial containing E-1,2-dichloroethene (38.8 mg, 
0.400 mmol) and 3.91 (45.7 mg, 0.200 mmol). The resulting solution was allowed to stir 
for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed >98% consumption of starting trisubstituted alkene. The 
resulting orange oil was purified by silica gel chromatography (1% EtOAc in hexanes) to 
afford 3.56 (43.6 mg, 0.175 mmol, 87% yield) in 96:4 E:Z ratio as colorless oil. IR (neat): 
2955 (w), 2929 (w), 2898 (w), 2857 (w), 1640 (w), 1252 (s), 1126 (s), 1085 (s), 833 (s), 
772 (s); 1H NMR (400 MHz, CDCl3): δ 5.8 (1H, p, J = 1.3 Hz), 3.9 (1H, dqd, J = 7.2, 6.1, 
5.2 Hz) , 2.2 (1H ddd, J = 13.5, 7.2, 1.0 Hz), 2.1 (1H, ddd, J = 13.4, 5.2, 1.1 Hz), 1.8 (3H, 
d, J = 1.4 Hz), 1.1 (3H, d, J = 6.1 Hz), 0.9 (9H, s), 0.0 (3H, s), 0.0 (3H, s); 13C NMR (100 
MHz, CDCl3): δ 136.0, 114.1, 66.7, 47.3, 26.0, 23.9, 18.2, 17.2, -4.4, -4.7; HRMS [M-
H]+ calcd for C12H26ClOSi: 249.1441, found: 249.1442. 
(Z)-(4-Chloro-3-methylbut-3-en-1-yl)benzene (Z-3.34): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.3 mg, 0.500 mmol) and 
(Z)-(3-methylpent-3-en-1-yl)benzene (8.0 mg, 0.0500 mmol). The resulting solution was 
allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and 
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analysis of the unpurified mixture revealed 98% consumption of (Z)-(3-methylpent-3-en-
1-yl)benzene. The resulting orange oil was purified by silica gel chromatography (100% 
pentane) to afford Z-3.34 (7.8 mg, 0.0432 mmol, 86% yield) in 91:9 Z:E ratio as colorless 
oil. IR (neat): 3027 (w), 2929 (w), 2859 (w), 1603 (w), 1494 (m), 1433 (m), 1031 (m), 741 
(s), 700 (s); 1H NMR (400 MHz, CDCl3): E-isomer (major): δ 7.34 –7.14 (5H, m), 5.80 
(1H, dt, J = 1.5, 0.7 Hz), 2.79 – 2.68 (2H, m), 2.55 – 2.46 (2H, m), 1.74 (3H, d, J = 1.6 
Hz); 13C NMR (100 MHz, CDCl3): δ 141.7, 138.2, 128.5, 128.5, 126.1, 112.3, 34.0, 33.2, 
21.2; HRMS [M+H]+ calcd for C11H14Cl: 181.0784, found: 181.0776. 
(Z)-Benzyl 7-chloro-2-(dibenzylamino)-6-methylhept-6-enoate (3.58): Following the 
general procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred 
by syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.2 mg, 0.250 mmol) 
and (Z)-benzyl 2-(dibenzylamino)-6-methyloct-6-enoate (22.1 mg, 0.0500 mmol). The 
resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% consumption 
of (Z)-benzyl 2-(dibenzylamino)-6-methyloct-6-enoate. The resulting orange oil was 
purified by preparative thin layer chromatography (5% EtOAc in hexanes) to afford 3.58 
(20.6 mg, 0.0446 mmol, 89% yield) in 86:14 Z:E ratio as colorless oil. IR (neat): 3030 
(w), 2922 (w), 2851 (w), 1728 (m), 1453 (w), 1143 (m), 964 (w); 1H NMR (400 MHz, 
CDCl3): Z isomer (major): δ 7.44−7.34 (5H, m), 7.33−7.26 (8H, m), 7.25−7.19 (2H, m), 
5.77−5.71 (1H, m), 5.26 (1H, d, J = 12.3 Hz), 5.16 (1H, d, J = 12.3 Hz), 3.91 (2H, d, J = 
13.9 Hz), 3.52 (2H, d, J = 13.9 Hz), 3.40−3.35 (1H, m), 2.16−2.01 (2H, m), 1.80−1.70 (2H, 
m), 1.64 (3H, d, J = 1.5 Hz), 1.61−1.53 (1H, m), 1.39−1.30 (1H, m); 13C NMR (100 MHz, 
CDCl3): δ 173.0, 139.7, 138.4, 136.3, 129.0, 128.7, 128.6, 128.4, 128.4, 127.1, 112.0, 66.1, 
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60.9, 54.7, 31.5, 29.2, 23.5, 20.9; HRMS [M+H]+ calcd for C29H33ClNO2: 462.2200, 
found: 462.2203. 
 (Z)-(4-Chloro-3-methylbut-3-en-1-yl)ferrocene (3.59): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.2 mg, 0.250 mmol) and 
(Z)-(3-methylpent-3-en-1-yl)ferrocene (13.4 mg, 0.0500 mmol). The resulting solution was 
allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and 
analysis of the unpurified mixture revealed 96% consumption of (Z)-(3-methylpent-3-en-
1-yl)ferrocene. The resulting red oil was purified by silica gel chromatography (100% 
hexanes to 1% EtOAc in hexanes) to afford 3.59 (13.6 mg, 0.0471 mmol, 94% yield) in 
88:12 Z:E ratio as orange oil. IR (neat): 3093 (w), 2926 (w), 2854 (w), 1639 (w), 1444 
(w), 1105 (m), 1000 (m), 816 (s); 1H NMR (400 MHz, CDCl3): Z isomer (major): δ 5.80 
(1H, q, J = 1.5 Hz), 4.13 (5H, s), 4.10 (2H, dd, J = 3.6, 2.5 Hz), 4.06 (2H, dd, J = 3.5, 1.7 
Hz), 2.45 (4H, brs), 1.75 (3H, d, J = 1.6 Hz); 13C NMR (100 MHz, CDCl3): δ 138.6, 111.8, 
88.7, 68.7, 68.0, 67.3, 33.4, 26.8, 21.3; HRMS [M+H]+ calcd for C15H18ClFe: 289.0446, 
found: 289.0451. 
(Z)-Methyl 8-chloro-7-methyloct-7-enoate (3.60): Following the general procedure, a 
solution of Mo-1 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by syringe to an 
oven-dried vial containing Z-1,2-dichloroethene (24.2 mg, 0.250 mmol) and (Z)-methyl 7-
methylnon-7-enoate (9.2 mg, 0.0499 mmol). The resulting solution was allowed to stir for 
4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the 
unpurified mixture revealed 94% consumption of (Z)-methyl 7-methylnon-7-enoate. The 
resulting orange oil was purified by silica gel chromatography (1.5% to 3% EtOAc in 
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hexanes) to afford 3.60 (9.1 mg, 0.0445 mmol, 89% yield) in 88:12 Z:E ratio as colorless 
oil. IR (neat): 2936 (m), 2860 (w), 1736 (s), 1436 (m), 1196 (m), 1170 (m); 1H NMR (400 
MHz, CDCl3): Z isomer (major): δ 5.77 (1H, s), 3.67 (3H, s), 2.32 (2H, t, J = 7.5 Hz), 
2.24−2.17 (2H, m), 1.72 (3H, d, J = 1.5 Hz), 1.68−1.61 (2H, m), 1.49−1.39 (2H, m), 
1.39−1.29 (2H, m); 13C NMR (100 MHz, CDCl3): δ 174.3, 138.7, 111.7, 51.6, 34.2, 31.7, 
28.9, 26.5, 24.9, 20.9; HRMS [M+H]+ calcd for C10H18ClO2: 205.0995, found: 205.0985. 
tert-Butyl (Z)-5-(4-chloro-3-methylbut-3-en-1-yl)-1H-indole-1-carboxylate (3.61): 
Following the general procedure, a solution of Mo-1 in benzene (0.1 M, 10 L, 1.0 mol) 
was transferred by syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.3 mg, 
0.251 mmol) and tert-butyl (Z)-5-(3-methylpent-3-en-1-yl)-1H-indole-1-carboxylate (15.0 
mg, 0.0501 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction 
was quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 
82% consumption of tert-butyl (Z)-5-(3-methylpent-3-en-1-yl)-1H-indole-1-carboxylate. 
The resulting red oil was purified by preparative thin layer chromatography (2% Et2O in 
pentane) to afford 3.61 (12.5 mg, 0.0391 mmol, 78% yield) in 87:13 Z:E ratio as clear 
colorless oil. IR (neat): 2976 (w), 2931 (w), 1708 (s), 1610 (m), 1439 (m), 1369 (m), 1341 
(m), 1288 (m), 1251 (m), 1146 (s), 764 (m); 1H NMR (400 MHz, CDCl3): Z isomer 
(major): δ 8.06 (1H, s), 7.54 (1H, d, J = 3.8 Hz), 7.47 (1H, dd, J = 8.0, 0.6 Hz), 7.12 (1H, 
dd, J = 8.0, 1.5 Hz), 6.53 (1H, dd, J = 3.8, 0.8 Hz), 5.85–5.76 (1H, m), 2.90–2.80 (2H, m), 
2.62–2.50 (2H, m), 1.77 (3H, d, J = 1.5 Hz), 1.68 (9H, s); 13C NMR (100 MHz, CDCl3): 
δ 138.4, 138.2, 128.9, 125.7, 123.6, 120.8, 115.0, 112.2, 107.3, 83.7, 34.7, 33.8, 28.4, 21.3; 
HRMS [M+H]+ calcd for C18H23ClNO2: 320.1417, found: 320.1416. 
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(Z)-1-(tert-Butyl)-4-(1-chloroprop-1-en-2-yl)benzene (Z-3.54): Following the general 
procedure, a solution of Mo-2 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1,2-dichloroethene (24.3 mg, 0.251 mmol) and 
(Z)-1-(tert-butyl)-4-(1-chloroprop-1-en-2-yl)benzene (9.4 mg, 0.0500 mmol). The 
resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed 86% consumption 
of starting material. The resulting red oil was purified by silica chromatography (100% 
hexanes) to afford Z-3.34 (6.8 mg, 0.0326 mmol, 65% yield) in >98:2 Z:E ratio as clear 
colorless oil. IR (neat): 2962 (m), 2868 (w), 1509 (m), 1463 (w), 1438 (w), 1400 (w), 1363 
(m), 1269 (m), 1114 (m), 1014 (m), 838 (s), 788 (m), 587 (s); 1H NMR (400 MHz, CDCl3): 
δ 7.42–7.38 (2H, m), 7.36–7.32 (2H, m), 6.10 (1H, q, J = 1.6 Hz), 2.09 (3H, d, J = 1.6 Hz), 
1.34 (9H, s); 13C NMR (100 MHz, CDCl3) δ 150.7, 137.8, 135.7, 127.7, 125.2, 112.3, 
34.8, 31.5, 23.5; HRMS [M+H]+ calcd for C13H18Cl: 209.1097, found: 209.1099.  
(Z)-2-(3-Chloro-2-methylallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.65): 
Following the general procedure, a solution of Mo-1 in benzene (0.1 M, 50 L, 5.0 mol) 
was transferred by syringe to an oven-dried vial containing E-1,2-dichloroethene (48.5 mg, 
0.500 mmol) and (Z)-4,4,5,5-tetramethyl-2-(2-methylhept-2-en-1-yl)-1,3,2-dioxaborolane 
(93% wt, 25.6 mg, 0.100 mmol). The resulting solution was allowed to stir for 4 h at 22 
°C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed >98% consumption of starting trisubstituted alkene. The resulting red oil 
was purified by silica gel chromatography (2% Et2O in pentane with silica gel dried at 140 
oC for 12 h) to afford 3.65 (18.0 mg, 0.0831 mmol, 83% yield) in 95:5 Z:E ratio as clear 
colorless oil. IR (neat): 2978 (m), 2931 (w), 1324 (s), 1142 (s), 967 (m), 846 (m), 770 (m); 
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1H NMR (400 MHz, CDCl3): δ 5.75 (1H, qt, J = 1.6, 0.9 Hz), 1.86 (2H, s), 1.79 (3H, d, J 
= 1.6 Hz), 1.25 (12H, s); 13C NMR (100 MHz, CDCl3): δ 136.3, 110.5, 83.6, 24.8, 23.1; 
HRMS [M+NH4]+ calcd for C10H22BClO2N : 234.1432, found: 234.1421. 
 (E)-(4-Bromo-3-methylbut-3-en-1-yl)benzene (E-3.67): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 10 L, 1.0 mol) was transferred by 
syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (62.5 mg, 0.500 mmol) 
and (E)-(3-methylpent-3-en-1-yl)benzene (16.0 mg, 0.100 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
and analysis of the unpurified mixture revealed 95% consumption of (E)-(3-methylpent-3-
en-1-yl)benzene that resulted in the formation of a mixture of Br- and F-alkenes (95:5 
bromo:fluoro). The resulting orange oil was purified by silica gel chromatography (100% 
pentane) to afford E-3.67 (20.3 mg, 0.0902 mmol, 90% yield) in >98:2 E:Z ratio as 
colorless oil. The spectral data for this compound were consistent with those reported in 
the literature.78 
(E)-N,N-Dibenzyl-13-bromo-12-methyltridec-12-en-1-amine (3.71): Based on the 
general procedure, a solution of Mo-1 in benzene (0.1 M, 10 L, 1.0 mol) was transferred 
by syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (31.2 mg, 0.250 
mmol) and (E)-N,N-dibenzyl-12-methyltetradec-12-en-1-amine (20.3 mg, 0.0500 mmol). 
The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% consumption 
of (E)-N,N-dibenzyl-12-methyltetradec-12-en-1-amine that resulted in the formation of a 
                                                 
(78) Stoermer, M. J.; Pinhey, J. T. Molecules 1998, 3, M58. 
Page 231 
mixture of Br- and F-alkenes (93:7 bromo:fluoro). The resulting orange oil was purified by 
silica gel chromatography (100% hexanes to 1% EtOAc in hexanes) to afford 3.71 (21.2 
mg, 0.0451 mmol, 90% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 2924 (m), 2852 
(w), 1452 (w), 1264 (m), 1028 (w); 1H NMR (400 MHz, CDCl3): δ 7.38−7.35 (4H, m), 
7.32−7.28 (4H, m), 7.25−7.20 (2H, m), 5.88 (1H, dd, J = 2.5, 1.2 Hz), 3.55 (4H, s), 
2.42−2.38 (2H, m), 2.12−2.07 (2H, m), 1.78 (3H, d, J = 1.2 Hz), 1.55−1.46 (2H, m), 
1.45−1.37 (2H, m), 1.28−1.20 (14H, m); 13C NMR (100 MHz, CDCl3): δ 142.2, 140.3, 
128.9, 128.2, 126.8, 101.0, 58.4, 53.6, 38.5, 29.8, 29.7, 29.7, 29.6, 29.6, 29.2, 27.7, 27.4, 
27.2, 19.2; HRMS [M+H]+ calcd for C28H41BrN: 470.2422, found: 470.2445. 
(E)-2-(4-Bromo-3-methylbut-3-en-1-yl)benzo[b]thiophene (3.72): Based on the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 10 L, 1.0 mol) was transferred by 
syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (31.2 mg, 0.250 mmol) 
and (E)-2-(3-methylpent-3-en-1-yl)benzo[b]thiophene (10.8 mg, 0.0499 mmol). The 
resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% consumption 
of (E)-2-(3-methylpent-3-en-1-yl)benzo[b]thiophene that resulted in the formation of a 
mixture of Br- and F-alkenes (97:3 bromo:fluoro). The resulting orange oil was purified by 
silica gel chromatography (100% hexanes to 0.5% EtOAc/hexanes) to afford 3.72 (13.4 
mg, 0.0477 mmol, 95% yield) in >98:2 E:Z ratio as white solid. M.p. 76–78 °C; IR (neat): 
3058 (w), 2922 (w), 2850 (w), 1632 (w), 1436 (m), 1264 (w), 822 (m); 1H NMR (400 
MHz, CDCl3): δ 7.76 (1H, d, J = 7.8 Hz), 7.67 (1H, d, J = 7.6 Hz), 7.33−7.26 (2H, m), 
7.00 (1H, s), 6.02−5.95 (1H, m), 3.07−3.01 (2H, m), 2.59−2.52 (2H, m), 1.87 (3H, d, J = 
1.2 Hz); 13C NMR (100 MHz, CDCl3): δ 144.9, 140.4, 140.2, 139.5, 124.3, 123.8, 123.0, 
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122.3, 121.1, 102.8, 39.8, 29.2, 19.3; HRMS [M+H]+ calcd for C13H14BrS: 281.0000, 
found: 280.9999. 
(E)-2-(5-Bromo-4-methylpent-4-en-1-yl)isoindoline-1,3-dione (3.73): Following the 
general procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred 
by syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (31.3 mg, 0.251 
mmol), (E)-2-(4-methylhex-4-en-1-yl)isoindoline-1,3-dione (12.2 mg, 0.0501 mmol) and 
toluene (75 L). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction 
was quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 
>98% consumption of (E)-2-(4-methylhex-4-en-1-yl)isoindoline-1,3-dione that resulted in 
the formation of a mixture of Br- and F-alkenes (92:8 bromo:fluoro). The resulting orange 
oil was purified by silica gel chromatography (1.5% to 5% EtOAc in hexanes) to afford 
3.73 (12.9 mg, 0.0419 mmol, 84% yield) in >98:2 E:Z ratio as pale yellow solid. M.p. 78–
80 °C; IR (neat): 2928 (w), 2853 (w), 1771 (w), 1705 (s), 1395 (m), 1369 (w), 1083 (w); 
1H NMR (400 MHz, CDCl3): δ 7.85 (2H, dd, J = 5.4, 3.1 Hz), 7.72 (2H, dd, J = 5.5, 3.0 
Hz), 5.96 (1H, d, J = 1.2 Hz), 3.70−3.64 (2H, m), 2.18 (2H, t, J = 7.6 Hz), 1.87−1.81 (2H, 
m), 1.79 (3H, d, J = 1.1 Hz); 13C NMR (100 MHz, CDCl3): δ 168.5, 140.5, 134.1, 132.2, 
123.4, 102.2, 37.6, 35.7, 26.4, 19.1; HRMS [M+H]+ calcd for C14H15BrNO2: 308.0286, 
found: 308.0283. 
(Z)-(4-bromo-3-methylbut-3-en-1-yl)benzene (Z-3.67): Following the general 
procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by 
syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (31.2 mg, 0.250 mmol) 
and (Z)-(3-methylpent-3-en-1-yl)benzene (8.0 mg, 0.0500 mmol). The resulting solution 
was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet CDCl3 
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and analysis of the unpurified mixture revealed >98% consumption of (Z)-(3-methylpent-
3-en-1-yl)benzene that resulted in the formation of a mixture of Br- and F-alkenes (83:17 
bromo:fluoro). The resulting red oil was purified by silica gel chromatography (1% Et2O 
in pentane) to afford Z-3.67 (7.5 mg, 0.0.333 mmol, 66% yield) in 95:5 Z:E ratio as clear 
colorless oil. The spectral data for this compound were consistent with those reported in 
the literature.79 
 (Z)-2-(3-(4-Bromo-3-methylbut-3-en-1-yl)phenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3.75): Following the general procedure, a solution of Mo-1 in benzene 
(0.1 M, 10 L, 1.0 mol) was transferred by syringe to an oven-dried vial containing Z-1-
bromo-2-fluoroethene (31.2 mg, 0.250 mmol) and (Z)-4,4,5,5-tetramethyl-2-(3-(3-
methylpent-3-en-1-yl)phenyl)-1,3,2-dioxaborolane (14.3 mg, 0.0500 mmol). The resulting 
solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet 
CDCl3 and analysis of the unpurified mixture revealed >98% consumption of (Z)-4,4,5,5-
tetramethyl-2-(3-(3-methylpent-3-en-1-yl)phenyl)-1,3,2-dioxaborolane that resulted in the 
formation of a mixture of Br- and F-alkenes (86:14 bromo:fluoro). The resulting orange oil 
was purified by silica gel chromatography (100% hexanes to 1% EtOAc in hexanes) to 
afford 3.75 (12.8 mg, 0.0365 mmol, 73% yield) in 91:9 Z:E ratio as colorless oil. IR (neat): 
2977 (w), 2928 (w), 2859 (w), 1426 (w), 1359 (s), 1320 (m), 1144 (s), 1078 (w); 1H NMR 
(400 MHz, CDCl3): E isomer (major):δ 7.69−7.63 (2H, m), 7.36−7.28 (2H, m), 5.90 (1H, 
s), 2.74 (2H, dd, J = 9.8, 6.7 Hz), 2.51 (2H, dd, J = 9.9, 6.5 Hz), 1.79 (3H, dd, J = 1.5, 0.8 
Hz), 1.35 (12H, s); 13C NMR (100 MHz, CDCl3): δ 141.2, 140.9, 134.8, 132.7, 131.5, 
                                                 
(79) Stoermer, M. J.; Pinhey, J. T. Molecules 1998, 3, M57. 
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128.0, 101.4, 83.9, 36.6, 33.1, 25.0, 22.5; HRMS [M+H]+ calcd for C17H25BBrO2: 
351.1131, found: 351.1140. 
(2S,4aR,6S,7R,8S,8aS)-7-(Benzyloxy)-8-(((Z)-5-bromo-4-methylpent-4-en-1-yl)oxy)-
6-(4-methoxyphenoxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxine (3.74): Based on 
the general procedure, a solution of Mo-1 in benzene (0.1 M, 25 L, 2.5 mol) was 
transferred by syringe to an oven-dried vial containing Z-1-bromo-2-fluoroethene (31.2 
mg, 0.250 mmol), (2S,4aR,6S,7R,8S,8aS)-7-(benzyloxy)-6-(4-methoxyphenoxy)-8-(((Z)-
4-methylhex-4-en-1-yl)oxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxine (28.0 mg, 
0.0499 mmol) and benzene (175 μL). The resulting solution was allowed to stir for 4 h at 
22 °C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed >98% consumption of (2S,4aR,6S,7R,8S,8aS)-7-(benzyloxy)-6-(4-
methoxyphenoxy)-8-(((Z)-4-methylhex-4-en-1-yl)oxy)-2-phenylhexahydropyrano[3,2-
d][1,3]dioxine that resulted in the formation of a mixture of Br- and F-alkenes (89:11 
bromo:fluoro). The resulting orange oil was purified by silica gel chromatography (10% to 
20% EtOAc in hexanes) to afford 3.74 (25.6 mg, 0.0409 mmol, 82% yield) in 93:7 Z:E 
ratio as white solid. M.p. 140–142 °C; IR (neat): 2922 (w), 2856 (w), 1509 (s), 1226 (s), 
1078 (s), 1064 (s), 1028 (s), 1007 (s), 823 (m); 1H NMR (400 MHz, CDCl3): E isomer 
(major):δ 7.57 (2H, dd, J = 7.6, 1.7 Hz), 7.41−7.26 (8H, m), 7.07 (2H, d, J = 9.0 Hz), 6.82 
(2H, d, J = 9.0 Hz), 5.85 (1H, s), 5.58 (1H, s), 4.97 (1H, d, J = 10.9 Hz), 4.90 (1H, dd, J = 
7.8, 1.4 Hz), 4.85 (1H, d, J = 11.0 Hz), 4.37 (1H, d, J = 12.3 Hz), 4.32 (1H, d, J = 3.1 Hz), 
4.09 (1H, dd, J = 12.3, 1.6 Hz), 4.02 (1H, dd, J = 9.6, 7.9 Hz), 3.78 (3H, s), 3.76−3.68 (1H, 
m), 3.68−3.60 (1H, m), 3.57−3.50 (1H, m), 3.48 (1H, s), 2.29−2.22 (2H, m), 1.83−1.76 
(2H, m), 1.75 (3H, d, J = 1.4 Hz); 13C NMR (100 MHz, CDCl3): δ 155.5, 151.8, 141.4, 
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138.9, 138.0, 129.1, 128.4, 128.3, 128.2, 127.7, 127.0, 119.2, 114.6, 103.4, 101.5, 101.1, 
80.4, 78.1, 75.5, 73.8, 70.1, 69.4, 66.8, 55.8, 31.2, 27.4, 22.3; HRMS [M+Na]+ calcd for 
C33H37BrO7Na: 647.1620, found: 647.1640. 
(E)-(3-Methyloct-3-en-1-yl)benzene (3.77): Following the general procedure, a solution 
of Mo-3 in benzene (0.1 M, 30 L, 3.0 mol) was transferred by syringe to an oven-dried 
vial containing (E)-5-decene (42.1 mg, 0.300 mmol) and (E)-(3-methylpent-3-en-1-
yl)benzene (16.0 mg, 0.100 mmol). The resulting solution was allowed to stir for 4 h at 40 
°C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed 71% consumption of (E)-(3-methylpent-3-en-1-yl)benzene. The resulting 
red oil was purified by silica gel chromatography (100% hexanes) to afford 3.77 (14.0 mg, 
0.0692 mmol, 69% yield) in >98:2 E:Z ratio as colorless oil. IR (neat): 3026 (w), 2955 (s), 
2924 (s), 2855 (m), 1602 (w), 1494 (m), 1426 (m), 1378 (w), 741 (m), 696 (s); 1H NMR 
(400 MHz, CDCl3): δ 7.31–7.15 (5H, m), 5.15 (1H, tq, J = 7.2, 1.4 Hz), 2.84–2.51 (2H, 
m), 2.34–2.12 (2H, m), 1.99 (2H, q, J = 6.8 Hz), 1.66 (3H, s), 1.33–1.25 (4H, m), 0.97–
0.78 (3H, m); 13C NMR (100 MHz, CDCl3): δ 142.7, 134.4, 128.5, 128.3, 125.7, 125.5, 
41.8, 34.9, 32.1, 27.8, 22.5, 16.2, 14.2; HRMS [M+H]+ calcd for C15H23: 203.1800, found: 
203.1796. 
tert-Butyldimethyl(pent-3-en-1-yloxy)silane (3.78): A solution of 1-propenylmagnesium 
bromide in THF (0.5 M, 12 mL, 6.00 mmol) was added slowly to a solution of ethylene 
oxide in THF (2.5−3.3 M, 2.0 mL) at 0 °C. The resulting solution was allowed to stir for 2 
h at 22 °C, after which the reaction was quenched by the addition of a saturated aqueous 
solution of NH4Cl (2.0 mL). The aqueous layer was washed with Et2O (3 x 5 mL), the 
combined organic layers were dried over MgSO4 and volatiles were removed by rotary 
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evaporator in an ice bath at 60 torr to obtain crude pent-3-en-1-ol. The resulting yellow oil 
was sufficiently clean and used in the next step without further purification. 
TBSCl (0.90 g, 5.97 mmol) was added in one portion to a solution of pent-3-en-1-ol from 
above and imidazole (0.45 g, 6.61) in 6 mL of CH2Cl2 at 0 °C. The resulting mixture was 
allowed to stir for 1 h at 22 °C. The reaction mixture was diluted with pentane (10 mL) 
then filtered through a pad of celite, and volatiles were removed in vacuo. The resulting 
slightly yellow oil was purified by silica gel chromatography (5% Et2O in hexanes) to 
afford 3.78 (595 mg, 2.97, 60% yield over 2 steps) in 61:39 E:Z ratio as colorless oil. The 
spectral data for this compound were consistent with those reported previously.80 
 (E)-tert-Butyldimethyl((4-methyl-6-phenylhex-3-en-1-yl)oxy)silane (3.79): Following 
the general procedure, a solution of Mo-3 in benzene (0.1 M, 15 L, 1.5 mol)was 
transferred by syringe to an oven-dried vial containing tert-butyldimethyl(pent-3-en-1-
yloxy)silane (61:39 E:Z mixture, 30.0 mg, 0.150 mmol) and (E)-(3-methylpent-3-en-1-
yl)benzene (8.0 mg, 0.0500 mmol). The resulting solution was allowed to stir for 4 h at 40 
°C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed 58% consumption of (E)-(3-methylpent-3-en-1-yl)benzene. The resulting 
red oil was purified by silica gel chromatography (1% to 2% Et2O in hexanes) to afford 
3.79 (7.9 mg, 0.0259 mmol, 52% yield) in 93:7 E:Z ratio as colorless oil. IR (neat): 2926 
(s), 2855 (s), 1462 (m), 1381 (m), 1252 (s), 1090 (s), 833 (s), 774 (s), 734 (s), 697 (s); 1H 
NMR (400 MHz, CDCl3): δ 7.31–7.23 (2H, m), 7.21–7.14 (3H, m), 5.14 (1H, ddd, J = 
8.7, 5.9, 1.4 Hz), 3.55 (2H, t, J = 7.2 Hz), 2.75–2.63 (2H, m), 2.33–2.17 (4H, m), 1.67 (3H, 
                                                 
(80) Wang, Y.; Qin, C.; Jia, X.; Leng, X.; Huang, Z. Angew. Chem. Int. Ed. 2017, 56, 1614 –1618. 
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s), 0.90 (9H, s), 0.06 (6H, s); 13C NMR (100 MHz, CDCl3): δ 142.6, 136.7, 128.5, 128.4, 
125.8, 121.0, 63.2, 41.9, 34.9, 32.0, 30.0, 26.1, 18.6, 16.4, -5.1; HRMS [M+NH4]+ calcd 
for C19H36ONSi: 322.2566, found: 322.2555. 
 (Z)-(3-Methyloct-3-en-1-yl)benzene (3.80): Following the general procedure, a solution 
of Mo-4 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by syringe to an oven-dried 
vial containing (E)-5-decene (21.0 mg, 0.150 mmol) and (Z)-(3-methylpent-3-en-1-
yl)benzene (8.0 mg, 0.0500 mmol). The resulting solution was allowed to stir for 4 h at 22 
°C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed 65% consumption of (Z)-(3-methylpent-3-en-1-yl)benzene. The resulting 
red oil was purified by silica gel chromatography (100% hexanes) to afford 3.80 (6.5 mg, 
0.0321 mmol, 64% yield) in 84:16 Z:E ratio as colorless oil. IR (neat): 2957 (s), 2925 (s), 
2857 (s), 1494 (m), 1453 (m), 1376 (w), 966 (m), 741 (m), 696 (s); 1H NMR (400 MHz, 
CDCl3): Z isomer (major): δ 7.35–7.09 (5H, m), 5.24–5.05 (1H, m), 2.67 (2H, dd, J = 9.3, 
6.8 Hz), 2.32 (2H, dd, J = 9.3, 6.9 Hz), 1.90 (2H, q, J = 7.2 Hz), 1.79–1.70 (3H, m), 1.37–
1.14 (4H, m), 0.87 (3H, t, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3): δ 142.6, 134.3, 
128.5, 128.4, 126.4, 125.9, 34.7, 34.2, 32.3, 27.6, 23.6, 22.6, 14.2; HRMS [M+H]+ calcd 
for C15H23: 203.1800, found: 203.1804. 
3.9.3. Synthesis of Indiacen B 
4,4,5,5-Tetramethyl-2-((1E,3E)-3-methylpenta-1,3-dien-1-yl)-1,3,2-dioxaborolane 
(3.82): According to a previously reported procedure,41 3.82 was prepared by a boron-
Wittig reaction with LiTMP (347 mg, 2.36 mmol), bis[(pinacolato)boryl]methane (600 mg, 
2.36 mmol, 1.20 equiv) and trans-2-methyl-2-butenal (0.19 mL, 1.97 mmol) and 10 mL 
THF. The resulting yellow oil was purified by silica gel chromatography (5% EtOAc in 
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hexanes) to obtain 22 (384 mg, 1.85 mmol, 89% yield) in >98:2 E:Z ratio as clear colorless 
oil. The spectral data for this compound were consistent with those reported previously.41 
Indiacen B: An oven-dried 2-dram vial was charged with 3.50 (80% wt, 24.3 mg, 0.110 
mmol), 4-bromoindole-3-carboxyaldehyde (22.4 mg, 0.100 mmol), Pd(PPh3)4 (5.8 mg, 
0.00502 mmol), an aqueous solution of Na2CO3 (2.0 M, 0.15 mL, 0.300 mmol) and 2.0 mL 
of DME. The vial was sealed with a Teflon-lined screw cap and the resulting mixture was 
allowed to stir at 10 °C for 12 h, filtered through a short plug of celite, and concentrated in 
vacuo. The resulting yellow oil was purified by preparative thin layer chromatography 
(50% EtOAc in hexanes) to obtain a mixture of pinacol and indiacen B (90% by weight 
accounting for the mass of pinacol, 17.7 mg, 0.0647 mmol, 65% yield) in 96:4 E:Z ratio at 
the chloro-alkene site. The spectral data for this compound were consistent with those 
previously reported.10 
3.9.4. Synthesis of Dienoate 3.88 en route to Kimbeamide A 
1-Methoxy-4-((1E,4E)-4-methylhexa-1,4-dien-1-yl)benzene (3.85): In analogy to a 
previously reported procedure,43 an oven-dried 6-dram vial was charged with (E)-4-
methoxycinnamyl alcohol (493 mg, 3.00 mmol), (Z)-but-2-en-2-ylboronic acid (360 mg, 
3.60 mmol), Pd(PPh3)4 (35 mg, 0.0303 mmol) and 9.0 mL of THF. The vial was sealed 
with a Teflon-lined screw cap and the resulting mixture was allowed to stir at 80 °C for 12 
h, filtered through a short plug of celite rising with Et2O, and concentrated in vacuo. The 
resulting clear brown oil was purified by silica chromatography (5% EtOAc in hexanes) to 
obtain 3.85 (532 mg, 2.63 mmol, 88% yield) as a single stereoisomer. IR (neat): 2912 (w), 
2834 (w), 1607 (m), 1509 (s), 1294 (m), 1243 (s), 1173 (m), 1035 (m), 964 (m), 827 (m); 
1H NMR (500 MHz, CDCl3): δ 7.33–7.26 (2H, m), 6.87–6.79 (2H, m), 6.33 (1H, dt, J = 
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15.7, 1.5 Hz), 6.05 (1H, dt, J = 15.7, 7.1 Hz), 5.30 (1H, dddq, J = 7.8, 6.5, 5.2, 1.3 Hz), 
3.80 (3H, s), 2.84 (2H, dq, J = 7.1, 1.3 Hz), 1.66–1.58 (6H, m); 13C NMR (100 MHz, 
CDCl3): δ 158.8, 134.8, 130.7, 130.4, 127.2, 127.0, 119.6, 114.0, 55.4, 43.3, 16.0, 13.6; 
HRMS [M+H]+ calcd for C14H19O: 203.1436, found: 203.1438. 
4,4,5,5-Tetramethyl-2-((1E,4E)-4-methylhexa-1,4-dien-1-yl)-1,3,2-dioxaborolane 
(3.86): A solution of Mo-3 in benzene (0.1 M, 30 L, 3.0 mol was transferred by syringe 
to an oven-dried vial containing vinylboronic acid pinacol ester (30.8 mg, 0.200 mmol) 
and 3.85 (20.2 mg, 0.100 mmol). The resulting solution was allowed to stir for 4 h at 22 
°C. The reaction was quenched by addition of wet CDCl3 and analysis of the unpurified 
mixture revealed 82% consumption of 3.85. The resulting red oil was purified by silica gel 
chromatography (1% Et2O in pentane) to afford 3.86 (14.5 mg, 0.0653 mmol, 65% yield) 
in >98:2 E:Z ratio as colorless oil. IR (neat): 2977 (m), 2928 (w), 1635 (m), 1356 (s), 1316 
(s), 1143 (s), 970 (m), 849 (m); 1H NMR (400 MHz, CDCl3): δ 6.59 (1H, dt, J = 17.9, 6.6 
Hz), 5.43 (1H, dt, J = 17.9, 1.6 Hz), 5.24 (1H, dddd, J = 7.9, 6.6, 5.4, 1.3 Hz), 2.80 (2H, 
dq, J = 6.6, 1.3 Hz), 1.61–1.53 (6H, m), 1.26 (12H, s); 13C NMR (100 MHz, CDCl3): δ 
152.6, 133.4, 120.5, 83.2, 46.3, 24.9, 16.0, 13.6; HRMS [M+H]+ calcd for C13H24BO2: 
223.1869, found: 223.1879. 
Methyl (2E,4E,7E)-8-chloro-7-methylocta-2,4,7-trienoate (3.88): An oven-dried 2-
dram vial was charged with 3.49 (24.3 mg, 0.100 mmol), methyl (E)-3-bromopropenoate 
(16.5 mg, 0.100 mmol), PdCl2(dpephos) (0.7 mg, 0.00098 mmol), CsF (22.8 mg, 0.150 
mmol). The mixture was degassed by evacuation and back-fill with N2 three times before 
1 mL of anhydrous THF was added. The resulting mixture was allowed to stir at 60 oC for 
15 h, filtered through a short plug of celite, and concentrated in vacuo. The crude product 
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mixture was purified by silica gel chromatography (2% to 5% Et2O in pentane) to obtain 
3.88 as colorless oil in >98:2 stereoisomeric purity. IR (neat): 2950 (w), 1716 (s), 1644 
(m), 1615 (m), 1434 (m), 1303 (m), 1265 (m), 1246 (s), 1203 (m), 1162 (m), 1133 (s), 998 
(s); 1H NMR (400 MHz, CDCl3) δ 7.26 (1H, dd, J = 15.3, 10.9 Hz), 6.25–6.16 (1H, m), 
6.04 (1H, dtt, J = 15.3, 7.0, 0.7 Hz), 5.89–5.80 (2H, m), 3.75 (3H, s), 2.91 (2H, d, J = 7.0 
Hz), 1.77 (3H, d, J = 1.4 Hz); 13C NMR (150 MHz, CDCl3): δ 167.6, 144.4, 139.6, 136.2, 
130.6, 120.3, 114.2, 51.7, 40.4, 16.8; HRMS [M+H]+ calcd for C10H14ClO2: 201.0682, 
found: 201.0690. 
3.9.5. Synthesis of (±)-Coibacin D 
8-Bromooct-1-en-4-ol (3.89): An oven-dried round-bottom flask equipped with a 
magnetic stir bar was charged with methyl 5-bromovalerate (0.956 g, 4.90 mmol) and Et2O 
(24.5 mL) and the solution was cooled to −78 °C. Diisobutylaluminum hydride solution 
(1.0 M in cyclohexane, 5.4 mL, 5.39 mmol) was added dropwise over 10 min. The resulting 
solution was allowed to stir for 2 h at −78 °C under N2, after which CH3OH (1.5 mL) and 
then a saturated solution of Rochelle salt (16 mL) were added. The mixture was allowed to 
stir for 2 h at 22 °C to obtain two layers. The organic layer was separated and the aqueous 
layer was washed with Et2O (3 x 10 mL). The combined organic layers were dried over 
MgSO4 and concentrated in vacuo to afford crude aldehyde (0.638 g, 3.86 mmol, 79% 
yield) as yellow oil.  
The unpurified aldehyde was re-dissolved in toluene (7.7 mL) and allylboronic acid pinacol 
ester (0.87 mL, 4.64 mmol) was added. The solution was allowed to stir for 12 h at 22 °C, 
after which the reaction was quenched by the addition of 1M HCl (15 mL). The aqueous 
layer was then washed with Et2O (3 x 10 mL) and the combined organic layers were washed 
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with brine (10 mL), then dried over MgSO4 and concentrated in vacuo to afford yellow oil, 
which was purified by silica gel chromatography (2.5% to 7% EtOAc in hexanes) to afford 
3.89 (0.609, 2.94 mmol, 76% yield) as pale yellow oil. IR (neat): 3347 (br), 2935 (m), 
2864 (w), 1640 (w), 1433 (m), 1237 (m), 1052 (m), 994 (s), 914 (s); 1H NMR (400 MHz, 
CDCl3): δ 5.89−5.74 (1H, m), 5.17−5.09 (2H, m), 3.65 (1H, dt, J = 11.7, 5.7 Hz), 3.44−3.37 
(2H, m), 2.36−2.25 (1H, m), 2.19−2.08 (1H, m), 1.94−1.82 (2H, m), 1.66 (1H, brs), 
1.63−1.43 (4H, m); 13C NMR (100 MHz, CDCl3): δ 134.7, 118.5, 70.4, 42.1, 35.9, 33.9, 
32.8, 24.5; HRMS [M+H-H2O]+ calcd for C8H14Br: 189.0279, found: 189.0273. 
(9E,12E)-13-Chloro-12-methyltrideca-1,9,12-trien-4-ol (3.90): Prepared in analogy to a 
previously reported procedure46. In a N2-filled glove box, an oven-dried vial equipped with 
a magnetic stir bar was charged with di-tert-butylmethylphosphine (1.9 mg, 12 mol), 
palladium (II) acetate (1.3 mg, 6.0 mol), powdered NaOH (14.4 mg, 0.360 mmol), 3.49 
(29.1 mg, 0.120 mmol), 3.89 (49.7 mg, 0.240 mmol) and anhydrous 1,4-dioxane (0.6 mL). 
The vial was sealed and removed from the glove box. The mixture was allowed to stir for 
24 h at 40 °C, after which it was allowed to cool to room temperature. The mixture was 
passed through a short plug of silica gel eluting with EtOAc (3 x 1 mL). The filtrate was 
concentrated in vacuo to afford brown oil, which was purified by silica gel chromatography 
(2% to 6% EtOAc in hexanes) to afford 3.90 (24.9 mg, 0.913 mmol, 76% yield) as pale 
yellow oil. IR (neat): 2928 (w), 2855 (w), 1640 (w), 1435 (w), 1264 (m), 911 (m); 1H 
NMR (400 MHz, CDCl3): δ 5.89−5.77 (2H, m), 5.52−5.42 (1H, m), 5.39−5.29 (1H, m), 
5.20−5.09 (2H, m), 3.70−3.59 (1H, m), 2.72 (2H, d, J = 6.5 Hz), 2.35−2.26 (1H, m), 
2.19−2.09 (1H, m), 2.05−1.99 (2H, m), 1.75 (3H, s), 1.71−1.67 (1H, m), 1.48−1.45 (2H, 
m), 1.41−1.32 (4H, m); 13C NMR (100 MHz, CDCl3): δ 138.1, 135.0, 133.3, 126.5, 118.3, 
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112.7, 70.7, 42.1, 20.4, 36.8, 32.5, 29.5, 25.3, 16.7; HRMS [M-H]+ calcd for C14H22ClO: 
241.1359, found: 241.1351. 
(2Z,10E,13E)-14-Chloro-13-methyltetradeca-2,10,13-triene-1,5-diol (S1): In a N2-
filled glove box, a solution of Ru-3 (3.1 mg, 4.0 mol) in CH2Cl2 (160 L) was transferred 
by syringe to an oven-dried vial containing Z-2-butene-1,4-diol (14.1 mg, 0.160 mmol) and 
3.90 (19.4 mg, 0.0799 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. 
The reaction was quenched by addition of wet CH3CN and concentrated in vacuo. Analysis 
of the unpurified mixture revealed 85% consumption of 3.90. The resulting brown oil was 
purified by silica gel chromatography (10% to 40% EtOAc in hexanes) to afford 3.92 (15.3 
mg, 0.0561 mmol, 70% yield) in 94:6 Z:E ratio as pale yellow oil. IR (neat): 3347 (br), 
2923 (s), 2854 (m), 1638 (w), 1435 (m), 1083 (m), 1010 (s), 969 (s); 1H NMR (400 MHz, 
CDCl3): δ 5.89 (1H, dtt, J = 12.4, 6.8, 1.3 Hz), 5.81 (1H, dd, J = 2.7, 1.4 Hz), 5.70−5.61 
(1H, m), 5.52−5.43 (1H, m), 5.34 (1H, dddd, J = 14.0, 7.3, 2.8, 1.5 Hz), 4.21 (1H, dd, J = 
11.8, 7.7 Hz), 4.12 (1H, dd, J = 12.6, 6.5 Hz), 3.69−3.61 (1H, m), 2.72 (2H, d, J = 6.7 Hz), 
2.32−2.24 (2H, m), 2.06−1.99 (2H, m), 1.95 (1H, brs), 1.75 (3H, d, J = 1.4 Hz), 1.50−1.34 
(7H, m); 13C NMR (100 MHz, CDCl3): δ 138.1, 133.2, 131.7, 129.6, 126.6, 112.7, 70.8, 
58.0, 40.4, 37.1, 35.3, 32.5, 29.5, 25.4, 16.8; HRMS [M+H]+ calcd for C15H26ClO2: 
273.1621, found: 273.1624. 
 (±)-Coibacin D: Prepared in analogy to a previously reported procedure81. An oven-dried 
round-bottom flask equipped with a magnetic stir bar was charged with 3.92 (13.6 mg, 
0.0499 mmol), (diacetoxyiodo)benzene (48.2 mg, 0.150 mmol), TEMPO (2.3 mg, 0.0147 
                                                 
(81) Oliveira, J. M.; Freitas, J. C. R.; Comasseto, J. V.; Menezes, P. H. Tetrahedron 2011, 67, 3003–3009. 
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mmol) and CH2Cl2 (0.5 mL). The solution was allowed to stir for 3 h at 22 °C under N2, 
after which the reaction was quenched by the addition of a saturated solution of Na2S2O3. 
The aqueous layer was then extracted with CH2Cl2 (3 x 1 mL) and the combined organic 
layers were washed successively with saturated NaHCO3 (2 mL), saturated NH4Cl (2 mL), 
and brine (2 x 2 mL), then dried over MgSO4 and concentrated in vacuo to afford yellow 
oil, which was purified by silica gel chromatography (5% to 15% EtOAc in hexanes) to 
afford (±)-coibacin D (11.0 mg, 0.0409 mmol, 82% yield) as pale yellow oil. The spectral 
data for this compound were identical to those reported previously.48 
3.9.6. Synthesis of Enyne 3.98 en route to Pateamine A 
(E)-tert-Butyldimethyl((4-methylhex-4-en-2-yl)oxy)silane (3.94): In analogy to a 
previously reported procedure,82 t-BuLi (12.5 mL, 1.7M in pentane, 21.3 mmol) was added 
dropwise to a stirred solution of (E)-2-bromobut-2-ene (1.00 mL, 9.85 mmol) in 25 mL of 
THF at –78 °C. The resulting solution was allowed to stir at  ̶ 78 oC for 30 min then S-
propylene oxide (1.04 mL, 14.9 mmol) was added in one portion. The reaction mixture was 
allowed to stir at  –78 °C for 1 h and then warm to 22 °C and stir at for an addition 1 h. At 
this point, the reaction was quenched by the addition of a saturated solution of NH4Cl (10 
mL) at 0 °C. The separated aqueous layer was extracted with Et2O (3 x 25 mL). The 
combined organic layers were washed with de-ionized water (25 mL), brine (25 mL), dried 
over MgSO4, and concentrated in vacuo to obtain (E)-4-methylhex-4-en-2-ol (1.05 g, 9.19 
mmol, 93% yield). The resulting clear colorless oil was sufficiently clean and used in the 
next step without further purification. 
                                                 
(82) Wuts, P. G. M.; Thompson, P. A.; Callen, G. R. J. Org. Chem. 1983, 48, 5398–5400. 
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TBSOTf (0.85 mL, 3.69 mmol) was added in a dropwise manner to a solution of (E)-4-
methylhex-4-en-2-ol and Et3N (1.0 mL, 7.21 mmol) in 15 mL of CH2Cl2 at 0 °C. The 
solution was allowed to warm to 22 °C and stir for 3 h. Volatiles were removed in vacuo 
and the resulting slightly yellow oil was purified by silica gel chromatography (10% Et2O 
in pentane) to afford 3.94 (0.753 g, 3.28 mmol, 89% yield) in >98:2 E:Z ratio as colorless 
oil. IR (neat): 2956 (m), 2928 (m), 2892 (m), 2857 (m), 1472 (m), 1462 (m), 1374 (m), 
1361 (m), 1252 (m), 1128 (m), 1093 (m), 1068 (m), 1027 (m), 831 (s), 805 (m), 772 (s); 
1H NMR (400 MHz, CDCl3): δ 5.22 (1H, q, J = 6.4 Hz), 3.90 (1H, h, J = 6.1 Hz), 2.16 
(1H, dd, J = 13.1, 6.6 Hz), 2.01 (1H, dd, J = 13.1, 6.2 Hz), 1.61–1.54 (5H, m), 1.09 (3H, 
d, J = 6.1 Hz), 0.88 (9H, s), 0.04 (3H, s), 0.02 (3H, s); 13C NMR (100 MHz, CDCl3): δ 
132.9, 121.1, 67.4, 50.1, 25.8, 23.6, 18.1, 16.2, 13.3, -4.6, -4.9; HRMS [M + H]+ calcd for 
C13H29OSi: 229.1988, found: 229.1995. 
(S,E)-tert-Butyl((8,8-diethoxy-4-methyloct-4-en-6-yn-2-yl)oxy)dimethylsilane (S1): In 
the glovebox, 4.0 mL anhydrous THF was added to a mixture of  3.97 (81% wt of bromo-
alkene, 412 mg, 1.14 mmol), Pd[(t-Bu3)P]2 (35 mg, 0.0685 mmol), CuI (26 mg, 0.136 
mmol), DABCO (254 mg, 2.26 mmol), and 3,3-diethoxy-1-propyne (175 mg, 1.36 mmol) 
in an oven-dried 2-dram vial. The vial was sealed with a Teflon-lined screw cap and the 
mixture was allowed to stir at 22 °C for 12 h. The reaction mixture was filtered through a 
pad of celite and the filtrate was concentrated in vacuo. The crude product mixture was 
purified by silica gel chromatography (2–5% Et2O in pentane) to obtain S1 (286 mg, 0.738 
mmol, 74% yield). IR (neat): 2973 (m), 2955 (m), 2929 (m), 2884 (m), 2857 (m), 2215 
(w), 1472 (w), 1462 (w), 1444 (w), 1354 (m), 1327 (m), 1254 (m), 1171 (m), 1124 (m), 
1106 (m), 1087 (s), 1051 (s), 1026 (s), 1002 (s), 833 (s), 773 (s); 1H NMR (400 MHz, 
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CDCl3): δ 5.41 (1H, d, J = 1.5 Hz), 5.32 (1H, dt, J = 2.3, 1.1 Hz), 3.94 (1H, h, J = 6.1 Hz), 
3.76 (2H, dq, J = 9.5, 7.1 Hz), 3.61 (2H, dq, J = 9.5, 7.1 Hz), 2.25 (1H, ddd, J = 13.2, 6.6, 
1.0 Hz), 2.13 (1H, ddd, J = 13.2, 5.9, 1.0 Hz), 1.90 (3H, d, J = 1.2 Hz), 1.24 (6H, t, J = 7.1 
Hz), 1.10 (3H, d, J = 6.1 Hz), 0.87 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 151.0, 106.4, 92.1, 87.2, 83.5, 67.3, 60.9, 60.8, 49.0, 26.0, 23.8, 20.3, 18.2, 15.3, 
-4.4, -4.7; HRMS [M+H-EtOH]+ calcd for C17H31O2Si: 295.2093, found: 295.2090. 
(S,E)-7-((tert-Butyldimethylsilyl)oxy)-5-methyloct-4-en-2-ynal (3.98): In analogy to a 
previously reported procedure,35 a mixture of S1 (34.0 mg, 0.100 mmol) and SiO2 (0.60 g, 
60−200 mesh) in 1.0 mL of CH2Cl2 was treated with a solution of oxalic acid (10% w/w in 
H2O, 60 L). The resulting mixture was allowed to stir at 22 oC for 45 min, then filtered 
through a plug of celite, and concentrated in vacuo. The resulting yellow oil was purified 
by silica gel chromatography (5% Et2O in pentane) to obtain 3.98 as slight yellow oil (25.2 
mg, 0.0946 mmol, 95% yield). The spectral data for this compound were consistent with 
those reported previously.51 
3.9.7. CM of Isoprenoid Substrates 
(Z)-tert-butyl((7-fluoro-3-methylhept-6-en-1-yl)oxy)dimethylsilane (3.11): Following 
the general procedure, a solution of Mo-3 in benzene (0.1 M, 10 L, 1.0 mol) was 
transferred by syringe to an oven-dried vial containing (Z)-1-bromo-2-fluoroethene (50.0 
mg,  0.400 mmol) and tert-butyl((3,7-dimethyloct-6-en-1-yl)oxy)dimethylsilane (27.1 mg, 
0.100 mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% 
consumption of tert-butyl((3,7-dimethyloct-6-en-1-yl)oxy)dimethylsilane that resulted in 
formation of a 92:8 mixture of fluoro- and bromo-alkenes. The resulting red oil was 
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purified by silica gel chromatography (1% EtOAc in hexanes) to afford a 92:8 mixture of 
fluoro- and bromo-alkene products (90% weight accounting for the mass of bromo-alkene, 
26.1 mg, 0.0902 mmol, 90% yield) in >98:2 Z:E (F-alkene) ratio as colorless oil. 1H NMR 
(400 MHz, CDCl3): δ 6.4 (1H, ddt, J = 86.0, 4.7, 1.5 Hz), 4.7 (1H, dtd, J = 43.5, 7.6, 4.7 
Hz), 3.7 – 3.6 (2H, m, 1H), 2.2 – 2.1 (2H, m), 1.6 – 1.5 (2H. m), 1.4 – 1.2 (4H, m), 0.9 (9H 
s), 0.0 (6H, s).; 13C NMR (101 MHz, CDCl3): δ 147.6 (d, J = 255.5 Hz), 111.2 (d, J = 5.3 
Hz), 61.4, 39.9, 36.6 (d, J = 1.8 Hz), 29.1, 26.1, 20.3 (d, J = 5.1 Hz), 19.5, 18.4, -5.2 (d, J 
= 1.9 Hz); 19F NMR (376 MHz, CDCl3): δ −131.4 (dd, J = 85.9, 43.4 Hz); HRMS [M+H]+ 
calcd for C14H30OFSi: 261.2045, found: 261.2035. 
(Z)-2-(3-fluoroallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.113): Following the 
general procedure, a solution of Mo-3 in benzene (0.1 M, 260 L, 26 mol) was transferred 
by syringe to an oven-dried vial containing (Z)-1-bromo-2-fluoroethene (500 mg, 4.00 
mmol) and 3-methyl-2-butenylboronic acid pinacol ester (392 mg, 2.00 mmol). The 
resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed 96% consumption 
of 3-methyl-2-butenylboronic acid pinacol ester that resulted in formation of a 95:5 mixture 
of fluoro- and bromo-alkenes. The resulting red oil was purified by Kugelrohr distillation 
(40 oC, 1 torr) to afford pure 3.113 (115 mg, 0.618 mmol, 62% yield) in 98:2 Z:E ratio as 
colorless oil. IR (neat): 2979 (m), 1671 (m), 1371 (s), 1324 (s), 1142 (s), 1051 (m), 970 
(m), 846 (m), 753 (m); 1H NMR (400 MHz, CDCl3): δ 6.47 (ddt, J = 85.8, 4.6, 1.7 Hz, 
1H), 4.84 (dtd, J = 43.0, 8.0, 4.6 Hz, 1H), 1.70 (d, J = 8.0 Hz, 2H), 1.26 (s, 12H); 13C NMR 
(101 MHz, CDCl3): δ 147.70 (d, J = 254.6 Hz), 106.22 (d, J = 6.1 Hz), 83.55, 24.84; 19F 
NMR (376 MHz, CDCl3): Z-isomer (major): δ −131.90 (dd, J = 86.0, 43.0 Hz), E-isomer 
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(minor): δ −130.14 (dd, J = 86.3, 19.2 Hz); HRMS [M+H]+ calcd for C9H17O2BF: 
187.1306, found: 187.1305. 
(Z)-9-((3-fluoroallyl)oxy)-7H-furo[3,2-g]chromen-7-one (3.115): Following the general 
procedure, a solution of Mo-3 in benzene (0.1 M, 15 L, 1.5 mol) was transferred by 
syringe to an oven-dried vial containing a solution of (Z)-1-bromo-2-fluoroethene (18.7 
mg, 0.150 mmol) and imperatorin (13.5 mg, 0.0500 mmol) in 85 L of toluene. The 
resulting solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by 
addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% consumption 
of imperatorin that resulted in exclusive formation of fluoro-alkene. The resulting red oil 
was purified by silica gel chromatography (20% EtOAc in hexanes) to afford 3.115 (12.5 
mg, 0.0480 mmol, 96% yield) in 98:2 Z:E ratio as slight yellow solid. IR (neat): 1718 (s), 
1673 (m), 1623 (m), 1584 (s), 1439 (m), 1399 (s), 1326 (s), 1145 (s), 1094 (s), 987 (m), 
753 (m); 1H NMR (600 MHz, CDCl3): δ 7.76 (d, J = 9.6 Hz, 1H), 7.69 (d, J = 2.2 Hz, 1H), 
7.38 (s, 1H), 6.82 (d, J = 2.2 Hz, 1H), 6.54 (dd, J = 83.2, 4.8 Hz, 1H), 6.37 (d, J = 9.6 Hz, 
1H), 5.31 (dtd, J = 40.6, 7.1, 4.8 Hz, 1H), 5.16 (d, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ 160.5, 150.5 (d, J = 264.6 Hz), 148.5, 146.9, 144.4, 143.8, 131.2, 126.1, 116.6, 
114.9, 113.8, 107.4 (d, J = 2.9 Hz), 106.9, 65.3 (d, J = 7.5 Hz); 19F NMR (376 MHz, 
CDCl3): Z-isomer (major): δ –124.10 (ddt, J = 83.3, 40.6, 2.0 Hz), E-isomer (minor): δ 
−122.08 (ddt, J = 82.2, 17.0, 2.6 Hz); HRMS [M+H]+ calcd for C14H10FO4: 261.0563, 
found: 261.0559. 
(Z)-2-(4-fluorobut-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.116): 
Following the general procedure, a solution of Mo-3 in benzene (0.1 M, 18 L, 1.8 mol) 
was transferred by syringe to an oven-dried vial containing (Z)-1-bromo-2-fluoroethene 
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(112 mg, 0.896 mmol) and 4-methyl-3-pentenylboronic acid pinacol ester (63.0 mg, 0.300 
mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 98% 
consumption of 4-methyl-3-pentenylboronic acid pinacol ester that resulted in formation 
of a 95:5 mixture of fluoro- and bromo-alkenes. The resulting red oil was purified by 
Kugelrohr distillation (40 oC, 1 torr) to afford a 97:3 mixture of fluoro- and bromo-alkene 
products (97% weight accounting for the mass of bromo-alkene, 47.3 mg, 0.229 mmol, 
76% yield) in 98:2 Z:E (F-alkene) ratio as clear colorless oil. IR (neat): 2979 (w), 2929 
(w), 1670 (w), 1366 (s), 1323 (s), 1143 (s), 967 (m), 846 (m), 754 (m); 1H NMR (400 
MHz, CDCl3): δ 6.37 (ddt, J = 85.9, 4.7, 1.5 Hz, 1H), 4.75 (dtd, J = 43.4, 7.6, 4.7 Hz, 1H), 
2.21 (qt, J = 7.7, 1.7 Hz, 2H), 1.23 (s, 12H), 0.86 (t, J = 7.7 Hz, 2H); 13C NMR (101 MHz, 
CDCl3): δ 147.0 (d, J = 255.8 Hz), 113.0 (d, J = 5.3 Hz), 83.2, 24.92, 17.4 (d, J = 5.7 Hz); 
19F NMR: (376 MHz, CDCl3): Z-isomer (major): δ −131.70 (ddt, J = 85.6, 43.2, 1.6 Hz), 
E-isomer (minor): δ −132.55 (ddt, J = 86.1, 19.0, 2.2 Hz); HRMS [M+H]+ calcd for 
C10H19O2BF: 201.1462, found: 201.1457. 
Methyl (Z)-2-((3-fluoroallyl)oxy)-3-methoxybenzoate (3.117): Following the general 
procedure, a solution of Mo-3 in benzene (0.1 M, 40 L, 4.0 mol) was transferred by 
syringe to an oven-dried vial containing (Z)-1-bromo-2-fluoroethene (37.5 mg, 0.300 
mmol) and methyl 3-methoxy-2-((3-methylbut-2-en-1-yl)oxy)benzoate (25.0 mg, 0.100 
mmol). The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed >98% 
consumption of methyl 3-methoxy-2-((3-methylbut-2-en-1-yl)oxy)benzoate that resulted 
in exclusive formation of fluoro-alkene. The resulting red oil was purified by silica gel 
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chromatography (5% to 10% EtOAc in hexanes) to afford 3.117 (20.0 mg, 0.0832 mmol, 
83% yield) in 97:3 Z:E ratio as slight yellow oil. 1H NMR (400 MHz, CDCl3): δ 7.3 (1H, 
dd, J = 7.6, 1.3 Hz), 7.1 (1H, t, J = 7.9 Hz), 7.1 (1H, dd, J = 8.1, 1.3 Hz), 6.5 (1H, dd, J = 
83.8, 4.7 Hz), 5.3 (1H, dtd, J = 41.6, 7.1, 5.0 Hz), 4.7 (2H, d, J = 7.1 Hz), 3.9 (6H, d, J = 
9.1 Hz); 13C NMR (101 MHz, CDCl3): δ 166.8, 153.7, 149.5 (d, J = 262.8 Hz), 147.5, 
126.5, 124.1, 122.3, 115.8, 108.0 (d, J = 2.9 Hz), 65.3 (d, J = 7.5 Hz), 56.2, 52.2; 19F NMR: 
(376 MHz, CDCl3): Z-isomer (major): δ − 125.7 (ddt, J = 83.6, 41.7, 2.0 Hz), E-isomer 
(minor): δ −124.3 (ddt, J = 83.5, 16.8, 2.7 Hz); HRMS [M+H]+ calcd for C12H14O4F: 
241.0876, found: 241.0864. 
7-(((2E,6Z)-7-fluoro-3-methylhepta-2,6-dien-1-yl)oxy)-2H-chromen-2-one (3.18): 
Following the general procedure, a solution of Mo-3 in benzene (0.1 M, 10 L, 1.0 mol) 
was transferred by syringe to an oven-dried vial containing a solution of (Z)-1-bromo-2-
fluoroethene (18.7 mg, 0.150 mmol) and auraptene (14.9 mg, 0.0500 mmol) in 90 L of 
toluene. The resulting solution was allowed to stir for 4 h at 22 °C. The reaction was 
quenched by addition of wet CDCl3 and analysis of the unpurified mixture revealed 90% 
consumption of auraptene that resulted in formation of a 95:5 mixture of fluoro- and 
bromo-alkenes. The resulting red oil was purified by preparative thin-layer 
chromatography (20% EtOAc in hexanes) to afford a 95:5 mixture of fluoro- and bromo-
alkene products (94% weight accounting for the mass of bromo-alkene, 10.9 mg, 0.0355 
mmol, 71% yield) in 97:3 Z:E (F-alkene) ratio as viscous yellow oil. IR (neat): 2921 (w), 
2855 (w), 1727 (s), 1671 (m), 1610 (s), 1555 (m), 1506 (m), 1401 (m), 1349 (m), 1277 (s), 
1229 (s), 1199 (m), 1121 (s), 832 (s), 751 (m); 1H NMR (400 MHz, CDCl3): δ 7.63 (d, J 
= 9.5 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 6.84 (dd, J = 8.5, 2.4 Hz, 1H), 6.81 (d, J = 2.4 Hz, 
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1H), 6.44 (ddt, J = 85.6, 4.7, 1.5 Hz, 1H), 6.24 (d, J = 9.5 Hz, 1H), 5.48 (tq, J = 6.5, 1.3 
Hz, 1H), 4.70 (dtd, J = 43.3, 7.6, 4.7 Hz, 1H), 4.61 (dd, J = 6.5, 0.5 Hz, 2H), 2.33 – 2.25 
(m, 2H), 2.15 (t, J = 7.5 Hz, 2H), 1.77 (s, 3H); 13C NMR (101 MHz, CDCl3): δ 162.2, 
161.4, 156.0, 148.1 (d, J = 256.7 Hz), 143.6, 141.4, 128.8, 119.3, 113.4, 113.2, 112.6, 110.1 
(d, J = 5.2 Hz), 101.8, 65.5, 38.9 (d, J = 1.9 Hz), 30.5, 21.0 (d, J = 5.0 Hz), 16.7; 19F NMR 
(376 MHz, CDCl3): Z-isomer (major): δ −130.22 (dd, J = 85.6, 43.1 Hz),  E-isomer 
(minor): δ −129.80 (dd, J = 85.4, 18.9 Hz); HRMS [M+H]+ calcd for C17H18FO3: 
289.1240, found: 289.1228. 
(2E,6Z)-7-fluoro-3-methylhepta-2,6-dien-1-yl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-
methyl-1H-indol-3-yl)acetate (3.19): Following the general procedure, a solution of Mo-
3 in benzene (0.1 M, 25 L, 2.5 mol) was transferred by syringe to an oven-dried vial 
containing a solution of (Z)-1-bromo-2-fluoroethene (31.2 mg, 0.250 mmol) and 
indomethacin geranyl ester (24.7 mg, 0.0500 mmol) in 75 L of toluene. The resulting 
solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet 
CDCl3and analysis of the unpurified mixture revealed 95% consumption of indomethacin 
geranyl ester that resulted in formation of an 93:7 mixture of fluoro- and bromo-alkenes. 
The resulting red oil was purified by preparative thin-layer chromatography (10% EtOAc 
in hexanes) to afford a 94:6 mixture of fluoro- and bromo-alkene products (93% weight 
accounting for the mass of bromo-alkene, 16.2 mg, 0.0311 mmol, 62% yield) in >98:2 Z:E 
(F-alkene) ratio as viscous yellow oil. IR (neat): 2929 (w), 1731 (s), 1678 (s), 1590 (m), 
1476 (s), 1356 (s), 1314 (s), 1221 (s), 1142 (s), 1067 (s), 735 (s); 1H NMR (400 MHz, 
CDCl3): δ 7.64 (d, J = 8.7 Hz, 1H), 7.45 (d, J = 8.7 Hz, 2H), 6.95 (d, J = 2.5 Hz, 1H), 6.85 
(d, J = 9.0 Hz, 1H), 6.65 (dd, J = 9.0, 2.5 Hz, 1H), 6.39 (ddt, J = 85.7, 4.7, 1.5 Hz, 1H), 
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5.33 (tq, J = 7.1, 1.3 Hz, 1H), 4.67 (dtd, J = 85.7, 7.5, 4.7 Hz, 1H), 4.63 – 4.59 (m, 2H), 
3.81 (s, 3H), 3.64 (s, 2H), 2.36 (s, 3H), 2.26 – 2.16 (m, 2H), 2.07 (t, J = 7.5 Hz, 2H), 1.69 
– 1.64 (m, 3H); 13C NMR (101 MHz, CDCl3): δ 171.0, 168.4, 156.2, 148.0 (d, J = 256.7 
Hz), 141.6, 139.4, 136.1, 134.1, 131.3, 130.9 (d, J = 11.9 Hz), 129.3, 119.0, 115.1, 112.8, 
111.7, 110.1, 62.0, 55.8, 38.9, 30.6, 21.0, 16.4, 13.5; 19F NMR (376 MHz, CDCl3): δ 
−130.29 (ddt, J = 85.7, 43.3, 1.7 Hz); HRMS [M+NH4]+ calcd for C10H19FO2N: 484.1691, 
found: 484.1683. 
(Z)-5-(3-fluoroallyl)-3-methyl-1-phenyl-1H-pyrazole (3.20): Following the general 
procedure, a solution of Mo-3 in benzene (0.1 M, 25 L, 10.0 mol) was transferred by 
syringe to an oven-dried vial containing (Z)-1-bromo-2-fluoroethene (18.7 mg, 0.150 
mmol), 3-methyl-5-(3-methylbut-2-en-1-yl)-1-phenyl-1H-pyrazole (11.3 mg, 0.0500 
mmol), and triphenylborane (13.3 mg, 0.0550 mmol) in 50 L of toluene. The resulting 
solution was allowed to stir for 4 h at 22 °C. The reaction was quenched by addition of wet 
CDCl3 and analysis of the unpurified mixture revealed 98% consumption of 3-methyl-5-
(3-methylbut-2-en-1-yl)-1-phenyl-1H-pyrazole that resulted in formation of a 93:7 mixture 
of fluoro- and bromo-alkenes. The resulting red oil was purified by silica gel 
chromatography (5% to 10% EtOAc in hexanes) to afford a 94:6 mixture of fluoro- and 
bromo-alkene products (93% weight accounting for the mass of bromo-alkene, 11.4 mg, 
0.0490 mmol, 98% yield) in >98:2 Z:E (F-alkene) ratio as slight yellow oil. IR (neat): 2924 
(w), 1673 (m), 1597 (m), 1549 (m), 1502 (s), 1430 (m), 1365 (m), 1071 (m), 1022 (m), 965 
(m), 786 (m), 695 (s); 1H NMR (400 MHz, CDCl3): δ 7.56 – 7.30 (m, 4H), 6.51 (ddt, J = 
84.2, 4.7, 1.7 Hz, 1H), 6.04 (s, 1H), 4.88 (dtd, J = 40.9, 7.4, 4.7 Hz, 1H), 3.47 (dtd, J = 7.4, 
1.7, 0.7 Hz, 2H), 2.31 (s, 3H); 13C NMR (101 MHz, CDCl3): δ 149.8, 149.2, 147.8, 142.3 
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– 139.5 (m), 129.2, 127.7, 125.3, 107.3 (d, J = 4.7 Hz), 106.1, 20.5 (d, J = 7.0 Hz), 13.7.; 
19F NMR: (376 MHz, CDCl3): Z-isomer (major): δ −128.78 (ddt, J = 84.2, 40.8, 1.8 Hz), 
E-isomer (minor): δ −127.79 (ddt, J = 84.0, 17.5, 2.2 Hz); HRMS [M+H]+ calcd for 
C13H14FN2: 217.1141, found: 214.1133. 
(Z)-1-(2-(2,4-dichlorophenyl)-2-((3-fluoroallyl)oxy)ethyl)-1H-imidazole (3.21): 
Following the general procedure, a solution of Mo-3 in benzene (0.1 M, 100 L, 10.0 
mol) was transferred by syringe to an oven-dried vial containing (Z)-1-bromo-2-
fluoroethene (75 mg, 0.600 mmol), 1-(2-(2,4-dichlorophenyl)-2-((3-methylbut-2-en-1-
yl)oxy)ethyl)-1H-imidazole (65.1 mg, 0.200 mmol), and triphenylborane (53.3 mg, 0.220 
mmol) in 300 L of toluene. The resulting solution was allowed to stir for 12 h at 22 °C 
then concentrated under reduced pressure. The resulting red foamy solid was dissolved in 
2 mL of thf then treated with 3 M NaOH (aq) solution (0.40 mL, 1.20 mmol) and H2O2 (30 
wt% aq solution, 125 L, 1.20 mmol). Vigorous evolution of gases was observed. When 
the effervescence reaction subsided, the resulting cloudy solution was allowed to stir at 50 
°C for 2 h after which time 0.5 mL of 3M NaOH (aq) was added. The separated aqueous 
layer was extracted with Et2O (3 x 2 mL). The combined organic layers were dried over 
MgSO4  and concentrated under reduced pressure. The residual yellow oil was purified by 
silica gel chromatography (1% to 2% MeOH in CH2Cl2) to afford a 94:6 mixture of fluoro- 
and bromo-alkene products (93% weight accounting for the mass of bromo-alkene, 57.6 
mg, 0.170 mmol, 85% yield) in 98:2 Z:E (F-alkene) ratio as yellow viscous oil. IR (neat): 
2936 (w), 2879 (w), 1670 (m), 1588 (m), 1561 (m), 1504 (m), 1469 (m), 1229 (m), 1090 
(s), 821 (s), 733 (s), 661 (s); 1H NMR (400 MHz, CDCl3): δ 7.44 (t, J = 1.1 Hz, 1H), 7.41 
(dd, J = 1.8, 0.6 Hz, 1H), 7.31 – 7.23 (m, 2H), 7.02 (s, 1H), 6.92 (s, 1H), 6.49 (ddt, J = 
Page 253 
83.6, 4.8, 1.3 Hz, 1H), 4.91 (dd, J = 7.4, 2.7 Hz, 1H), 4.77 (dddd, J = 41.1, 7.6, 6.7, 4.8 Hz, 
1H), 4.17 (dd, J = 14.5, 2.7 Hz, 1H), 4.09 – 3.88 (m, 3H); 13C NMR (101 MHz, CDCl3): 
δ 150.2 (d, J = 263.6 Hz), 137.8, 134.8, 134.1, 133.2, 129.5, 129.1, 128.4, 127.8, 119.8, 
106.9 (d, J = 3.3 Hz), 76.8, 61.0 (d, J = 7.1 Hz), 51.3; 19F NMR: (376 MHz, CDCl3): Z-
isomer (major): δ −123.56 (dddd, J = 82.8, 16.8, 3.5, 2.1 Hz), E-isomer (minor): δ −124.74 
(ddt, J = 83.6, 41.0, 2.0 Hz); HRMS [M+H]+ calcd for C14H14Cl2FN2O: 315.0467, found: 
315.0478. 
3.9.8. NMR Spectra 
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1H NMR of E-3.34
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13C NMR of E-3.34
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1H NMR of Z-3.34 
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1H NMR of Z-3.34 
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1H NMR of E-3.54
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13C NMR of E-3.54
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1H NMR of Z-3.54
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1H NMR of Z-3.54 
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1H NMR of 3.51 
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Chapter Four 
In situ Protection/Deprotection for Catalytic Olefin Metathesis in 
the Presence of Polar Protic Functional Groups 
4.1. Introduction 
Recent developments regarding stereoretentive cross-metathesis have provided 
solutions to compelling yet previously unsolved problems such as kinetically E-selective 
CM1 as well as synthesis of E- and Z-trisubstituted alkenes by CM.2 Recently, CM has 
found widespread use in both academic and industrial settings owing to the advancement 
of easily handled and high-performance catalysts.3,4 The functional group compatibility of 
metathesis catalysts, among other attributes, contributes directly to the implementation of 
CM in organic synthesis as the need to protect certain functional groups and the ensuing 
deprotection step would not only decrease the overall efficiency of a synthetic route 
(additional reactions as well as purification steps) but also deter synthetic chemists from 
considering CM in their retrosynthetic planning. In general, metathesis catalysts are not as 
stable towards certain functional groups as many target-oriented small scale syntheses have 
suggested.5 For Ru-carbene complexes, it has been established that Lewis basic amine 
groups are problematic and can cause catalyst decomposition.6 High-oxidation state Mo-
                                                 
(1) Nguyen, T. T.; Koh, M. J.; Shen, X.; Romiti, F.; Schrock, R. R.; Hoveyda, A. H. Science 2016, 352, 569–
575. 
(2) Nguyen, T. T.; Koh, M. J.; Mann, T. J.; Schrock, R. R.; Hoveyda, A. H. Nature 2017, 552, 347−354. 
(3) Taber, D. F.; Frankowski. K. J. J. Org. Chem. 2003, 68, 6047−6048.  
(4) Ondi, L.; Nagy, G. M.; Czirok, J. B.; Bucsai, A.; Frater, G. E. Org. Process Res. Dev. 2016, 20, 1709–
1716. 
(5) C. S. Higman, J. A. M. Lummiss, D. E. Fogg, Angew. Chem. Int. Ed. 2016, 55, 3552–3565 and references 
cited therein.  
(6) B. J. Ireland, B. T. Dobigny, D. E. Fogg. ACS Catal. 2015, 4690–4698. 
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alkylidenes, despite being more Lewis acidic at the metal center compared to Ru-carbenes,7 
are often more tolerant towards tertiary amines. 
1.0 mol%
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Scheme 4.1.1. Examples of In situ Protection of Lewis Basic Nitrogen Lone Pairs in OM
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Nevertheless, aromatic nitrogen-containing moieties can deactivate such catalysts due to 
formation of a stable amine adduct.8 In situ protection of the problematic Lewis basic amine 
                                                 
(7) R. R. Schrock, A. H. Hoveyda, Angew. Chem. Int. Ed. 2003, 42, 4592−4633. 
(8) For examples of stable bipyridine adducts of Mo alkylidene complexes, see: (a) Lichtscheidl, A. G.; Ng, 
V. W. L.; Müller, P.; Takase, M. K.; Schrock, R. R.; Malcolmson, S. J.; Meek, S. J.; Li, B.; Kiesewetter, E. 
T.; Hoveyda, A. H. Organometallics 2012, 31, 4558−4564. (b) Heppekausen, J.; Fürstner, A. Angew. Chem. 
Int. Ed. 2011, 50, 7829–7832.  
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moieties has been established for CM processes (Scheme 4.1). For example, CM of amine 
substrates9 with Ru-carbenes can be carried out with the corresponding hydrochloride 
salts10 or in the presence of a strong Bronsted acid  (e.g. p-toluenesulfonic acid11, 
trifluoroacetic acid,12 (±)-camphorsulfonic acid).13 Ring-closing metathesis (RCM) and 
CM of nitrogen-containing heterocycles with Mo-alkylidenes was made possible by the 
addition of an aprotic Lewis acid such as tris(pentafluorophenyl)borane14 or 
triphenylborane15 (instead of protic acids) due to the incompatibility of high-oxidation state 
alkylidenes with these functionalities.7 
Whereas Ru-carbene complexes are largely compatible with alcohols and 
carboxylic acids16 except for those that contains strongly nucleophilic alkyl ligands,17 these 
moieties need to be fully protected prior to reaction with high-oxidation state Mo 
alkylidenes. As a results, CM of substrates with polar protic groups with Mo-alkylidenes 
can be less efficient than those with Ru-carbenes due to the required protection and 
deprotection steps. A relevant examples pertains to the dominant use of Ru-carbenes in 
large-scale ethenolysis of methyl oleate,18 a renewable plant oil. Methyl oleate often 
                                                 
(9) For a comprehensive review of OM involving amine-containing substrates, see: Compain, P. Adv. Synth. 
Catal. 2007, 349, 1829–1846 and references sited therein. 
(10) Fu, G. C.; Nguyen, S. T.; Grubbs, R. H. J. Am. Chem. Soc. 1993, 115, 9856–9857. 
(11) Wright D. L.; Schulte II, J. P.; Page, M. A. Org. Lett. 2000, 2, 1847–1850. 
(12) Edwards, A. S.; Wybrow, R. J.; Johnstone, C.; Adams, H.; Harrity, J. P. A. Chem. Commun. 2002, 
1542–1543. 
(13) Verhelst, S. H. L.; Paez Marinez, B.; Timmer, M. S. M.; Lodder, G.; van der Marel, G. A.; Overkleeft, 
H. S.; van Boom, J. H. J. Org. Chem. 2003, 68, 9598–9603. 
(14) Shen, X.; Nguyen, T. T.; Koh, M. J.; Xu, D.; Speed, A. W. H.; Schrock, R. R.; Hoveyda, A. H. Nature 
2017, 541, 380−385. 
(15) See Chapter Three, Section 3.7. 
(16) Koh, M.-J.; Khan, R. K. M.; Torker, S.; Yu, M.; Mikus, M. S.; Hoveyda, A. H. Nature 2015, 517, 181–
186.  
(17) Keitz, B. K.; Endo, K.; Herbert, M. B.; Grubbs, R. H. J. Am. Chem. Soc. 2011, 133, 9686–9688. 
(18) Thomas, R. M.; Keitz, B. K.; Champagne, T. M.; Grubbs, R. H. J. Am. Chem. Soc. 2011, 133, 7490–
7496 and references cited therein. 
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contains trace amount of water and protic compounds in technical-grade samples; as a 
result, most reported studies employed the moisture-stable Ru-carbene complexes.18 
However, it has been shown that Mo-alkylidenes can deliver comparable turnover 
numbers19 as long as purified methyl oleate was used. We envisioned that an in situ 
protection of polar protic groups (alcohols, carboxylic acids, etc.) would obviate the 
redundant protection/deprotection sequence in OM of substrates bearing those functional 
groups, thus broadening considerably the scope of OM processes catalyzed by high-
oxidation-state Mo alkylidenes. In addition, removal of protic impurities in feedstock 
alkene starting material may be performed in situ prior to OM so that a separate and costly 
purification step may not be necessary. For such an in situ protection/purification protocol 
to be practically useful, the following requirements need to be met: Firstly, the protecting 
reagent must be inexpensive and readily available. Secondly, protection must proceed 
quantitatively in a short amount of time and the byproduct of such process must be either 
easily removed or completely benign to high-oxidation-state alkylidenes. Lastly, the 
protecting group must be easily removed in situ and under mild conditions. 
4.2. In situ Protection/Deprotection of Alcohols for Catalytic CM 
 As far as we are aware, there is only one report of RCM with an in situ protected 
alcohol20 catalyzed by Mo-alkylidene (Scheme 4.2.1). A mixed boronic ester (4.10) was 
generated from diisopropoxy-allylboronate 4.9 through a ligand exchange with allylic 
alcohol 4.8. After removal of the isopropyl alcohol byproduct under reduced pressure, 4.10 
was subjected directly to 5.0 mol% of chiral binaptholate Mo-3 to effect an 
                                                 
(19) Marinescu, S. C.; Schrock, R. R.; Müller, P.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 10840–
10841. 
(20) Jernelius, J. A.; Schrock, R. R.; Hoveyda, A. H. Tetrahedron, 2004, 60, 7345−7351. 
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enantioselective ring-closing metathesis (RCM). Ensuing oxidation converted the 
unpurified RCM product to diol 4.11 in 57% overall yield as a single stereoisomer (>98% 
ee, >98% Z:E). Thus, a net stereoselective and enantioselective CM was achieved in a one-
pot protocol starting from unprotected allylic alcohol 4.8. However, the above approach is 
applicable to only secondary and tertiary alcohols20 (no example of primary alcohols was 
reported). Moreover, complete ligand exchange between 4.8 and 4.9 was slow (~16 h at 22 
oC). Last but not least, the cross-partner is limited to allylboronate 4.9, thus significantly 
narrowing the scope of this method. 
 
 Due to the drawbacks of diisopropoxy-allylboronate 4.9 as an in situ protecting 
reagent for alcohols, we set out to look for alternative boron-based compounds that would 
better satisfy our envisioned requirements as discusses in section 4.1. Recently, Bertrand 
and coworkers reported an interesting dehydrocoupling reaction between alcohols and 
commercially available pinacolborane21 [HB(pin), pin = pinacolato, Scheme 4.2.2]. 
Notably, a variety of alcohols were quantitatively converted within minutes to alkoxy-
                                                 
(21) Romero, E. A.; Peltier, J. L.; Jazzar, R.; Bertrand, G. Chem. Commun., 2016, 52, 10563−10565 
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boronic esters (e.g. 4.13 and 4.14) and dehydrocoupling with pinacolborane proved to be 
much more facile than hydroboration even in the presence of proximal terminal alkenes 
and alkynes.22 Moreover, the only byproduct of dehydrocoupling processes is hydrogen  
 
gas which does not interfere with CM and could be easily removed from the reaction 
mixture when needed. As a proof of concept, we carried out the in situ protection of 
unpurified citronellol in the presence of a slight excess of HB(pin) (1.1 equiv.). 
Dehydrocoupling proceeded rapidly as reported (vigorous evolution of H2 gas was 
observed) and excess HB(pin) was removed under reduced pressure. The resulting alkoxy-
B(pin) was reacted immediately with Z-1-bromo-2-fluoroethene 4.6 without further 
purification according to previously reported procedure.23 To our delight, complete 
consumption of the in situ protected citronellol was afforded with only 0.8 mol% of Mo-2 
and the Z-fluoroalkene product 4.16 was isolated in 90% yield and as a single stereoisomer 
                                                 
(22) Tucker, C. E.; Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482−3485. 
(23) See Chapter Three, Section 3.7 
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after routine silica gel chromatography. The excellent efficiency of the above reaction 
strongly suggested that the (pin)B-alkoxy group was sufficiently stable under CM 
conditions and yet labile enough so that quantitative deprotection could be effected simply 
by exposure to mildly acidic silica gel. 
 
 The in situ protection/deprotection protocol is applicable to tertiary alcohol-
containing alkenes as well (Scheme 4.2.3). Unpurified dihydromyrcenol 4.17 underwent 
the same in situ protection protocol as described above followed by CM with Z-1-
propenylboronate 4.18 and Mo-4 to furnish 4.19 in 65% yield and exclusive Z-selectivity. 
As noted above, uncatalyzed hydroboration of alkenes with HB(pin) is a sluggish process24 
                                                 
(24) For studies on transition metal-catalyzed hydroboration of alkenes, see: (a) Pereira, S.; Srebnik, M. J. 
Am. Chem. Soc. 1996, 118, 909−910. (b) Pereira, S.; Srebnik, M. Tetrahedron Lett. 1996, 37, 3283−3286. 
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compared to dehydrocoupling; therefore, in situ protection of alcohols could be carried out 
in the presence of 5.0 equiv. of 1,2-dibromoethene 4.21 (commercially available as an 
inseparable 64:36 Z:E mixture) and 1.1 equiv. HB(pin). The resulting protected alcohol 
was subjected to CM with monoaryloxide chloride complex Mo-5,25 a recently developed 
family of Mo-alkylidenes that are able to deliver unprecedented level of Z selectivity. It 
merits mentioning that excess HB(pin) needs not be removed in this case. 
To probe the possibility of using HB(pin) to remove trace amount of protic 
impurities in commercial alkene samples, we turned our attention to the synthesis of Z-γ-
chloroboronate 4.25 by catalytic CM (Scheme 4.2.4).25 Different batches of Z-
crotylboronate 4.23 from commercial vendors are contaminated with varying amount of 
pinacol that is difficult to remove from 4.23 by means of distillation. Pinacol is extremely 
detrimental to Mo-5 as a sequential addition experiment showed that at least 3.0 mol% of 
Mo-5 was completely decomposed by this impurity (<5% conv. of 4.23) and that CM 
reached completion with just 2.0 mol% of catalyst. As HB(pin) reacts rapidly with alcohols 
(Scheme 4.2.2 and Scheme 4.2.3) and water26 to furnish alkoxyboronates, we treated Z-
crotylboronate 4.23 with 10 mol% HB(pin) before carrying out CM with 4.24. Indeed, 1.6 
mol% of Mo-5 was sufficient to fully consume Z-crotylboronate 4.23 (from the same batch 
that was contaminated with ~1% pinacol), thus providing 96% yield of Z-γ-chloroboronate 
4.25 in gram quantities and in excellent stereoselectivity.27 The promising preliminary 
                                                 
(c) Wu, J. Y.; Moreau, B.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 12915−12917. (d) Ely, R. J.; Morken, J. 
P. J. Am. Chem. Soc. 2010, 132, 2534−2534. 
(25) Koh, M.-J.; Nguyen, T. T.; Lam, J. K.; Hyvl, J.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. Nature 
2017, 542, 80–85.  
(26) Bolañ o, T.; Esteruelas, M. A.; Gay, M. P.; Oñ ate, E.; Pastor, I. M.; Yus, M. Organometallics 2015, 34, 
3902−3908. 
(27) F. W. van der Mei, Notebook 7, Hoveyda Research Group, Unpublished Results. 
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results above point to the potential use of inexpensive and commercially available 
pinacolborane as both an in situ protecting reagent for Mo-alkylidene-catalyzed CM of 
alcohols as well as a convenient in situ ‘purifying’ additive in cases where trace amount of 
protic impurities are present. 
 
4.3. In situ Protection/Deprotection of Carboxylic Acids for Catalytic OM 
 Dehydrocoupling of carboxylic acids with HB(pin) was unsuccessful (Scheme 
4.3.1). Although H2 gas was detected (by 1H NMR analysis of the crude product mixture, 
singlet at δ 4.6 ppm) upon addition of HB(pin) to 7-octenoic acid 4.26, only one boron–
containing species was observed after one hour at ambient temperature. The 11B chemical 
shift of this intermediate most likely corresponds to bis(pinacolatoboryl)oxy 4.29 
(literature value 11B NMR δ +21.6 ppm28, observed δ  +21.7 ppm with respect to BF3∙OEt2). 
                                                 
(28) Ng, C. K.; Wu, J.; Hor,  T. S. A.; Luo, H.-K. Chem. Commun. 2016, 52, 11842−11845 and references cited 
therein. 
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In fact, 4.29 is the most common byproduct generated from HCO2B(pin) in several studies 
regarding Ru-catalyzed HB(pin) addition to carbon dioxide.28 The formation of 4.29 was 
reminiscent of a report by Brown and coworkers in which acetoxyborabicycle 4.30 partially 
disproportionated to 4.31 and acetic anhydride.29  
 
Peculiarly, we did not observe any carboxylic anhydride, based on infrared 
spectroscopic analysis of the crude mixture, the only detectable C=O stretch is at 1709 cm-
1). Regardless of how 4.29 was formed, we thought that its formation was most likely 
stemmed from the instability of the carboxy-B(pin) intermediate (e.g. 4.28). If so, addition 
of a stoichiometric amount of N-methylimidazole (Scheme 4.1.1) may generate a more 
stable tetracoordinate boron species (Scheme 4.3.2). Indeed, treatment of acid 4.32 with an 
                                                 
(29) Kramer, G. W.; Brown, H. C. J. Organomet. Chem. 1977, 132, 9−27. 
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equimolar amount of HB(pin) and N-methylimidazole led to the isolation of 4.33 as a white 
solid; its 11B chemical shift, δ +5.6 ppm, agrees with a tetravalent boron compound. 
However, CM of 4.33 with Z-1,2-dichloroethene 4.24 was inefficient (<5% conv.). 
Likewise, pure 4.34, isolated and purified by recrystallization from the reaction of 4.32 
with 9-BBN and N-methylimidazole (11B chemical shift: δ +0.7 ppm), was not tolerated by 
Mo-alkylidenes. It could be that N-methylimidazole was not completely bound to the boron 
center in 4.33 and 4.34 upon dissolution during CM reaction and free N-methylimidazole 
rapidly sequestered the Mo-alkylidene.8 
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To avoid complications arising from the additional amine additive, we chose to use 
the sterically bulky bis(2,4,6-triisopropylphenyl)borane [(trip)2BH]30 which can be easily 
synthesized in two steps starting from boron trifluoride. In addition, pre-complexation of 
(trip)2BH  with alkene is strongly disfavored due to four sizable isopropyl groups around 
the boron center so that hydroboration of alkenes does not occur even after 24 hours at 20 
oC.30 As a result, dehydrocoupling of oleic acid 4.35 proceeded readily with 1.05 equiv. of 
(trip)2BH in the presence of excess alkene cross-partner 4.24. CM of the resulting 
carboxyborane with 3.0 mol% of Mo-4 afforded Z-alkenyl chloride 4.36 in 96% yield and 
95% Z selectivity. Again, complete removal of the boron-protecting group was effected 
simply by adsorbing the unpurified product mixture to silica gel before chromatography 
 
purification. Notably, CM of in situ protected oleic acid 4.35 afforded similar yield and 
stereoselectivity that was obtained previously with purified methyl oleate 4.37 (Scheme 
                                                 
(30) Pelter, A.; Smith, K.; Buss, D.; Norbury, A. Tetrahedron Lett. 1991, 32, 6239−6242. 
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4.3.2).31 Despite these promising results, the amount of waste generated from 
dehydrocoupling of carboxylic acids with (trip)2BH is significantly more than that with 
HB(pin), thus making the in situ protection/deprotection sequence with this reagent 
comparatively less practical.  
4.4. In situ Boron-Tethered RCM to Enable Efficient and Stereoselective Net CM 
with Equimolar Ratio of Alkenes 
 Synthesis of five- to eight-membered rings through catalytic RCM represents an 
efficient and widely used application of olefin metathesis (OM) because of the following 
attractive features: pre-organization of two reacting alkene partners in close proximity can 
translate to high reactivity even for challenging cases such as tetrasubstituted alkene 
RCM.32,33 Reactions can be performed at unusually high concentration34 (as opposed to 
macrocyclic RCM).35 At times, two alcohol-containing alkenes can be tethered by a 
suitable silicon group so that RCM could proceed efficiently and in high stereoselectivity.36 
Subsequent removal of the temporary silicon linker would convert the cyclic product to an 
acyclic alkene, which is the product of a net stereoselective CM. This strategy proves to be 
a powerful method for CM reactions that would have been essentially impossible. Relevant 
examples can be found in the total synthesis of epothilone37 and (+)-TMC-151C.38 Certain 
                                                 
(31) Koh, M.-J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; Hoveyda, A. H. Nature 2016, 531, 459–465. 
(32) S. M. Paek, Molecules 2012, 17, 3348−3358. 
(33) Vanderwal, C. D.; Atwood, B. R. Aldrichimica Acta 2017, 50, 17−27 and references cited therein.  
(34) Hanson, P. R.; Maitram, S.; Chegondi, R.; Markley J. L. In Handbook of Metathesis; Grubbs, R. H., 
O’Leary, D. J., Eds; Wiley–VCH, 2014; pp 1–170. 
(35) Monfette, S.; Fogg, D. E. Chem. Rev. 2009, 109, 3783–3816.  
(36) Hoye, T. R.; Promo, M. A. Tetrahedron Lett. 1999, 40, 1429−1432. 
(37) Gaich, T.; Mulzer, J. Org. Lett. 2005, 7, 1311−1313. 
(38) Matsui, R.; Seto, K.; Sato, Y.; Suzuki, T.; Nakazaki, A.; Kobayashi, S. Angew. Chem. Int. Ed. 2011, 50, 
680−683.  
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drawbacks of this three-step protocol can be attributed to the need to fully ‘protect’ the 
alcohol groups and an inevitable deprotection step, thus negatively affecting the yield of 
the entire process. 
In light of the rapid and quantitative in situ protection of alcohols with HB(pin), we 
became interested in the idea of tethering two allylic alcohols by two successive 
dehydrocoupling reactions. RCM of the resulting diene intermediate would proceed with 
high efficiency and stereoselectivity. To probe the possibility of boron-tethered RCM, we 
first investigated the in situ double dehydrocoupling allylic alcohol 4.39 with 0.5 equiv. of 
2,4,6-triisopropylphenylborane [(trip)BH2, Scheme 4.4.1)].39 TripBH2 exists as a stable 
dimeric boron compound that is resistant to redistribution and isomerization39 (as opposed 
to thexylborane); however, its capability of hydroborating alkenes40 poses a new issue: 
would dehydrocoupling of alcohols still be more facile than hydroboration of alkenes? 
Unfortunately, we detected only cyclic boronate 4.41 which indicated that the second 
dehydrocoupling between 4.40 and another molecule of 4.39 could not compete with 
intramolecular hydroboration of the pendant terminal alkene. To avoid undesired 
hydroboration, we turned out attention to bis(dimethylamino)phenylborane 4.42 as this 
compound can be easily prepared from commercially available dichlorophenylborane in 
one step41 and amino-borane 4.42 undergoes irreversible protonolysis upon exposure to 
alcohols.42 In the event, in situ tethering of 4.39 was carried out with 0.5 equiv. of 4.42 
followed by removal of dimethylamine byproduct under reduced pressure, the resulting 
                                                 
(39) Pelter, A.; Smith, K.; Buss, D.; Jin, Z. Heteoatom Chemistry 1992, 3, 275−277.  
(40) Smith, K.; Pelter, A.; Jin, Z. J. Chem. Soc. Perkin Trans 1 1993, 395−396. 
(41) Meller, A.; Maringgele, W.; Hennemuth, K. Zeitschrift fuer Anorganische und Allgemeine Chemie 1979, 
449, 77−82. 
(42) Cragg, R. H.; Miller, T. J. J. Organomet. Chem. 1982, 235, 135−141.  
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boronate 4.43 was then subjected to RCM conditions with 5.0 mol% Mo-2.  After two 
hours at ambient temperature and mild vacuum (30 torr), the putative unpurified product 
4.44 was treated with 1.0 equiv. of pinacol to effect deprotection. The desired acyclic 
alkene 4.45 was isolated in 74% yield and as a single Z isomer, which strongly suggested 
that the boron-tethered RCM outcompeted bimolecular CM even at high concentration (1.0 
M); otherwise, CM of an allylic-branched alkene would deliver the product in exclusive E 
selectivity due to substrate control.43 Notably, the entire sequence of 
protection/tethering/RCM/deprotection was performed in one vessel without the need to 
isolate any of the intermediates. 
 
                                                 
(43) Chatterjee, A. K.;  Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 
11360−11370. 
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Next, we attempted the CM of two different allylic alcohols 4.39 and 4.46 (Scheme 
4.4.2) using the boron-tethering protocol described above. Sequential addition of 4.39 and 
4.46 to amino-borane 4.42 followed by RCM of the resulting putative mixed boronate 4.47 
with Mo-2 and removal of the boron tether with pinacol (deprotection with silica gel was 
not as effective in this case) revealed that the desired product 4.49 was generated in 
exclusive Z selectivity albeit in only 34% yield and the major byproduct was 4.45 (46% 
conv., >98% Z). The above result suggested that 4.47 may undergo redistribution reaction 
typically observed with trivalent boron compounds to generate 4.43 (Scheme 4.4.1) and 
4.50; RCM of 4.43 would afford 4.45 in high Z selectivity. If this is true, blocking the  
 
Page 367 
partially vacant p orbital of boron in the mixed boronate 4.47 would slow down 
redistribution and could lead to higher yield of 4.49. Efforts in this direction are ongoing 
in our laboratory. 
4.5. Conclusions 
 In summary, we demonstrated that protic groups such as alcohols and carboxylic 
acids that are problematic with high-oxidation-state alkylidenes could be effectively 
masked in situ prior to CM reactions by an appropriate borane reagent. Commercial sample 
of alkenes that are usually contaminated with protic impurities could be ‘purified’ in situ 
by sub-stoichiometric amount of pinacolborane. Deprotection of the in situ boron-based 
protecting group proceeded under mild conditions and could be performed in the same 
vessel. The one-pot protection/cross-metathesis/deprotection of alcohol and carboxylic 
acid-containing alkenes described herein is likely to have an impact on the diversity of 
organic molecules that can be prepared in a laboratory setting. 
 Attempts to tether two different allylic alcohols through ligand exchange with an 
amino-borane compound for the ensuing RCM proved to be feasible. In situ removal of the 
boron tether delivered the net CM product in excellent stereoselectivity although efficiency 
was less than desired due to the facile redistribution reaction of the putative mixed boronic 
ester intermediate. Studies to address this issue are ongoing in this laboratory. 
4.6. Experimental Section 
4.6.1. General 
Unless otherwise noted, transformations were performed with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum line techniques. Infrared (IR) spectra were recorded on a 
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Bruker FTIR Alpha (ATR Mode) spectrometer, vmax in cm-1. Bands are characterized as 
broad (br), strong (s), medium (m), or weak (w). 1H NMR spectra were recorded on a 
Varian Unity INOVA 400 (400 MHz), 500 (500 MHz), or 600 (600MHz_ spectrometer. 
Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance 
resulting from incomplete deuterium incorporation as the internal standard (CDCl3: δ 7.26 
ppm, C6D6: δ 7.16 ppm, CD2Cl2: δ 5.32 ppm, CD3OD: δ 3.31 ppm). Data are reported as 
follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR spectra were 
recorded on a Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometers with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 ppm, 
C6D6: δ 128.00 ppm, CD2Cl2: δ 54.00 ppm, CD3OD: δ 49.00 ppm). High-resolution mass 
spectrometry was performed on a Micromass LCT ESI-MS and JEOL Accu TOF Dart 
(positive mode) at the Boston College Mass Spectrometry Facility. Melting points were 
determined using a Thomas Hoover Uni-melt capillary melting point apparatus. Values for 
E:Z ratios of products were determined by 1H NMR analysis of unpurified mixtures. 
Solvents: 
Solvents (CH2Cl2, Et2O, pentane, benzene and toluene) were purified under a positive 
pressure of dry argon gas by a modified Innovative Technologies purification system. 
Tetrahydrofuran was distilled from Na/benzophenone. Methanol was distilled over Mg. 
Acetone, N,N-dimethylformamide (anhydrous), 1,2-dimethoxyethane (anhydrous) and 1,4-
dioxane (anhydrous) were used as received. All purification procedures of CM products 
Page 369 
were carried out with reagent grade solvents (purchased from Fisher) under bench-top 
conditions. 
Reagents: 
Pinacolborane (Oakwood), N-methylimidazole (Aldrich), (Z)-1,2-dichloroethene (TCI), 
1,2-dibromoethene (mixture of cis and trans, Aldrich), (Z)-1-propenylboronic acid pinacol 
ester (Aldrich) were distilled over CaH2 before use. 
9-Borabicycle[3.3.1]nonane dimer,44 bis(2,4,6-triisopropylphenyl)borane,30 2,4,6-
triisopropylphenylborane,39 and bis(dimethylamino)phenylborane41 were prepared 
according to reported procedures. 
(Z)-1-bromo-2-fluoroethene (Synquest), (±)-β-citronello (TCI), dihydromyrcenol 
(Aldrich), oleyl alcohol (Aldrich), oleic acid (Aldrich), 5-hexenoic acid (TCI), 7-octenoic 
acid (TCI), (Z)-crotylboronic acid pinacol ester (Aldrich), (S)-1-phenyl-2-propen-1-ol 
(Aldrich), 2-methyl-2-propen-1-ol (Acros) were used as received. 
Preparation of organometallic complexes 
Mo-2,45 Mo-4,31 and Mo-525Error! Bookmark not defined. were prepared according to 
previously reported procedures. Mo complexes were manipulated under an atmosphere of 
N2 in a glove box.  
4.6.2. Cross-Metathesis (CM) Reactions 
(Z)-7-fluoro-3-methylhept-6-en-1-ol (4.16): In a N2-filled glove box, an oven-dried 8 mL 
vial equipped with a magnetic stir bar was charged with (±)--citronellol (31.3 mg, 0.200 
                                                 
(44) Soderquist, J. A.; Brown, H. C. J. Org. Chem. 1981, 46, 4599−4600. 
(45) Zhang, H.; Yu, E. C.; Torker, S.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 16493–
16496. 
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mmol) and pinacolborane (31 L, 0.210 mmol). Vigorous evolution of H2 gas was 
observed. Once effervescence subsided, the solution was allowed to stir for 30 min at 22 
°C, after which the volatiles were removed in vacuo (2 torr, 5 min). The resulting colorless 
oil was treated with Z-1-bromo-2-fluoroethene (75.0 mg, 0.600 mmol) followed by a 
solution of Mo-2 (0.1 M in benzene, 16 L, 1.6 mol). The solution was allowed to stir for 
4 h at 22 °C, after which the reaction was quenched by the addition of wet CDCl3 and 
analysis of the unpurified mixture (1H NMR) revealed >98% consumption of (±)--
citronellol that resulted in formation of a 95:5 mixture of fluoro- and bromo-alkenes. The 
resulting red oil was purified by silica gel chromatography (10% to 20% EtOAc in hexanes) 
to afford 2 in >98:2 Z:E ratio as clear colorless oil (94% weight of fluoroalkene accounting 
for the mass of bromo-alkene, 27.9 mg, 0.179 mmol, 90% yield). IR (neat): 3330 (br), 
2955 (m), 2922 (s), 2872 (w), 1671 (s), 1457 (m), 1378 (s), 1048 (s), 960 (s), 751 (s); 1H 
NMR (400 MHz, CDCl3): δ 6.64 – 6.37 (m, 1H), 5.46 (dt, J = 13.9, 1.6 Hz, 1H), 4.33 (dd, 
J = 6.2, 1.6 Hz, 2H), 3.74 – 3.60 (m, 2H), 3.60 – 3.48 (m, 2H), 1.27 (s, 12H); 13C NMR 
(101 MHz, CDCl3): δ147.7 (d, J = 255.8 Hz), 111.1 (d, J = 5.4 Hz), 61.1, 39.8, 36.6 (d, J 
= 1.9 Hz), 29.1, 20.3 (d, J = 5.0 Hz), 19.4; 19F NMR (376 MHz, CDCl3): Z-isomer: δ 
−131.3 (ddt, J = 85.9, 43.4, 1.7 Hz); HRMS [M+H]+ calcd for C8H16FO: 147.1185, found: 
147.1190. 
 (Z)-2,6-dimethyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oct-7-en-2-ol (4.19): 
In a N2-filled glove box, an oven-dried 8 mL vial equipped with a magnetic stir bar was 
charged with dihydromyrcenol (15.6 mg, 0.100 mmol) and  pinacolborane (16 L, 0.110 
mmol). Gentle evolution of H2 gas was observed. Once effervescence subsided, the solution 
was allowed to stir for 30 min at 22 °C, after which the volatiles were removed in vacuo (2 
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torr, 5 min). The resulting colorless oil was treated with Z-1-propenylboronic acid pinacol 
ester (37 L, 0.198 mmol) followed by a solution of Mo-4 (0.1 M in benzene, 30 L, 3.0 
mol). The solution was allowed to stir for 12 h at 22 °C, after which the reaction was 
quenched by the addition of wet CDCl3 and analysis of the unpurified mixture (1H NMR) 
revealed 83% consumption of dihydromyrcenol. The resulting red oil was purified by silica 
gel chromatography (5% to 25% EtOAc in hexanes) to afford pure 4.19 (18.4 mg, 0.0652 
mmol, 65% yield) in >98:2 Z:E ratio as colorless oil. IR (neat): 3383 (br), 2974 (m), 2934 
(m), 1626 (m), 1420 (m), 1370 (m), 1258 (s), 1143 (s), 968 (m), 778 (m); 1H NMR (400 
MHz, CDCl3): δ 6.13 (dd, J = 13.5, 9.9 Hz, 1H), 5.26 (dd, J = 13.5, 0.5 Hz, 1H), 2.97 – 
2.84 (m, 1H), 1.54 − 1.21 (m, 18H), 1.18 (d, J = 2.7 Hz, 6H), 0.95 (d, J = 6.6 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ 160.9, 82.9, 71.1, 44.0, 37.6, 36.1, 29.5, 29.2, 25.0, 25.0, 22.1, 
21.4; HRMS [M+H]+ calcd for C16H32BO3: 282.2448, found: 282.2435. 
(Z)-10-bromodec-9-en-1-ol (4.22): In a N2-filled glove box, an oven-dried 8 mL vial 
equipped with a magnetic stir bar was charged with oleyl alcohol (26.8 mg, 0.100 mmol), 
1,2-dibromoethene (93.0 mg, 0.500 mmol) and pinacolborane (16 L, 0.110 mmol). 
Vigorous evolution of H2 gas was observed. Once effervescence subsided, the resulting 
solution was treated with a solution of Mo-5 (0.1 M in benzene, 30 L, 3.0 mol). The 
solution was allowed to stir for 2 h at 22 °C, after which the reaction was quenched by the 
addition of wet CDCl3 and analysis of the unpurified mixture (1H NMR) revealed 89% 
consumption of oleyl alcohol. The resulting red oil was purified by silica gel 
chromatography (10% EtOAc in hexanes) to afford pure 4.22 (16.3 mg, 0.0693 mmol, 69% 
yield) in >98:2 Z:E ratio as colorless oil. 1H NMR (400 MHz, CDCl3): δ 6.1 (1H, dt, J = 
7.0, 1.2 Hz), 6.1 (1H, q, J = 7.0 Hz), 3.6 (2H, t, J = 6.7 Hz), 2.2 (2H, qd, J = 7.1, 1.3 Hz), 
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1.6 – 1.5 (2H, m), 1.5 – 1.2 (10H, m); 13C NMR (101 MHz, CDCl3): δ 135.1, 107.7, 63.2, 
32.9, 29.8, 29.5, 29.5, 29.2, 28.2, 25.9 
(Z)-2-(3-chloroallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4.25): In a N2-filled 
glove box, an oven-dried 8 mL vial equipped with a magnetic stir bar was charged with Z-
crotylboronic acid pinacol ester (4.0 g, 21.9 mmol), Z-1,2-dichloroethene (6.4 g, 66 mmol), 
pinacolborane (320 L, 2.2 mmol) and 3.5 mL of benzene. Gentle evolution of H2 gas was 
observed. The resulting solution was allowed to stir for 20 min at 22 °C then treated with 
a solution of Mo-5 (0.1 M in benzene, 333 L, 33.3 mol). The resulting solution was 
allowed to stir for 2 h at 22 °C. The reaction was quenched by methanol and analysis of 
the unpurified mixture revealed >98% consumption of Z-crotylboronic acid pinacol ester. 
The resulting red oil was purified by distillation under reduced pressure to afford 4.25 (4.3 
g, 98% purity by weight, 20.8 mmol, 96% yield) in >98:2 Z:E ratio as clear colorless oil. 
The spectral data for this compound is consistent with those previously reported25. 
(Z)-10-chlorodec-9-enoic acid (4.36): In a N2-filled glove box, an oven-dried 8 mL vial 
equipped with a magnetic stir bar was charged with oleic acid (28.2 g, 0.100 mmol), Z-1,2-
dichloroethene (49.0 g, 0.500 mmol), Trip2BH (43.9 mg, 0.105 mmol) and 50 μL of 
toluene. Vigorous evolution of H2 gas was observed. One effervescence subsided, the 
resulting solution was allowed to stir for 15 min at 22 °C then treated with a solution of 
Mo-4 (0.1 M in benzene, 30 L, 3.0 mol). The resulting solution was allowed to stir for 
4 h at 22 °C. The reaction was quenched by wet CDCl3 and analysis of the unpurified 
mixture revealed >98% consumption of oleic acid. The resulting red oil was purified by 
silica gel chromatography (5% to 20% EtOAC in hexanes) to afford 4.36 (19.6 g, 0.0957 
mmol, 96% yield) in 95:5 Z:E ratio as clear colorless oil. 1H NMR (400 MHz, CDCl3): δ 
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11.5 (1H, bs), 6.0 (1H, dt, J = 7.0, 1.6 Hz), 5.7 (1H, q, J = 7.0 Hz), 2.3 (2H, t, J = 7.5 Hz), 
2.2 (2H, qd, J = 7.2, 1.6 Hz), 1.6 (2H, p, J = 7.3 Hz), 1.5 – 1.2 (8H, m); 13C NMR (101 
MHz, CDCl3): δ 180.2, 131.9, 118.1, 34.1, 29.1, 29.1, 29.0, 28.4, 27.1, 24.8. 
4.6.3. In situ Boron-Tethered Ring-Closing Metathesis (RCM) Reactions 
(1S,4S,Z)-1,4-diphenylbut-2-ene-1,4-diol (4.45): In a N2-filled glove box, an oven-dried 
8 mL vial equipped with a magnetic stir bar was charged with (S)-1-phenyl-2-propen-1-ol 
(26 μL, 0.200 mmol), 4.42 (17.6  mg, 0.100 mmol) and 50 μL of toluene. The resulting 
solution was allowed to stir for 30 min at 22 °C, after which the volatiles were removed in 
vacuo (2 torr, 5 min). The resulting colorless oil was treated with a solution of Mo-2 (0.1 
M in benzene, 50 L, 5.0 mol) and 150 μL of toluene. The reaction solution was allowed 
to stir for 2 h under vacuum (30 torr) at 22 °C, after which pinacol (12.0 mg, 0.101 mmol) 
and 200 μL of Et2O was added. The resulting cloudy solution was allowed to stir for 1 h 
at22 °C, after which the volatiles were removed in vacuo. Analysis of the unpurified 
mixture revealed 76% consumption of (S)-1-phenyl-2-propen-1-ol. The resulting orange 
oil was purified by silica gel chromatography (20% EtOAC in hexanes) to afford 4.45 (17.8 
mg, 0.0741 mmol, 74% yield) in >98:2 Z:E ratio as clear colorless oil. The spectral data 
for this compound is consistent with those previously reported.46 
(S,Z)-3-methyl-1-phenylbut-2-ene-1,4-diol (4.49): In a N2-filled glove box, an oven-
dried 8 mL vial equipped with a magnetic stir bar was charged with (S)-1-phenyl-2-propen-
1-ol (13 μL, 0.100 mmol), 4.42 (17.6  mg, 0.100 mmol) and 200 μL of toluene. The 
resulting solution was allowed to stir for 1 h at 22 °C then 2-methyl-2-propen-1-ol (8.4 μL, 
                                                 
(46) Grigorjeva, L.; Kinens, A.; Jirgensons, A. J. Org. Chem. 2015, 80, 920–927. 
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0.100 mmol) was added. The resulting solution was allowed to stir for another hour at 22 
°C, after which the volatiles were removed in vacuo (2 torr, 5 min). The resulting colorless 
oil was treated with a solution of Mo-2 (0.1 M in benzene, 50 L, 5.0 mol) and 150 μL 
of toluene. The reaction solution was allowed to stir for 3 h under vacuum (100 torr) at 22 
°C, after which pinacol (12.0 mg, 0.101 mmol) and 200 μL of Et2O was added. The 
resulting cloudy solution was allowed to stir for 1 h at22 °C, after which the volatiles were 
removed in vacuo. Analysis of the unpurified mixture revealed 97% consumption of (S)-
1-phenyl-2-propen-1-ol. The resulting orange oil was purified by silica gel 
chromatography (50% EtOAC in hexanes) to afford 4.49 (6.0 mg, 0.0337 mmol, 34% 
yield) in >98:2 Z:E ratio as clear colorless oil. The spectral data for this compound is 
consistent with those previously reported.47 
4.6.3. NMR Spectra 
 
 
 
 
 
 
                                                 
(47) Alonso, D. A.; Nájera, C.; Sansano, J. M. Tetrahedron 1994, 50, 6603−6620. 
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1H NMR of 4.16
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13C NMR of 4.16
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19F NMR of 4.16
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1H NMR of 4.19
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13C NMR of 4.19
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1H NMR of 4.22 
 
Page 381 
13C NMR of 4.22
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1H NMR of 4.36
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13C NMR of 4.36
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1H NMR of 4.45
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1H NMR of 4.49
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